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Abstract
The design and development of new chemical reactions is crucial to the ongoing
success of organic synthesis research. In this work the scope and utility of a re-
cently discovered regioselective palladium-catalysed allylic alkylation (Pd-AA) cas-
cade was explored through increasing the range of non-symmetric pyran-based bis-
electrophiles and β-dicarbonyl bis-nucleophiles that can be used in this reaction.
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Four differentially protected tri-substituted dihydropyrans based on glucose were
synthesised, including 2,3-unsaturated silyl glycosides and α,β-unsaturated lactones.
These substrates were assessed as bis-electrophiles in the Pd-AA cascade. One silyl
glycoside bis-electrophile, possessing a carbonate leaving group, was shown to be an
excellent substrate for reaction with a number of cyclic bis-nucleophiles. Further-
more, a series of regioisomeric methylated 4-hydroxycoumarins were synthesised,
tested and found to be equally effective as bis-nucleophiles in the Pd-AA cascade
with both acyclic and cyclic bis-electrophiles.
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Advances made during this research include a novel Ferrier reaction with silanol
nucleophiles, which was found to produce silyl glycosides, albeit in low yields. Ad-
ditionally, several Perlin aldehydes were generated by the Ferrier-type hydrolysis of
3,4,6-tri-O-acetyl-d-glucal and led to the discovery of discrepant structural assign-
ments in the literature. Furthermore, a 13C NMR shielding template was generated
as a tool for the stereochemical assignment of tri-substituted dihydropyrans.
An extended variant of the Pd-AA cascade was achieved by employment of the bis-
nucleophile Meldrum’s acid with the optimal tri-substituted bis-electrophile in the
presence of H2O. The reaction afforded a γ-butyrolactone that could serve as a
potential intermediate en route to the synthesis of the biologically interesting com-
ii
pounds thromboxanes A2 and B2. This extended Pd-AA cascade, although currently
unoptimised, is capable of performing five synthetic transformations in one-pot and
holds the potential to improve on the current syntheses of the thromboxanes.
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Chapter 1
Introduction
1.1 Palladium in Organic Synthesis
1.1.1 Introduction
Discovered by Wollaston in 1803 and named after the asteroid Pallas, palladium is
a remarkable metal and has become one of the most useful tools in organic syn-
thesis.1 Since palladium is an expensive noble metal, its derivatives have mainly
been employed as catalysts. Invention of the Wacker process in 1959 and its sub-
sequent development represent one of the most important milestones in the history
of organopalladium chemistry. The catalytic reduction or alkenes (Scheme 1.1) and
Wacker oxidation of ethene (Scheme 1.2) demonstrated that palladium and its com-
pounds can serve as catalysts for both oxidation and reduction.2
C C
H2, cat. Pd 
(heterogeneous)
HC CH
1 2
Scheme 1.1 Catalytic hydrogenation of alkenes with palladium
H2C CH2
PdCl2 (cat.)
CuCl2 (cat.), O2, H2O
CH3CHO
3 4
Scheme 1.2 Wacker oxidation of ethene
1
1.1.2 pi-Allyl Palladium Complexes
Palladium has a great affinity for non-polar pi-compounds such as alkenes, alkynes
and even arenes.2 Upon complexation with transition metals, pi-compounds are ren-
dered more reactive toward nucleophilic reagents.
Allyl palladium derivatives readily react with a wide variety of nucleophilic reagents
to undergo nucleophilic substitution reactions, with palladium serving as a leaving
group surrogate. The reaction of butadiene with PdCl2 reported in 1957 most likely
represents the first synthesis of allyl palladium complexes.3 Early investigations of
allyl palladiums mainly dealt with structural features and other purely organometal-
lic aspects and it wasn’t until Tsuji’s work in 1965 that these compounds became
prevalent in organic synthesis.2
1.1.3 The Tsuji-Trost Reaction
Tsuji’s extension of the Wacker process and proposal of its mechanism (nucleophilic
attack of H2O on ethylene complexed with Pd or Pd-complexed ethylene) led to
the discovery of carbon-carbon bond formation between pi-allylpalladium chloride
(5) and diethyl sodiomalonate (6) to give the allylated malonate (7).4 This reaction
remained stoichiometric in palladium for a few years whereupon its catalytic version
was discovered and subsequently extensively developed by Tsuji,5 Trost,6 and many
others (Scheme 1.3). This reaction is now widely referred to as the Tsuji-Trost reac-
tion and has become one of the most widely investigated areas of organopalladium
chemistry.2
X Pd(II)LnX Nu Pd(0)Ln X
Pd(0)Ln Nu
Pd
Cl
2
1/2 NaCH(COOEt)2 DMSO CH(COOEt)2 Pd NaCl
5 6 7
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Scheme 1.3 Development of the Tsuji-Trost reaction
Oxidative addition of allyl electrophiles to Pd has been shown to proceed with inver-
sion.7 This process is thought to involve pi-complexation followed by intramolecular
nucleophilic displacement of a leaving group by palladium with inversion. It is
2
now understood that there are two general mechanistic classes within Tsuji-Trost
reactions and these are distinguished by the nature of the nucleophile.8 “Hard” nu-
cleophiles, defined as those derived from conjugate acids with pKa > 25, involve
attack at Pd which is followed by reductive elimination to provide allylic substi-
tution with overall inversion.9 On the other hand, “soft” nucleophiles, defined as
those derived from conjugate acids with pKa < 25, normally attack directly at the
pi-allyl ligands proceeding via inversion at the site of substitution and leading to
substitution of allylic electrophiles with overall retention (Scheme 1.4).6
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Scheme 1.4 Asymmetric induction in Tsuji-Trost reactions with the use of soft
and hard nucleophiles
1.1.4 Asymmetric Allylic Alkylation Reactions
Transition metal-catalysed asymmetric allylic alkylation (AAA) reactions (Scheme 1.5)
are enantioselective extensions of the Tsuji-Trost reaction and are unique and ver-
satile for several reasons. The presence of a carbon-carbon double bond in the
overall product is very advantageous to total synthesis as it provides great potential
for further functionalisation.10 These reactions also have numerous modes of enan-
tiodiscrimination, which compares to most asymmetric reactions where there is only
one. In AAA reactions both the electrophile and nucleophile may be prochiral in
3
which case the stereochemistry of positions resulting from either or both substrates
can be controlled. Furthermore, AAA reactions have the potential to form many
different types of bonds with the same catalyst. The electrophile is always an allylic
carbon; however the nucleophilic centre may be H, N, O, S, C, etc., thereby provid-
ing access to C-H, C-N, C-O, C-S, C-C bonds from the same reaction type. Finally,
the reaction may be altered to undergo net inversion or net retention mechanisms by
changing the metal centre of the catalyst. While palladium involves a net retention
via a double inversion path with “soft” nucleophiles and a net inversion path with
“hard” nucleophiles (vide supra), many other metals have been found to catalyse
allylic alkylation, e.g. Rh, Ru, Ir, Mo, W and Cu, by different mechanisms and with
alternative stereochemical consequences.
R'R
n
∗ R'R
n
∗ R'R
n
LG
[M] / L*
Nu
Nu Nu
18 19 20
M = Pd, Rh, Ir, Mo etc.
L* = chiral ligands
Scheme 1.5 Transition metal catalysed asymmetric allylic alkylation reaction
The first example of enantioselective palladium-catalysed allylic substitution with
a stabilised nucleophile was reported in 1977.11 When the racemic mixture 21 was
treated with the sodium salt of methyl phenylsulfonylacetate in the presence of a
palladium catalyst composed of Pd(PPh3)4 and chiral ligand (+)-DIOP, alkylation
product 22 was produced in a 77% yield and desulfonylation of this product afforded
23 with 24% ee (Scheme 1.6). Since this achievement, a vast amount of work has
been carried out to exploit the asymmetric capability of allylic alkylations.8,12
CO2Me
OAc Pd(II)L*
CO2Me
H
Nu CO2Me
PhO2S CO2Me
CO2Me
CO2Me
i
77%
ii
21 22 23
Reagents and Conditions: i) NaCH(SO2Ph)CO2Me, Pd(PPh3)4, (+)-DIOP; ii) 6% Na(Hg),
Na2HPO4, MeOH.
Scheme 1.6 Enantioselective palladium-catalysed allylic substitution with a sta-
bilised nucleophile
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1.2 Allylic Alkylation Cascades
1.2.1 Cascade Reactions
In recent years, examination of biosynthesis as a means to guide synthetic strat-
egy (a.k.a. biomimetic synthesis) has led to the use of cascade reactions.13 Nature’s
synthetic transformations typically avoid protecting groups and many are cascade re-
action sequences. Cascade (also known as domino, tandem, or sequential) reactions
have been defined to be chemical processes in which at least two chemical reactions
take place in a single operation without a change in the reaction conditions and
where the latter transformations take place at the functionalities produces by the
former bond forming reactions.14,15 The benefits of cascade reactions are undeniable
and include atom economy, alongside economies of time, labour, resource and waste
management.16 Additionally they are often accompanied by high levels of stereose-
lectivity.13 Therefore, these impressive reactions can be considered a stepping stone
on the path to “green chemistry” because the savings involved when several trans-
formations are carried out in one synthetic operation can be significant.17 These can
include reducing several individual steps to a single process, with only one solvent
system, workup procedure and purification.
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Scheme 1.7 Robinson’s one pot synthesis of tropinone (32)
Cascade reactions not only improve the practical efficiency of a synthetic scheme
but also enhance the aesthetic appeal of a proposed synthetic route by enabling the
generation of complex molecules in a concise fashion. It is not surprising then that
cascade reactions, whether intentionally or otherwise, have attracted the attention
of organic chemists since the early days of total synthesis. Robinson’s 1917 one pot
synthesis of tropinone18 (32) set the groundwork for the field of cascade reactions
5
(Scheme 1.7).17 His elegant synthesis constructs tropinone from succindialdehyde
(24), methylamine (25), and either acetone or its dicarboxylic acid derivative (26),
through the consecutive action of both an intermolecular and intramolecular Man-
nich reaction, followed by double decarboxylation.
1.2.2 Palladium-Catalysed Allylic Alkylation (Pd-AA) Cas-
cades
Palladium catalysts have proven to be reliable tools in a variety of cascade reactions.
A generic Pd-AA cascade is one where an allyl bis-electrophile (33) is employed
alongside a bis-nucleophile (34) in the presence of a Pd(0) species. As shown below,
these annulation reactions can afford an array of vinyl substituted ring systems (35)
(Scheme 1.8).
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Scheme 1.8 General Pd-AA cascade
The problem with these reactions is in differentiating the two nucleophilic and elec-
trophilic centres in order to gain regiochemical control. Figure 1.1 demonstrates the
large number of regiochemical possibilities that can occur in the initial step alone of
a Pd-AA cascade. In theory, either nucleophilic centre may attack one of two allylic
systems at either terminus. The number of possibilities is further compounded by
the second addition. Typically, this challenge is overcome by employment of sym-
metric bis-electrophiles or bis-nucleophiles, thereby reducing the number of product
possibilities. However, this solution will not be appropriate for many synthetic tar-
gets.
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Figure 1.1 Regiochemical possibilities for the initial addition step of a Pd-AA
cascade
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1.2.3 Development of Pd-AA Cascades of Acyclic and Cyclic
Bis-Electrophiles
During the course of research by a recently completed Ph.D. scholar in this group, Dr
Mark Bartlett, into furanopyrone based natural products, a novel Pd-AA cascade
was discovered. An initial model system involving 4-hydroxy-6-methyl-α-pyrone
(39) and bis allyl carbonate (40) afforded vinyl-substituted furopyrone 41 in an
84% yield (Scheme 1.9).19
O
O
OH
OCO2Me
OCO2Me
O
O
O
i
84%
39 40 41
Reagents and Conditions: i) Pd2(dba)3, PPh3, MeCN, NEt3, 1 h, rt.
Scheme 1.9 Acyclic Pd-AA cascade
Further development of Pd-AA cascades on cyclic electrophiles led to the discov-
ery that non-symmetric pyran substrates (cis-42 or trans-42) can serve as effective
bis-electrophiles with a variety of cyclic β-dicarbonyl nucleophiles (43) to provide
a high degree of regio- and diastereoselectivity (Scheme 1.10). The combination of
allylic carbonate and anomeric siloxy leaving groups provides control of the many
possible regiochemical outcomes due to their differing capabilities as leaving groups.
The anomeric siloxy group has a relatively low reactivity and both sterics and elec-
tronics lead to preferential ionisation of the allylic carbonate group. Furthermore,
the presence of two inductively electron-withdrawing oxygen atoms at C-1 of the
dihydropyran disfavours cationic character at the adjacent C-2. This has been pro-
posed to cause an increase in the cationic character of C-4 in the initial pi-allyl
Pd intermediate, resulting in the preferential alkylation of C-4 over C-2.20 Interest-
ingly, it was also observed that the annulation proceeds stereoconvergently to give
a cis-fused furopyran (44) irrespective of whether the starting material is cis- or
trans-substituted.21
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To investigate the scope of this method, a variety of cyclic β-dicarbonyl compounds
were explored and found to be effective in the cascades (Scheme 1.10). Of particular
note was the use of Meldrum’s acid (52) which provided a γ-butyrolactone (53) via
acetone extrusion/acyl ketene trapping sequence (Scheme 1.11). The product struc-
ture (53) has the potential to serve as a synthetic intermediate for the synthesis of
natural products (vide infra).21
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Scheme 1.11 Pd-AA cascade of a dihydropyran with Meldrum’s acid
1.3 Prostaglandins
1.3.1 Discovery of Prostaglandins
In the 1930s von Euler and Goldblatt independently discovered that lipid fractions
isolated from both the genital glands and human semen exhibited vasodepressor
and smooth muscle stimulating activity. The substances found to be responsible
for this activity were provisionally termed “prostaglandins” due to the belief that
they were produced in the prostate gland. In actual fact, it has been shown that
prostaglandins (PGs) are, in general, produced from arachidonic acid (56) close to
the site where they are to exert a tissue-specific effect, whereupon they are rapidly
metabolised to less active materials.22
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Scheme 1.12 Biosynthesis of the thromboxanes (59, 60) and prostacyclin (58)
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1.3.2 Structure Elucidation
The sequence of events by which arachidonic acid (56) is converted to PGG2 (57)
and from there to primary and secondary prostaglandins, their metabolites and
other substances (Scheme 1.12) was elucidated and explored in depth in the mid-
dle of the twentieth century. It wasn’t until 1960, when Bergstrom et al. isolated
crystalline prostaglandin compounds, that the general structure of PGs was eluci-
dated (Figure 1.2). Bergstrom’s group discovered not only that prostaglandins are
unsaturated, hydroxylated fatty acids with 20-carbon skeletons that always contain
a 5-membered ring, but also demonstrated that these compounds were biosynthe-
sised from polyunsaturated fatty acids e.g. arachidonic acid (56). Further work
completed in this area by Samuelsson’s group led to the discovery that the exocyclic
oxygen atoms originated from the same molecule of oxygen and therefore a likely
intermediate is an endoperoxide.22
COOH
HO
R2
R1
61
R1 = O or α-OH, H
R2 = O or α-OH, H
Figure 1.2 Structure of the prostaglandins
In 1973, Samuelsson isolated two endoperoxide containing prostaglandins; PGG2
(57) and PGH2 (62) (Figure 1.3), proving the earlier hypothesis. In contrast to the
previously discovered prostaglandins, the endoperoxides have a short half-life, ca. 5
minutes, in biological systems.22
HOO
COOH
O
O
HO
COOH
O
O
57 62
Figure 1.3 Prostaglandin endoperoxides
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1.3.3 Bioactivity of Prostaglandins
Since their discovery, it has been found that PGs contribute to a multitude of biologi-
cal processes exhibiting a broad spectrum of activity and have therefore found a num-
ber of clinical uses. These include, but are not limited to, regulation of gastric acid
secretion, promotion of the healing of peptic ulcers, regulation of ovarian function,
induction of labour, termination of pregnancy, and treatment of asthma, inflam-
mation and shock. PGs have also been examined as pro- and anti-inflammatories
as, for example, overproduction of PGs in tissue is a main cause of rheumatoid
arthritis, and treatment is based around inhibition of natural PG biosynthesis. As-
pirin is known to reduce inflammation and alleviate pain by interfering with PG
biosynthesis.22
1.4 Thromboxanes
1.4.1 Discovery of Thromboxanes
From the work carried out by Hamberg, Svensson and Samuelsson in 1974-1975,
it was discovered that endoperoxide PGG2 (57) is a precursor not only to the
prostaglandins and prostacyclin PGI2, (58) but also to another biologically interest-
ing family of oxygenated heterocycles known as the thromboxanes.23,24 Of particular
note is the short-lived but extremely potent substance thromboxane A2 (TXA2) (59)
(Scheme 1.12).25,26
1.4.2 Thromboxane A2
TXA2 (59) is a prostanoid signalling molecule generated by blood platelets and is
known to have the opposite biological effect to PGI2 (58). These two molecules
are produced in the body to set up a delicate equilibrium: PGI2 prevents platelets
from aggregating and adhering to blood vessel walls and therefore causes smooth
muscles (in particular, blood vessels) to relax, whereas TXA2 induces platelets to
clump, aggregate and adhere to blood vessels, causing the vessels to contract. TXA2
therefore appears to be an important factor in blood clotting (thrombosis).25,27
However, it has a half-life of only 30 seconds in aqueous solutions, in which the
strained oxetane ring is rapidly hydrolysed, converting TXA2 to thromboxane B2
(TXB2) (60).28,29
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1.4.3 Thromboxane B2
Unlike its precursor, TXB2 is biologically inert as a platelet-aggregating agent. How-
ever, it has been demonstrated that TXB2 can be converted to the biologically active
TXA2 (see Section 1.4.10).30,31 Therefore TXB2 is recognized as a valuable substance
for study of a variety of biochemical processes which will aid in research aimed at
reducing fatalities in patients at risk of thrombosis and heart attack.27
HO
COOH
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OH
HO
60
Figure 1.4 Thromboxane B2
1.4.4 First Total Synthesis of Thromboxane B2
The first total synthesis of TXB2 was completed by Nelson and Jackson in 1976
whilst part of the then Upjohn Company (Scheme 1.13). The synthesis began with
the benzoylated Corey aldehyde (63), a known and commercially available PG inter-
mediate that was pioneered by Corey in his landmark syntheses of prostaglandins
F2α and E2.32,33 Upon treatment with Florisil® (an activated magnesium silicate
gel), an α, β-unsaturated aldehyde (64) was obtained. After reduction of the alde-
hyde and protection of the resulting alcohol, dihydroxylation with osmium tetrox-
ide produced a diol (65), which was then subsequently cleaved with paraperiodic
acid, opening the cyclopentyl ring and leading to the unstable keto-aldehyde (66),
which was immediately reduced with NaBH4 and silylated. Selective deprotection
of the primary TMS ether of 67, followed by Collins oxidation afforded aldehyde
68. Treatment with methanolic HCl afforded cyclic methyl acetal 69, which was
then deprotected to afford primary alcohol 70. Primary alcohol oxidation allowed
a Horner-Wadsworth-Emmons reaction to attach the first side chain, and reduction
followed by a Wittig reaction afforded attachment of the second side-chain, finishing
with hydrolysis to produce TXB2 in less than 1% overall yield in 15 steps.25
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Scheme 1.13 First total synthesis of TXB2 by the Upjohn Company
15
1.4.5 Syntheses of TXB2 from Corey Prostanoid Intermedi-
ates
Since the first total synthesis there have been a number of reported syntheses of
TXB2. The Upjohn group developed another synthesis (Scheme 1.14) shortly after
their original, which also started from another known Corey prostanoid intermediate
(79), which allowed smoother formation of the 6-membered cyclic core of thrombox-
ane. Jones’ oxidation followed by a Baeyer-Villiger reaction withm-chloroperbenzoic
acid gave a dilactone (80), which, when treated with a tertiary amine, led to the
ring opened elimination product (81). Reduction of the remaining lactone with
diisobutylaluminium hydride (DIBALH), esterification with diazomethane, followed
by dissolution in methanolic HCl and addition of trimethyl orthoformate, afforded
the cyclic methyl acetal (82). Saponification followed by iodolactonisation, reduc-
tive removal of the iodine from the intermediate iodolactone with tri-n-butyltin
hydride and finally hydrogenation, afforded the deprotected γ-lactone intermediate
(70) which could then be converted to TXB2 using the known procedure. This
method decreased the number of reaction steps to the intermediate from 9 to 7,
mildly improving the efficiency of the synthetic route to TXB2.22,34
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Reagents and Conditions: i) 1. Jones [O], 2. mCPBA; ii) tertiary amine e.g. 1,5-diazabicyclo
undec-5-ene; iii) 1. DIBALH, 2. CH2N2, 3. MeOH / H+ / HC(OMe)3; iv) 1. NaOH, 2. CO2, 3.
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Scheme 1.14 1976 formal total synthesis of TXB2 by The Upjohn Company
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1.4.6 Syntheses of TXB2 from Carbohydrates
The Corey group produced a formal synthetic route to TXB2 by utilising sugar chem-
istry (Scheme 1.15). Their simple and stereocontrolled route began with the optically
active sugar precursor methyl α-d-glucoside (85) that was converted in a highly effi-
cient manner, by a known procedure, to the unsaturated derivative (86). Claisen re-
arrangement, induced through heating with excessN,N -dimethylacetamide dimethy-
laminal in diglyme, resulted in stereospecific formation of the dimethyl amide (87).
Treatment with iodine under hydrolytic conditions afforded the iodolactone, which
could then be deiodinated with tributyltin hydride to produce the hydroxylactone
(70) in high yield and only 5 steps.35
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75%
ii
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Reagents and Conditions: i) N,N -dimethylacetamide dimethylaminal, diglyme;
ii) I2, THF:H2O, 2. Bu3SnH.
Scheme 1.15 1977 synthesis of the thromboxane intermediate (70) from a sugar
derivative
In 1977, Hanessian’s group achieved a total synthesis of TXB2 from the readily acces-
sible d-glucose derivative methyl 4,6-O-benzylidene-2-deoxy-α-d-ribohexopyranoside
(88) that exploited the compound’s functionality and stereochemistry (Scheme 1.16).
Hydrogenolysis, selective silylation of the primary alcohol and Pfitzner-Moffatt ox-
idation of the secondary alcohol followed by Horner-Wadsworth-Emmons conden-
sation with the anion derived from trimethylphosphonoacetate and potassium tert-
butoxide afforded a mixture of E/Z alkene isomers (89) in high overall yield. The
mixture was then subjected to hydrogenation to remove the double bond, followed
by debenzoylation to produce the γ-lactone (90). The remaining pathway to TXB2
followed the known methodology for attachment of side-chains25 resulting in a 12-
step synthesis with a greatly improved overall yield of around 15%.36
Alongside their other synthesis, the Corey group also developed a synthesis of TXB2
in a racemic form in 12 steps with an overall yield of less than 10% which will
not be commented on further.26 In 1980, the work of Kelly and Roberts resulted
in a synthesis of the bicyclic γ-lactone intermediate (70) of TXB2 (Scheme 1.17).
Starting with laevoglucosan (97), a cheap and readily available sugar derivative,
allylation of an easily formed epoxide37 (98) with a Grignard reagent afforded the
TXB2 intermediate (70) in six steps with an overall yield of around 20%.38
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Scheme 1.16 1977 synthesis of TXB2 by Hanessian et al.
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Scheme 1.17 1980 synthesis of the TXB2 intermediate (70) from laevoglucosan
(97)
1.4.7 Palladium-Assisted Synthesis of TXB2
Research into the total synthesis of TXB2 then slowed down quite significantly until
1989 when the Verdoorn group in South Africa significantly enhanced the efficiency
of the synthesis by developing a short, facile route to the bicyclic γ-lactone inter-
mediate (70) of TXB2 (Scheme 1.18). Starting with tri-O-acetyl-d-glucal (102), a
Ferrier rearrangement with isopropanol using catalytic Pd(MeCN)Cl2 afforded the
corresponding 2,3-unsaturated sugar derivative (103). Reacting the sugar with Mel-
drum’s acid in the presence of catalytic Pd(PPh3)4 led to an unexpected cascade of
reactions affording the protected unsaturated bicyclic γ-lactone (104). Introduction
of the methoxy group at the C-1 position was achieved in high yield through bromi-
nation in methanol to afford 105 which was reductively debrominated affording the
saturated furopyran (106) in an essentially quantitative yield. Through subsequent
selective removal of the ester groups followed by decarboxylation, the desired bi-
cyclic γ-lactone intermediate (70) was obtained in an overall yield of 48% in six
steps.39
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Scheme 1.18 1989 palladium-assisted synthesis of the thromboxane intermediate
(70)
1.4.8 Recent Synthetic Routes to TXB2
Since Verdoon’s efficient synthesis, there have been a few elaborations on the total
synthesis of TXB2. One particular synthesis, reported in 1996,40 involves a 22-
step sequence and poor overall yield, employing (R,R)-tartaric acid as a chiral pool
reagent. The synthesis provides a means to overcome the longstanding problem of
establishing the chemistry of the C-15 hydroxyl group through employment of the
Uchimoto method to introduce the trans-alkene bond of the C-5 side-chain, followed
by palladium-catalysed allylic transposition of the acetate (Scheme 1.19).
Marvin and Burke carried out the most recent (2007) synthetic work on TXB2.
Their synthetic strategy involved an interesting ketalisation/ring-closing metathesis
step (Scheme 1.20) to rapidly assemble the bicyclic acetal scaffold 114, followed by
functionalisation including employment of the Uchimoto/Pd catalysed allylic trans-
position methodology discussed above. However, this lengthy synthesis afforded
TXB2 in 16 steps from a C 2-symmetric diene diol with an overall yield of only
5%.28
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Scheme 1.19 Side-chain attachment method used in the 1996 synthesis of TXB2
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Scheme 1.20 Key transformation of Marvin and Burke’s 2007 synthesis of TXB2
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1.4.9 Summary of the Existing Total Syntheses of Throm-
boxane B2
The use of Corey’s lactone derivatives (e.g. 63 or 79) provided a cornerstone for
early syntheses of TXB2, however it requires lengthy ring-opening and ring-closing
sequences to convert the cyclopentane to a 6-membered ring. Examination of the
structure of TXB2 shows the presence of a 6-membered lactol and can be considered
as a 2,4,6-trideoxy-d-ribo-hexopyranose in which positions 4 and 6 are the sites of
C -branching and chain extension respectively.36 Therefore it seems reasonable that
the synthesis of this molecule should begin with a simple sugar or sugar derivative.
This rationale is emphasised through the advances made in the synthetic efficiency
of approaches to TXB2 when carbohydrate based starting materials were employed
(e.g. 85, 91, 97, 102). These compounds obviate the need to build up the cyclic
motif and, when the sugar moiety is chosen correctly, provide the stereochemistry
required for TXB2.
The combination of carbohydrate-based chemistry and palladium catalysis afforded
impressive results in Verdoorn’s formal synthesis of TXB2, which currently is the
most efficient route to the TXB2 intermediate (70). The methodology for attach-
ment of the side-chains remains largely unchanged from the original prostaglandin
procedure despite the issue of C-15 epimerisation. This was varied in 1996 with the
successful demonstration of Pd-catalysed allylic transposition by Masaki et al., and
has since been the method of choice for the final stage of TXB2 synthesis.
1.4.10 Total Synthesis of TXA2
In 1985 Bhagwat et al. reported the first and, thus far, only synthesis of TXA2
(59).30,31 Their first attempt (Scheme 1.21) began with TXB2 (60) which was es-
terified, peracetylated and selectively deacetylated at the more reactive anomeric
centre to afford 121. Dehydration to the unstable enol ether (122), deacetyla-
tion and immediate bromohydrin formation led to the 10-bromo-TXB2 methyl ester
(123). It was found that Mitsunobu cyclisation provided the oxetane ring in a low
yield. Radical initiation however did not produce the desired debromination due
to an interception of the intermediate C-10 free radical with the C-13, C-14 double
bond.
To overcome this problem, the allylic alcohol side-chain was anchored to the ester
side-chain by formation of the 1,15-macrolactone (129), thereby inducing confor-
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Scheme 1.21 Attempted synthesis of TXA2 by Bhagwat et al. (1985)
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mational restriction of the approach of the intermediate C-10 radical. Thus, TXB2
was converted to the 1,15-macrolide using the Corey-Nicolaou procedure via the
thiopyridyl ester. Dehydration at C-11 proceeded smoothly with the Mukaiyama
reagent 2-chloro-1-methylpyridinium iodide, and immediate bromohydrin formation
provided 10-bromo-1,15-anhydro-TXB2 (130). Modified Mitsunobu etherification
then provided the 10-bromo-TXA2 derivative (131). A mild free-radical reduc-
tion with tributyltin hydride yielded the desired 1,15-anhydro-TXA2 (132), which
was then saponified, without loss of the bicyclic oxetane, and, upon dissolution in
MeOH/H2O in the presence of NaOH, produced the sodium salt of TXA2 (59).
Likewise, 132 may also be opened in THF or Et2O with Me3SiOK to yield the
potassium salt (Scheme 1.22).
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Scheme 1.22 Second generation route to TXA2 by Bhagwat et al. (1985)
Whilst 132 is biologically inactive, the saponification reaction mixture displayed
notable activity and reproduced the activities of natural platelet-derived TXA2 in
a variety of assays. Therefore it can be concluded that the sodium and potassium
salts of synthetic TXA2 are indistinguishable from natural TXA2. Bhagwat et al.
also noted that while TXA2 is rapidly hydrolysed to TXB2 in aqueous, high salt,
neutral buffers, its stability is significantly enhanced at high pH. It was also found
that the TXA2 salts were able to be stored for more than a week if kept at −20 ◦C
either as isolated solids or in basic methanol or THF solutions.30,31
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1.5 Research Objectives
The research objectives of this project were two-fold. The first was to explore and
expand the scope of Bartlett and Harvey’s Pd-AA cascade reactions with dihy-
dropyran substrates, and the second to improve on the current total syntheses of
the thromboxanes through employing such reactions with Meldrum’s acid, in a man-
ner similar to Verdoorn, while developing synthetic efficiencies to achieve shorter 8-
and 9-step syntheses of both TXA2 and TXB2, respectively.
1.5.1 Further Development of the Pd-AA Cascade
The first focus, to expand the scope of the Pd-AA cascade, was to be approached
from two angles, namely the synthesis and testing of both new bis-electrophiles
and new bis-nucleophiles. A variety of tri-substituted carbohydrate derived bis-
electrophiles (Scheme 1.23) were targeted to extend the scope from Bartlett’s di-
substituted dihydropyrans. Furthermore, if these compounds were capable of un-
dergoing the Pd-AA cascade efficiently, they would provide useful products due to
the presence of a synthetic handle, capable of functionalisation, carried through from
the C-5 substituent of the carbohydrate starting material.
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LG = OAc or OCO2Me
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Scheme 1.23 Planned bis-electrophiles and their corresponding Pd-AA cascade
products
Two classes of compounds were selected for evaluation as bis-electrophiles: 2,3-
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unsaturated glucosyl derivatives (134) and α,β-unsaturated lactones (135) (Scheme
1.23). Acetate and carbonate leaving groups at C-4 were considered due to the re-
ported success of both in related cascades by Verdoorn and Bartlett, respectively.
The choice of C-6 protecting group had more flexibility as it was assumed to not take
part in the cascade and was left to be decided during synthesis. α,β-Unsaturated
lactones were considered as starting materials for the Pd-AA cascades in order to
investigate the potential of these alternative bis-electrophiles. Their increased pla-
narity, when compared to the acetal derivatives, could aid in the initial pi-allyl-Pd
formation and then, after the initial alkylation at C-4, it was proposed that the
cascade might be completed by Michael addition of the second centre of the bis-
nucleophile to C-3. This would enhance the scope of the Pd-AA cascades by ex-
panding both the type of bis-electrophile that can be used and also the type of
product capable of being formed.
4-Hydroxycoumarins were found to be successful as bis-nucleophiles in Bartlett’s
scope studies, however only two examples had been tested (see Scheme 1.10, page 9).
Therefore, the synthesis and testing of methylated 4-hydroxycoumarin regioisomers
(Figure 1.5) was seen as an easy way to probe the effect the position of substitution
has upon reactivity in Pd-AA cascades.
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Figure 1.5 Planned bis-nucleophiles for Pd-AA cascade scope studies
1.5.2 Towards an Improved Synthesis of TXA2 and TXB2
The second focus of this research was to employ the Pd-AA cascade to improve on
the current syntheses of the thromboxanes. Using the most successful carbohydrate-
derived bis-electrophile developed during the scope studies outlined in Section 1.5.1,
an extended Pd-AA cascade with Meldrum’s acid would incorporate a carboxylic
acid from nucleophilic attack of the Meldrum’s acid-derived ketene (142) with water.
This functionality could be removed via in situ thermal decarboxylation to afford
the bicyclic scaffold, of e.g. 70, generated in several of the previous syntheses of
thromboxanes (Scheme 1.24). Developing this multistep process into an efficient
transformation would improve significantly upon Verdoorn’s Pd-catalysed route. If
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this endeavour was successful, a synthetic route towards both thromboxanes, via
TXA2, was planned to be worked on during the final stages of this project.
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Scheme 1.24 Planned extension of the Pd-AA cascade with Meldrum’s acid
The full synthetic plan (Scheme 1.25) towards the thromboxanes proposed exploita-
tion of the extended Pd-AA cascade chemistry with Meldrum’s acid, to produce the
fused bicyclic core of a thromboxane intermediate (145) in one step. Optimisation
of the traditional methods for side-chain attachment, namely Horner-Wadsworth-
Emmons (HWE) Wittig reactions, and asymmetric ketone reduction, would then
lead to a hydroxy-substituted dihydropyran (146). Lewis acid-promoted oxetane
formation would produce TXA2, followed by hydrolysis to afford TXB2. The novel
aspects of this proposed synthetic route to the thromboxanes are not only the ex-
tended Pd-AA cascade, but also retaining the glycal moiety throughout the process
of side-chain attachment and the biomimetic approach to formation of TXA2 prior
to formation of TXB2.
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Chapter 2
Results and Discussion
2.1 Synthesis of Bis-Electrophiles
The Pd-AA cascade in the proposed synthetic plan (Scheme 1.25) required a trisub-
stituted dihydropyran as the bis-electrophile. Although based on the disubstituted
pyrans employed by Bartlett, the design of the bis-electrophile remained flexible
with respect to the choice of leaving group (LG) at C-4 and protecting group (P) at
C-6 (Figure 2.1). Both acetates and carbonates were considered as potential leaving
groups due to their success in Pd-AA cascades with Meldrum’s acid as demonstrated
by both Verdoorn39 and Bartlett,19 respectively. C-6 could either be differentially
protected, for example as a silyl ether (viz 151 and 152) or was selected to mimic
the choice of C-4 leaving group, when applicable, in order to facilitate the synthesis
(Figure 2.1).
O
4
LG
OTBS6
OP
151: LG = OAc, OP = OTBS
152: LG = OCO2Me, OP = OTBS
153: LG = OP = OAc
154: LG = OP = OCO2Me
Figure 2.1 Design of tri-substituted dihydropyran bis-electrophiles
A flexible approach to starting material design was beneficial to this project in two
ways. In developing more than one bis-electrophile to test, the scope and limitations
of the Pd-AA cascade could be explored and the potential for optimisation in the
current synthesis of the thromboxane intermediate core is increased. A variety of
synthetic pathways were explored to achieve the synthesis of these bis-electrophiles.
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2.1.1 Achmatowicz Route to Acetate Bis-Electrophile 151
The Achmatowicz rearrangement converts 2-hydroxyalkylfurans to the correspond-
ing dihydropyrans, originally by reaction with Br2/MeOH41 and more recently with
NBS,42 m-CPBA43 or t-BuOOH/VO(acac)2.44 O’Doherty used an Achmatowicz re-
arrangement of furfural derivative 155 with NBS to afford the 2,3-unsaturated sugar
156 en route to 157.42 Interception of this route by TBS protection of hemiacetal
156 could lead to the C-6 OTBS bis-electrophile 151 (see section 2.1.2 page 32).
Starting from d-glucal (158), a synthetic route that merged with O’Doherty’s was
planned (Scheme 2.1). d-Glucal would be converted into the chiral substituted fu-
ran diol 159, a transformation first reported by Gonzalez et al.45 using the toxic
metal salt HgSO4 in concentrated H2SO4. A more recent publication by Babu et
al.46 demonstrated the use of relatively less toxic InCl3.3H2O in acetonitrile for the
same transformation. Employing this reaction as the inaugural step en route to 156
would shorten O’Doherty’s synthesis by two steps (Scheme 2.1).
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Scheme 2.1 Synthetic plan to bis-electrophile 151
d-Glucal was prepared from tri-O-acetyl-d-glucal using NaOMe in methanol, there-
fore methanol was chosen as the initial solvent for screening reaction conditions.
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In contrast to Babu’s use of InCl3.3H2O, anhydrous InCl3 was employed due to its
availability in our lab at the time of investigation. This variation was met with
failure, and even when the solvent was changed to acetonitrile only trace amounts
of the desired product 159 were observed, according to NMR spectroscopy of the
crude reaction mixture. It was then postulated that catalytic amounts of water
seemed necessary for this reaction. However, upon testing this theory (Table 2.1
Entries 3-5) the yield of this reaction remained minimal. Increasing the tempera-
ture of the reaction slightly (Table 2.1 Entries 5-6) was thought to better reflect
the ambient conditions of Babu et al.47 This resulted in a mild increase in yield,
however investigations of other Lewis acids were pursued.
Montmorillonite clay (MK10)48 was shown to successfully promote this reaction
by Yadav et al.,47 however this result was not successfully replicated in this work
(Table 2.1, Entry 7). A publication from 2007 found that FeCl3.6H2O in acetonitrile
at room temperature was capable of producing the furan diol in 82% yield.49 Indeed,
employing FeCl3.6H2O as the Lewis acid afforded a highest yield of 71% but only
when the reaction temperature was increased to reflux and water was added to the
solvent mix. Increasing the catalyst loading resulted in complete degradation of the
carbohydrate material present in the reaction mixture (Table 2.1, Entry 12).
The next synthetic step in this sequence was selective silyl protection of the primary
alcohol of the furan diol. Two attempts at this reaction at both 0 and -78 ◦C pro-
duced a mixture of recovered starting material, mono- and di-protected products,
with the major product in both reaction mixtures being the undesired latter. It
was thought that perhaps TBSOTf was too reactive a silylating agent50 so TBSCl,
as used by O’Doherty, would overcome this problem (see section 2.1.1 page 29).
However, a Darwinian approach to synthesis was employed in this project, and as
another more successful pathway towards a C-4 acetate bis-electrophile (153) was
being investigated concurrently with this one, the Achmatowicz route to the starting
material was abandoned.
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Scheme 2.2 TBS protection of chiral furan diol 159
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Table 2.1 Optimisation of d-glucal (158) to chiral furan diol 159 reaction
O
HO
OH
Reaction
Conditions
OH
O
OH
OH
158 159
Entry Lewis Acida Additives Solvent Temp Time Yield (%)
1 InCl3 - MeOH rt O/N SM
2 InCl3 - MeCN rt O/N Min.
3 InCl3 0.3 eq H2O MeCN rt O/N < 2
4 InCl3
0.3 eq + MeCN rt O/N Min.
4 drops H2O
5 InCl3 0.3 eq H2O MeCN 27 ◦C 2 days 9
6 InCl3 - MeCN 32 ◦C O/N 16
7 MK10b - MeCN 27 ◦C 2 days SM
8 FeCl3.6H2O - MeCN 32 ◦C O/N 21
9 FeCl3.6H2O - MeCN ∆ O/N 20
10 FeCl3.6H2O - MeCN ∆ O/N 33
11 FeCl3.6H2O -
14:1 ∆ O/N 71
MeCN:H2O
12c FeCl3.6H2O - MeCN ∆ O/N Degr.
aLewis acids added as 10 mol% except as otherwise indicated
bMontmorillonite K10 was used in a 300 w/w% loading
c50 mol% FeCl3.6H2O
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2.1.2 Ferrier Approach to Diacetate Protected Bis-Electr-
ophile 153
As discussed in subsection 1.4.9 (page 21), the cyclic core of the thromboxanes
is a 2,4,6-trideoxy-d-ribo-hexopyranose, in which positions 4 and 6 are the sites
of C -branching and chain extension, respectively.36 Since oxygen groups can be
easily functionalised, it seemed reasonable that the synthesis of this molecule should
begin with a simple sugar or sugar derivative. The Ferrier reaction, a.k.a. Ferrier
rearrangement, has been used as an effective means of converting glycals to 2,3-
unsaturated glycosides51 since its conception in 1962.52 This would provide a C-2
deoxygenated species and was thought to provide an ideal approach to diacetate
bis-electrophile 153.
The correct stereochemistry at positions 4 and 5 of the Pd-AA starting material
can be achieved through the use of readily available tri-O-acetyl-d-glucal (102), as
exemplified in the formal thromboxane synthesis of Verdoorn et al.39 The success
of a siloxy anomeric leaving group in the Pd-AA cascade of Bartlett encouraged
employment of a silanol nucleophile in the Ferrier reaction, where Verdoorn used
iso-propanol. Despite the wide scope of the Ferrier reaction,53 silanol nucleophiles
are currently unreported in the literature. Therefore, exploring these nucleophiles
in the Ferrier reaction could lead to a new avenue of research.
Table 2.2 Optimisation of Ferrier reaction of tri-O-acetyl-d-glucal (102) with
TBSOH (164)
O
OAc
OAc
AcO
Si OH
O
OAc
AcO
OTBSReactionConditions O
OAc
AcO
OH OH
OAc
AcO
OO/N
102 164 153 165 166
Entry Lewis Acida Solvent Additives Temp Yield153 165 166
1 CeCl3.7H2O DCM - rt - - -
2 CeCl3.7H2O MeCN - ∆ 5b trace 30
3 CeCl3.7H2O DCM mol sieves ∆ - - -
4 CeCl3.7H2O MeCN mol sieves ∆ - - -
5 InCl3 DCM - rt 4 3 15
6 MK10 DCM mol sieves rt 8 - -
7 MK10 DCM mol sieves 30 ◦C 14 - -
8 MK10 DCM mol sieves ∆ 32 - -
aAll Lewis acids in 10 mol% loading except MK10 which was used in a 300 w/w% loading
bNot identified as desired product until reisolated later in higher yield
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Investigation of the Ferrier reaction with silanols began with the preparation of
tert-butyldimethylsilanol (TBSOH) (164) following a literature method54 that pro-
ceeded without complications. The initial Ferrier reaction conditions (Table 2.2,
Entry 1) were chosen based on work carried out by Yadav et al.55 Their research
demonstrated that tri-O-acetyl-d-glucal could undergo Ferrier reactions efficiently
with a variety of alcohols (although silanols were not included in their examples)
in the presence of catalytic amounts of CeCl3.7H2O to afford the corresponding
2,3-unsaturated glycosides. Ambient conditions led to poor reactivity with TB-
SOH. When a higher temperature was employed, activity increased, however trans-
aldehyde 166 was found to be the major product, characterised by a vicinal 3JH,H
coupling constant of 16.0 Hz for the alkene protons (H-2, H-3) which is indicative of
trans geometry (Table 2.2, Entry 2). This product was assumed to be generated via
heterolytic cleavage of the C-3 acetyl group, a process most likely assisted by Lewis
acid coordination, and subsequent nucleophilic attack by adventitious water at C-1
of the allyloxycarbenium 167. After proton exchange, the α- and β-hemiacetals 165
would be produced (Scheme 2.3). Both anomers could then enter into an equilib-
rium with the open-chain cis-aldehyde 168 which can undergo essentially irreversible
isomerisation to trans-aldehyde 166. This transformation is well-documented in
the literature, including computational studies on the mechanism.56 Interestingly,
Fraser-Reid proposed in 1970, after he too synthesised 166, that the probable pres-
ence of this aldehyde in Emil Fischer’s impure preparation of tri-O-acetyl-d-glucal
(102) led to a positive test for an aldehyde function and, hence, the suffix “al” in
the name glucal.57
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Scheme 2.3 Formation of trans-aldehyde 166 from tri-O-acetyl-d-glucal
Alongside this major product, aldehyde 166, the desired product was isolated in a
5% yield, however the assignment of structure was made difficult by the presence
of two anomers whose H-2 and H-3 signals overlapped in the 1H NMR spectrum.
Specifically, two apparent singlets at 5.88 and 5.79 ppm were actually two pairs of
heavily tenting doublets (Figure 2.2). It was only upon close examination of the 1H
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integration pattern, COSY and HSQC spectra that this product was determined to
have the desired structure. Finally, mass spectrometry of the isolated compound
gave m/z [M+Na]+ = 367.1549 (calc. C16H28O6SiNa = 367.1547), and is consistent
with the assignment of 153.
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Figure 2.2 1H NMR spectrum of cis- and trans-153. Expansion showing pairs of
heavily tenting doublets attributed to H-2 and H-3
To minimise the production of hemiacetals 165 and therefore aldehyde side-products,
it seemed prudent to rigorously exclude water from the reaction and so the mixture
of silanol 164 and Lewis acid was stirred with molecular sieves before addition of
the glycal. By doing so, the reaction no longer produced the undesired products,
however, it was then found to not proceed at all with CeCl3.7H2O as the Lewis
acid (Table 2.2, Entries 3-4). ZnCl2 has been shown to be an efficient promoter
of the Ferrier reaction,58 however ZnBr2 was tested instead due to its availability
in our lab, but was found to be unsuccessful. Therefore, two other Lewis acids
that have successfully been used in Ferrier reactions were tested, namely Montmo-
rillonite K10 (MK10),59 and InCl3.60 Both Lewis acids promoted the formation of
the desired product, as a mixture with the side-products, albeit in low yields (e.g.
Table 2.2, Entry 5). Control reactions, without addition of TBSOH, revealed that
MK10 produced a reaction mixture with fewer side-products, and through the use of
molecular sieves and increasing the reaction temperature, the optimised conditions
for this reaction produced a yield of 32% (Table 2.2, Entries 6-8).
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The scope of this reaction was briefly exlored with a different silanol as the nucle-
ophile, namely tert-butyldiphenylsilanol (TBDPSOH). None of the desired product
was found to form under the optimised conditions used with TBSOH, which could
be due to the steric bulk of the nucleophile. Due to the poor yield after optimisation
of this novel approach to diacetate bis-electrophile 153, a more traditional route to
the substrate was sought.
2.1.3 Oxidative Route to Diacetate Bis-Electrophile 172
As discussed in Section 1.5.1 (page 24), α,β-unsaturated lactones (viz. 135, Fig-
ure 2.3) were proposed as an interesting variant of bis-electrophile. The increased
planarity of these types of compounds, alongside their Michael acceptor proper-
ties, could lead to different reactivity or regioselectivity in the Pd-AA cascades, and
therefore methods for their synthesis were sought.
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LG = OAc or OCO2Me
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Figure 2.3 Design of α, β-unsaturated δ-lactone bis-electrophiles
Pyridinium chlorochromate (PCC) has historically been used for the conversion of
glycals into α, β-unsaturated δ-lactones;61 however, in 2004, Yadav et al. reported
a mild and efficient protocol for this one-pot transformation using catalytic InCl3
under aqueous conditions in combination with a stoichiometric amount of IBX as a
novel reagent system.62 Mechanistically, the reaction is initiated by InCl3-induced
allylic rearrangement of the glycal with water to form an intermediate 2,3-dideoxy-
hex-2-enopyranose (169), which on subsequent oxidation by IBX results in the for-
mation of the corresponding cyclic enoate in 76-82% yield.
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Reagents and Conditions: i) 10 mol% InCl3, IBX, H2O.
Scheme 2.4 Yadav et al.’s one pot synthesis of α, β-unsaturated δ-lactones 171
IBX was prepared via a literature method63 but the initial attempt at replicating
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Yadav’s results was unsuccessful (Table 2.3, Entry 1). Due to the increased activity
noted when FeCl3.6H2O was employed as the Lewis acid in previous transformations
of glycals (vide supra), it was tested as an alternative to InCl3. This modification did
result in greater consumption of starting material but only led to a complex mixture
of products including, again, only trace amounts of product as seen by 1H NMR of
the crude reaction mixture (Table 2.3, Entry 2). Further modifications of Yadav’s
procedure were investigated, including variations in time, temperature, solvent sys-
tem, and Lewis acid, however the reaction either produced complex mixtures or did
not proceed at all, and only starting material (102) was retrieved (Table 2.3, Entry
3-8).
Table 2.3 Optimisation of IBX reaction
O
OAc
AcO
OAc
O
AcO
OAc
OH O
AcO
OAc
OLA (10 mol%) IBX (2.5 eq)
102 165 172
Entry Lewis Acida Solvent Temp Time Yield (172)
1 InCl3 9:1 MeCN/H2O ∆ O/N Min.
2 FeCl3.6H2O 9:1 MeCN/H2O ∆ O/N Min.
3 FeCl3.6H2O 9:1 MeCN/H2O ∆ 5 h Min.
4 InCl3 14:1 DMF/H2O rt O/N SM
5 FeCl3.6H2O 14:1 DMF/H2O rt O/N SM
6 FeCl3.6H2O 9:1 MeCN/H2O ∆ O/N SM
7b InCl3 9:1 MeCN/H2O ∆ O/N SM
8b MK10 9:1 MeCN/H2O ∆ O/N SM
9 - H2O 80 ◦C 2 h 0%c (54% 165)
10d - H2O 80 ◦C O/N 0%e
a10 mol% Lewis acids added except for MK10 which was used in a 300 w/w% loading
bStepwise addition of IBX
c19% trans-aldehyde 166
dIBX added prior to addition of 102
eMainly trans-aldehyde 166
It was imperative to improve conversion of 102 to the hemiacetal 165 in order
to probe the ability of IBX to oxidise the anomeric hydroxyl group. Earlier work
conducted by Baer et al.64 demonstrated the ability to convert 102 to 165 in the
absence of a Lewis acid in an 85% yield by simply heating 102 in water at 80 ◦C
with vigorous stirring for 30 min. Incorporating this method with Yadav’s IBX
oxidation was met with mixed success. Upon heating 102 in water at 80 ◦C for 30
min., TLC showed almost complete conversion to a slower moving spot, whereupon
2.5 eq. of IBX was added to the mixture. After two hours, all starting material
was consumed and the reaction was worked up and found to be predominantly
hemiacetal 165, although open-chain trans-aldehyde sideproducts (166 and others)
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were also observed (Table 2.3, Entry 9). A second attempt with a longer reaction
time demonstrated that the IBX was not active towards oxidation of the anomeric
hydroxyl of 165 (Table 2.3, Entry 10) in this manner because none of the desired
lactone (172) was observed, and therefore different oxidising agents were pursued.
When deciding on alternative oxidising agents to try for this transformation, those
previously used in allylic oxidations of α, β-unsaturated lactols were considered first;
these included MnO2,65 Fétizon’s reagent (Ag2CO3 on Celite™),66 PCC61,67 and
Jones’ reagent.68 Firstly, however, formation of 165 needed to be improved. At-
tempts at improving the yield from 54% (Table 2.3, Entry 9) culminated in a highest
isolated yield of 65%, achieved through increasing the reaction time to five hours
and conducting the reaction in absence of light. Conducting the reaction in the
dark suppresses production of trans-aldehyde side-products through light-induced
irreversible isomerisation of the open-chain cis-aldehyde 168 to trans-aldehyde 166,
a process demonstated by Fraser-Reid et al.69 (Scheme 2.5). Further comment and
new insight on this reaction can be found in Section 2.1.4 (page 38).
O
OAc
AcO
OAc
i
65%
O
AcO
OAc
OH
102 165
Reagents and Conditions: i) H2O, dark, 80 ◦C, 5 h.
Scheme 2.5 Optimised conditions for conversion of 102 to hemiacetal 165
With hemiacetal 165 in hand, the efficiency of both MnO2 and Fétizon’s reagent
in the oxidation of this substrate were tested concurrently. Whilst the trial MnO2
reaction returned all of the starting material hemiacetal, Fétizon’s reagent delivered
the desired α,β-unsaturated lactone bis-electrophile (172) cleanly in a 86% yield,
without the need for further purification. The remarkable success of this reaction
was accentuated by the lack of workup, with clean product accessible by filtration of
the crude reaction mixture through Celite™. This result thereby obviated the need
to probe the reactivity of other suggested oxidising agents.
O
AcO
OAc
OH i
86%
O
AcO
OAc
O
165 172
Reagents and Conditions: i) Fétizon’s reagent, benzene, ∆, O/N.
Scheme 2.6 Oxidation of hemiacetal 165 to lactone 172 with Fétizon’s reagent
Formation of hemiacetal 165 not only provided a clean pathway to lactone 172,
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but also uncovered a potentially facile route to the diacetate bis-electrophile 153
produced in low yield (32%) via the novel Ferrier reaction with TBSOH discussed
in section 2.1.2 (page 32). TBS protection of the anomeric hydroxyl of 165 due
to the absence of other hydroxyls on the substrate was expected to proceed rela-
tively smoothly and, indeed, on treating 165 with TBSCl in the presence of DMAP,
AgNO3 and pyridine in DCM, the desired diacetate bis-electrophile 153 was isolated
in a 73% yield. This modification improved the yield of formation of bis-electrophile
153 from glucal 102 with the two-step synthesis producing 153 in an overall yield
of 47% (Scheme 2.7). No steps were taken to improve the efficiency of the TBS
protection step, however this type of reaction is extremely common and in general
found to be high-yielding,70,71 therefore further work on this reaction is likely to
meet few problems.
O
OAc
AcO
OAc
i, ii
47% over 
2 steps
O
AcO
OAc
OTBS O
OAc
AcO
OAc
iii
32%
102102 153
Reagents and Conditions: i) H2O, dark, 80 ◦C, 5 h; ii) TBSCl, AgNO3, pyridine, DCM; iii)
TBSOH, MK10, DCM, ∆.
Scheme 2.7 Comparison of two successful syntheses of bis-electrophile 153
2.1.4 New Insight on Perlin-Type Aldehydes
The formation of trans-aldehyde 166 from Ferrier reactions of 102 in the presence
of water was noticed on more than one occasion during attempts to synthesise bis-
electrophile 153. This transformation is not new knowledge to the carbohydrate
research community as such aldehydes have been noted numerous times.72 However,
when first developed into a synthetically useful transformation by Perlin, Lesage
and Gonzalez in 1975 through the use of mercuric ion catalysis, alongside the major
trans-aldehyde 166, the trio also noticed another trans-aldehyde was produced.
The aldehyde mixture was not purified but Perlin et al. assigned the new trans-
aldehyde to be the product of acyl migration from C-4 to C-5 of aldehyde 166.
These aldehydes, alongside other δ-hydroxy-α, β-unsaturated aldehydes that can be
synthesised in this manner, have since been referred to as the Perlin aldehydes, and
the process by which they are made, Perlin hydrolysis (Scheme 2.8).
Interestingly, however, at the time that Perlin’s paper appeared in 1975, a manuscript
by Bert Fraser-Reid went to press outlining another synthesis of two trans-aldehydes
isolated from the hydrolysis of tri-O-acetyl-d-glucal.69 Fraser-Reid’s 1H NMR as-
signment of 166 mirrored that of Perlin’s. On the other hand, the two chemists’
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P = Ac, Bn, Me
Reagents and Conditions: i) HgSO4, 1,4-dioxane, dil. H2SO4, rt, 2-3 hr.
Scheme 2.8 Perlin hydrolysis of alkyl protected glycals (173) to afford Perlin
aldehydes 174 and 175
assignments of the acyl migrated product (176), although similar, did not match.
The most noticeable differences were between the assignments of H-2 and H-3 (Ta-
ble 2.4). The variation in 1H NMR shifts, coupled with results from the current
work (vide infra), indicate that Perlin’s assignment could be of another compound.
This incongruency went without comment from Fraser-Reid despite him recognising
Perlin’s paper in a note added in proof at the end of the publication. This oversight
could be due to the differing manner in which the two papers presented their 1H
NMR shifts, with Perlin reporting in delta (δ) and Fraser-Reid in tau (τ).
Table 2.4 Comparison of 1H NMR data reported for trans-aldehydes 166 and 176
5
4
3
2
OH
1
O6
OAc
AcO 5 4
3
2
OAc
1
O6
OH
AcO
166 176
Assigned Research
1H NMR shifts (δ)
Structure H-1 H-2 H-3 H-4 H-5 H-6
166
Perlina 9.58 6.4 6.98 5.61 4.1
Fraser-Reidb,c 9.62 6.22 6.93 5.57 4.5 - 4.0
This workd 9.59 6.26 6.88 5.56 4.06 4.21
176
Perlina 9.58 6.28 7.02 4.64 5.12 4.1
Fraser-Reidb,c 9.62 6.37 6.86 4.6 5.1 4.4 - 4.0
This workd 9.6 6.41 6.79 4.58 5.09 4.33
aSpectra recorded on a 100 MHz spectrometer.
bSpectra recorded on a 60 MHz spectrometer.
cShifts converted from tau to delta with formula δ = 10 - τ .
dSpectra recorded on a 500 MHz spectrometer.
Since 1975, due to their high degree of functionality and well-defined chiral centres,
Perlin aldehydes have been successfully utilised as chiral pool reagents in synthesis
by various research groups.72 It therefore seems surprising that since the original two
spectroscopic assignments of the acyl migrated aldehyde (176), no new spectral data
have been reported nor comment on the differing NMR data been made. Instead
only references to Perlin’s assignment of the compound have been reported. It would
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appear that few chemists are aware of Fraser-Reid’s 1975 paper, due to the lack of
comment or reference to it in their own work, or perhaps the outdated use of τ by
Fraser-Reid made quoting his data less favourable. In any case, it would seem that
until now, no side-by-side comparison of the NMR data has been made.
During optimisation of the conversion of glucal 102 to hemiacetal 165 in this project,
it was found that two major trans-aldehyde side-products were indeed formed. The
highest yielding aldehyde was assigned as 166 and the spectral data matched those
reported by both Perlin and Fraser-Reid. The next most abundant trans-aldehyde
had 1H NMR data that closely corresponded with those reported by Fraser-Reid for
the structure of 176. A compound with shifts closely corresponding to the alde-
hyde Perlin assigned to the structure of 176 was noticed in trace amounts along
the baseline of the 1H NMR of the crude reaction mixture, confirming that this
compound could indeed be different from the aldehyde isolated by Fraser-Reid and
in this work. 2D NMR data, unavailable to both Perlin and Fraser-Reid at their
time of reporting, was used to confirm the assignment of structure 176 to the NMR
shifts obtained on the aldehyde isolated in this work. Individual HMBC correlations
between the acetate carbonyl carbons (δ 171.1 and δ 170.3) and H-5 (δ 5.08) and one
H-6 (δ 4.34) of 176 in comparison to the HMBC correlations between the acetate
carbonyl carbons and H-4 (δ 5.56) and one H-6 (δ 4.21) of 166 clearly demonstrate
the connectivity of this aldehyde (Figure 2.4).
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O
O6
OH
O
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176 H C
Figure 2.4 1H - 13C HMBC correlations of 176
Although noticed in trace amounts in this work, the compound which could be the
aldehyde Perlin assigned to the structure of 176 was unfortunately not isolated.
Therefore, conclusions about the structure of this aldehyde cannot yet be made,
nor a definitive answer on whether Perlin’s aldehyde has a different structure than
the one he assigned his data to. However, based on the chemical shifts reported
by Perlin, it is postulated that the compound could be aldehyde 177 (Figure 2.5)
formed as a result of C-6 to C-5 acetyl migration of 166.
5
OAc
O6
OAc
HO
177
Figure 2.5 Proposed structure of the Perlin’s misassigned aldehyde
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2.1.5 Synthesis of Dicarbonate Bis-Electrophiles 154 and
178
With two C-4 acetate bis-electrophiles synthesised, work on their carbonate ana-
logues could begin. An initial route to these compounds (154 and 178) was en-
visioned through deprotection of the acetyl groups and subsequent carbonate pro-
tection of C-4 and C-6 of 153 and 172 (Scheme 2.9). Although this approach was
not very synthetically efficient, it was seen as a way to gain quick access to these
compounds so that they could be evaluated as bis-electrophiles in Pd-AA cascades.
A more synthetically efficient route, where these compounds are generated directly
from d-glucal is discussed later on in this section.
O OTBS
AcO
OAc
O OTBS
HO
OH
Deacetylation
O OTBS
MeO2CO
OCO2Me
Protection
O O
AcO
OAc
O O
HO
OH
Deacetylation
O O
MeO2CO
OCO2Me
Protection
153 179 154
172 180 178
Scheme 2.9 Planned synthetic route from acetate bis-electrophiles 153 and 172
to carbonate bis-electrophiles 154 and 178
Deprotection of 153 proceeded smoothly under basic conditions (NaOMe in methanol)
delivering an anomeric mixture of diols (179) in an 85% yield. However, attempts
to form dicarbonate 154 from the diols through protection with methyl chlorofor-
mate were unsuccessful. Examination of 1H NMR spectra of crude reaction mixtures
showed that, under the chosen conditions, no desired product formed; instead, for-
mation of substituted furans dominated. The structures of these furans were distin-
guished in the 1H NMR spectrum of the crude reaction mixture by their distinctive
broad singlets around 7.40 ppm and, after isolation of each, their spectra matched
those previously reported in the literature.73
O OTBS
HO
OH
i O
MeO2CO
MeO2CO
O
HO
MeO2CO
O
O
OO
179 181 182 183
Reagents and Conditions: i) ClCO2Me (2.5 eq), DMAP (2.5 eq), THF, 0 ◦C or rt, O/N.
Scheme 2.10 Formation of furans 181, 182 and 183 from diol 179
The transformation of 2,3-unsaturated glycosides to furans has been documented
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numerous times, including by Perlin when he observed rearrangement of d-glucal
(158) in the presence of acid and catalytic mercuric sulfate, and also previously in
our group by Dr Lynton Baird.74 In Baird’s research it was noted that when silyl
ether 184 or diol 185 were left in CDCl3 for extended periods of time, the com-
pounds would convert to furans 186 and 187, respectively. The stability of diacetate
188 in CDCl3 however suggested that the presence of a free hydroxyl group at C-4
is necessary for this transformation (Scheme 2.11).
4
O
HO
OR
OBn CDCl3 O
HO
RO
4
O
AcO
OAc
OBn CDCl3 O
AcO
AcO
184: R = TBS
185: R = H
186: R = TBS (93%)
187: R = OH (90%)
188 189
Scheme 2.11 Formation of furans from benzyl glycosides observed by Dr Lynton
Baird
Three mechanisms for the formation of the observed furans in this work are pro-
posed. The first (Scheme 2.12, green arrows) is consistent with Perlin and Baird’s
observations. Activation and elimination of the C-1 group and subsequent attack
at the anomeric centre by trace amounts of water could give hemiacetal 190. The
free C-4 hydroxyl could then attack the carbonyl of the open-chain aldehyde to give
dihydrofuran 191. Protonation of the anomeric hydroxyl would activate hemiac-
etal 192 toward elimination, giving the stable furan 193. The second mechanism
(Scheme 2.12, blue arrows) deviates from mechanisms proposed by both Perlin and
Baird, but is also plausible. Beginning with displacement of the C-1 OTBS by nu-
cleophilic attack of the C-4 hydroxyl, ring opening of the corresponding bridged
bicycle 194 to give furan 195 and subsequent elimination would afford the observed
furan 193. The third mechanism (Scheme 2.12, red arrows) begins with the same
displacement of the C-1 OTBS as in the second mechanism but then a concerted
formation of the furan is proposed over the previous step-wise mechanism. It is
unknown whether protection of the C-6 hydroxyl occurs prior to or after rearrange-
ment to the furan, and therefore both situations are considered in the case of all
mechanisms.
The first proposed mechanism made it clear that trace amounts of water might be
involved in the formation of the furan products, DCM was tested as a more suitable
solvent than THF due to its lower miscibility with water. This variation did result
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Scheme 2.12 Proposed mechanisms for the formation of furans from 2,3-
unsaturated glycosides 196
in decreased formation of furans, however also a decrease in consumption of starting
materials and still no formation of the desired product.
The conversion of lactone 172 to 178 was also afflicted with difficulties. Deacetyla-
tion of the lactone using NaOMe in MeOH afforded a complex mixture of products
whilst K2CO3 in MeOH led to a highly polar mixture of compounds that were unable
to be isolated. These issues made it apparent that installation of methyl carbonate
protecting groups would ideally be carried out prior to rearrangement of the gly-
cal to give the 2,3-unsaturation. Therefore a more direct route to the carbonate
bis-electrophiles 154 and 178 was proposed (Scheme 2.13).
Deacetylation of tri-O-acetyl-d-glucal (102) proceeded smoothly to give d-glucal
(158) in 97% yield; however, conversion to tricarbonate glucal 198 through reac-
tion with methyl chloroformate and stoichiometric DMAP, serving as both a catalyst
and base, was consistently low. The desired tricarbonate product (198) was able
to be isolated in 47-52% yields from crude reaction mixtures that also contained
the 3,6- and 4,6-dicarbonate products. Longer reaction times, increasing equiva-
lents of methyl chloroformate or using stoichiometric pyridine with catalytic DMAP
afforded similar results. Purifying the mixture, combining the regioisomeric dicar-
bonate products and resubjecting them to the conditions produced further 198 in a
30% yield and the unreacted dicarbonate products could be re-isolated for further
recycling. In all cases the 3,6-protected product was isolated in higher yields than
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Reagents and Conditions: i) NaOMe, MeOH; ii) ClCO2Me, DMAP, THF; iii) H2O, 80 ◦C; iv)
TBSCl, AgNO3, pyridine, DCM; v) Fétizon’s reagent, benzene.
Scheme 2.13 Planned route to dicarbonate bis-electrophiles 154 and 178
the 4,6-protected product indicating that the issues surrounding this reaction could
be due to steric hindrance induced upon dicarbonate formation.
Despite the problems associated with the protection of d-glucal (158), the syn-
thesis of the carbonate bis-electrophiles could be continued with the Ferrier-type
allylic rearrangement of glucal 198 with water. As discussed earlier in section 2.1.3
(page 35), conversion of tri-O-acetyl-d-glucal (102) to diacetate hemiacetal 165 in
hot water is a well established transformation, however the scope of this reaction has
not been probed outside of glycals with C-3 acetate leaving groups. It was therefore
pleasing to find that tri-O-(methoxycarbonyl)-d-glucal (198) could also undergo the
transformation to hemiacetal 199. More remarkably, the reaction was much more
successful than its acetate equivalent, providing a quantitative yield, with no trans-
aldehyde side-products, in a much shorter reaction time of only 30 minutes. Due to
the only by-products of the reaction being methanol and carbon dioxide formed from
the breakdown of the C-3 methylcarbonate leaving group, no workup was required
except removal of water. Furthermore, the yield is quantitative, no organic solvents
or metal promoters are used, there is no need for addition of reagents or catalysts , it
is atom economical and requires only short reaction times. This reaction is therefore
a wonderful example of the ideals of green chemistry.
Silyl protection of hemiacetal 199 with TBSCl proceeded smoothly providing car-
bonate bis-electrophile 154 in an 80% yield. Alternatively, oxidation of hemiacetal
199 with Fétizon’s reagent afforded lactone 178 in 97% yield (Scheme 2.14), thereby
completing the quartet of desired bis-electrophiles (Figure 2.6).
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Scheme 2.14 Synthesis of carbonate bis-electrophiles 154 and 178 from glucal
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Figure 2.6 Bis-electrophiles synthesised from tri-O-acetyl-d-glucal (102)
2.2 Development of a 13C NMR Shielding Profile
for Tri-Substituted Dihydropyrans
Stereochemistry is known to play a significant role in governing the properties of
compounds, including their chemical reactivity.75 This is especially true for small
ring compounds, such as those described in section 2.1, where the stereochemistry
of the ring substituents also has a profound effect on the overall conformation of
the compound,76 a dominant factor in reactivity.75 Indeed, upon developing the
methodology of the Pd-AA cascade, Bartlett observed a notable difference in re-
activity between cis- and trans-dihydropyran substrates cis-42 and trans-42. Al-
though both substrates were capable of undergoing the desired transformation to
45, trans-42 required a higher catalyst loading for efficient conversion to the product
(Table 2.5).19
Two of the tri-substituted bis-electrophiles, 153 and 154, prepared as described in
section 2.1 (page 28), were isolated as anomeric mixtures. The stereoconvergent
reaction of both dihydropyran diastereomers, demonstrated in Bartlett’s work, sug-
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Table 2.5 Comparison of reactivity of dihydropyrans cis-42 and trans-42 in a
Pd-AA cascade
O
OTBS
OCO2Me
O
OTBS
OCO2Me
or O
O
OH
O
O
O
OH
H
i
cis-42 trans-42 39 45
Reagents and Conditions: i) Pd(PPh3)4, Toluene, rt., O/N.
Entry Substrate Cat. mol % Yield
1 cis-42 5 83
2 trans-42 5 10
3 trans-42 20 74
gested that separation of the bis-electrophile diastereomers of 153 and 154 was
probably unnecessary. However, due to the differing reaction conditions required by
each diastereomer of 42, it seemed prudent to determine the stereochemistry of the
major and minor constituents of the bis-electrophile mixtures prior to testing them
as substrates in the Pd-AA cascades.
The stereochemistry in question was that of the substituents at the anomeric centre,
formed during the Ferrier reaction step. Although determination of the configura-
tions at C-1 of 2,3-unsaturated products formed by Ferrier reactions is complex and
depends upon many variables, substituted glucals when reacted with O-nucleophiles
are generally assumed to give predominantly α-products.53 This trend suggested that
the major constituent of each of the bis-electrophile mixtures was the α-anomer and
this is assumed to be true. However, an alternative method of analysis of the C-1
stereochemistry of these types of compounds was desired to allow for the assign-
ment of tri-substituted dihydropyrans formed through non-Ferrier type reactions
(e.g. the Achmatowicz route to 151), or the assignment of 1:1, or near 1:1, mixtures
of products of Ferrier reactions.
Stereochemical assignment of 3,6-dihydro-2H -pyrans is an interesting challenge due
to the structural properties of the compounds. Planarity established by the unsat-
uration in the ring, accompanied by the ring oxygen, limit the information on the
relative stereochemistry at C-1 and C-4 that could be taken from 3JHH coupling and
also reduce the number of 1,3-diaxial relationships, thereby limiting the utility of
NOE correlations. Bartlett noted these challenges and designed his own method of
assigning the relative stereochemistry of C-1 and C-4 by analysis of axial shielding
on the ring carbons.19 He demonstrated that there is a clear difference in the 13C
chemical shifts of cis- and trans-dihydropyran diastereomers of type cis-200 and
trans-200 (Figure 2.7). However, calculating the difference in chemical shift of each
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ring carbon of the compounds (∆δC) leads to a diagnostic shielding pattern which
can allow for the assignment of relative stereochemistry. Thus, subtracting the 13C
NMR chemical shifts of trans-3,6-dihydro-2H -pyrans from the equivalent signals of
the cis-diastereomer afforded a shielding pattern with positive values at positions
C-1, C-3 and C-4 and negative values at positions C-2 and C-5.This diagnostic pat-
tern, including the magnitudes of the differences, was found to fit well for a range
of disubstituted substrates with oxygen-tethered substituents.
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Figure 2.7 13C NMR shielding template for di-substituted dihydropyrans
With a limited number of examples to work with, Bartlett was unable to extend the
template to more highly substituted ring systems. However with the accumulation
of more examples and data in the present work, it was hoped that the method-
ology could be expanded. In section 2.1 a total of five anomeric mixtures of tri-
substituted dihydropyran compounds were isolated. These compounds completed a
pool of examples large enough that sufficient data was available for extension of the
methodology.
Following Bartlett’s method, 13C NMR resonances of the ring carbons of all five tri-
substituted dihydropyran mixtures synthesised in this work were assigned by analysis
of their respective HSQC spectra. Next, the magnitude of axial shielding (∆δC) was
calculated by subtracting the 13C shifts of each ring carbon in one diastereomer
from those in their diastereomeric counterpart. It was noticed that, by subtracting
the 13C shifts of the minor product (assigned as the β-anomer or 1,4-trans-isomer)
from those of the major product (assigned as the α-anomer or 1,4-cis-isomer), for all
five dihydropyran mixtures, very similar shielding profiles were produced (Table 2.6).
The profile produced from diol isomers cis- and trans-179 deviates in the ∆δC values
of C-2 and C-3 to a minor extent when compared to the rest of the compounds.
However this could be explained by the reduced conformational rigidity that comes
with removal of the C-4 and C-6 protecting groups, which would effect the average
shielding experienced by the ring carbons.
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Table 2.6 Relative 13C NMR shielding profiles of tri-substituted dihydropyrans
synthesised in this project
Entry Compounds Relative Ring Shielding
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An average shielding template was therefore generated from the mean values of all
five of these shielding profiles (Table 2.7, Figure 2.8). To some extent this new
shielding template matches the shape of Bartlett’s profile for disubstituted dihy-
dropyrans for C-2 to C-5, however the deviation in sign of the average ∆δC value
of C-1 demonstrates that it was indeed necessary to develop a new profile for these
more highly substituted dihydropyrans of type 201.
Table 2.7 13C NMR shifts of cis and trans tri-substituted dihydropyrans and
calculated ∆δC values and average ∆δC values
Cpd Substituents
13C NMR Shifts (cis, trans) (ppm)
∆δC (cis - trans)
R1, R2, R3 C-1 C-2 C-3 C-4 C-5
165 H, Ac, Ac 88.7, 90.9 128.4, 131.2 129.0, 127.4 65.1, 64.5 66.8, 73.1-2.2 -2.8 1.6 0.6 -6.3
199 H, CO2Me, CO2Me
88.8, 90.9 128.6, 131.6 128.7, 126.9 68.6, 67.9 66.5, 72.8
-2.2 -3 1.8 0.7 -6.3
153 TBS, Ac, Ac 89.1, 91.0 130.3, 133.0 127.0, 126.9 65.4, 64.8 66.8, 73.0-1.9 -2.7 1.7 0.6 -6.2
154 TBS, CO2Me, CO2Me
89.0, 91.0 130.7, 133.5 126.3, 124.7 68.8, 68.2 66.4, 72.6
-2 -2.8 1.6 0.6 -6.2
179 TBS, H, H 89.0, 91.0 129.0, 130.1 131.2, 130.7 64.5, 63.5 71.1, 78.4-2 -1.1 0.5 1 -7.3
Average ∆δC -2.1 -2.5 1.4 0.7 -6.5
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Figure 2.8 Average 13C NMR shielding template of tri-substituted dihydropyrans
201
To determine how applicable the average shielding template was for other similar
compounds, additional spectral data of tri-substituted dihydropyrans were sought
to analyse as comparisons. Although many compounds of this nature were found
in the literature, 13C NMR data of both cis- and trans-diastereomers were required,
accompanied with either a full set of 2D NMR data or all carbon positions assigned
to their NMR shifts. After a thorough search of available literature, no data that
matched all the criteria were found. Therefore, a search of NMR data of compounds
previously made within the research group was conducted and, even then, only two
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compounds were found to have sufficient data for this study. The first compound,
202 (see Figure 2.9), was synthesised and isolated as a mixture of cis- and trans-
diastereomers by Dr Lynton Baird during his PhD research.74 With OTBS groups
at C-4 and C-6 and an OBn group at C-1, this compound was seen as substan-
tially different from the dihydropyrans produced in this work and therefore was a
good compound for the assessment of the average shielding template. The second
compound, 103 (see Figure 2.10), was synthesised as a mixture of cis- and trans-
diastereomers by Dr Mark Bartlett during his PhD research.19 Although similar to
the compounds produced during this work, the anomeric isopropoxy group would
also provide an extension to the scope of the template.
When compared to the average shielding template, the relative ring shielding profile
produced by Baird’s dihydropyran mixture (202) was found to fit extremely well,
with all ∆δC values matching in sign and magnitude (Figure 2.9). This provided
evidence that the shielding template could fit well to a wide range of tri-substituted
dihydropyrans.
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Figure 2.9 Comparison of ring shielding template versus relative ring shielding of
tri-substituted dihydropyran 202
Surprisingly, however, Bartlett’s dihydropyran (103), although more closely related
to the compounds produced in this work, did not fit the average shielding as well as
did 202. Significant deviations in magnitude for C-1, C-3 and C-5 were observed,
although the general pattern of the template’s silhouette remained (Figure 2.10).
This example therefore made it clear that it is perhaps not the magnitudes of the
∆δC values that should be taken into account but rather the sign and overall pat-
tern of the profile produced. By doing so, it is believed that this template would
provide additional evidence for stereochemical assignments of glucose-derived Fer-
rier products and also could be a useful tool for the stereochemical assignment of
tri-substituted dihydropyrans formed through non-Ferrier type reactions.
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Figure 2.10 Comparison of ring shielding template versus relative ring shielding
of tri-substituted dihydropyran 103
2.3 Synthesis of Bis-Nucleophiles
2.3.1 Synthesis of Methyl Substituted 4-Hydroxycoumarins
During exploration of the scope of the earlier Pd-AA cascade, a variety of cyclic
β-dicarbonyl bis-nucleophiles were tested by Bartlett (See Scheme 1.10, page 9). In
general, it was found that nucleophiles with high enol content, such as α-pyrones and
coumarins, yielded the best results. Two coumarins were tested in the Pd-AA cas-
cade with bis-electrophile cis-42, namely 4-hydroxycoumarin (203) and 4-hydroxy-
7-methoxycoumarin (204), and provided the desired pyranofurochromenone prod-
ucts 46 and 47 in 77% and 68% yields, respectively.
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Reagents and Conditions: i) Pd(PPh3)4 (5 mol%), Toluene; ii) Pd(PPh3)4 (10 mol%), Toluene.
Scheme 2.15 Pd-AA cascade reactions of coumarin bis-nucleophiles 203 and 204
To expand the scope of coumarin bis-nucleophiles in Pd-AA cascades, methylated
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4-hydroxycoumarins were targeted as a means to probe regioisomeric effects of
coumarins in the cascade. An attractive two-step one-pot literature method for
the synthesis of 4-hydroxy-8-methylcoumarin from o-cresol and Meldrum’s acid was
reported by Moody et al.77 This simple and efficient synthesis, first developed by
Gao et al.78 stood out from other literature methods for its solvent-free and atom-
economic characteristics. The initiating step involved the neat reaction of o-cresol
(205) and Meldrum’s acid (52), whereupon expulsion of the sole by-product, ace-
tone, provided the intermediate carboxylic acid 206 in quantitative yield. Evacu-
ation to remove the acetone eliminated the need for a workup. The intermediate
acid was treated immediately with Eaton’s reagent, a dehydrating reagent readily
prepared from P2O5 and methanesulfonic acid,79 to afford the methylcoumarin 138.
Crystallisation of the crude reaction mixture then afforded the methylcoumarin 138
in a 98% yield according to Moody, although in only 60.5% yield by Gao.
OH
O
O
O
O
O
i
O
O
OH
O
ii
O
O
OH
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Reagents and Conditions: i) 100 ◦C, 3h.; ii) Eaton’s reagent, 70 ◦C, 4-5 h.
Scheme 2.16 One-pot synthesis of 4-hydroxy-8-methylcoumarin (138) from o-
cresol (205)
Following this literature procedure in the current work successfully produced the
desired methyl coumarin 138 from o-cresol (205). Purification by recrystallisa-
tion from 20% acetone in pentane, as reported in the literature,77 yielded min-
imal coumarin from the crude reaction mixture, however, changing recrystallisa-
tion solvents to absolute ethanol, as recommended by Gao, increased the product
yield to 34%. As no NMR analysis was carried out on the crude reaction mixture
prior to recrystallisation nor on the mother liquor, no comment can be made on
whether the differing results are due to the success of the reaction or isolation of
the product. Nevertheless, the procedure was also found to be capable of producing
the corresponding regioisomeric methylcoumarins from m- and p-cresol in similar
isolated yields. However, m-cresol (207) yielded both possible regioisomers (139
and 141), which were isolated by recrystallisation as an inseparable 1.3:1 mixture
(Scheme 2.17). Although not ideal, it was not seen as crucial to separate the two
products because insight into the reactivity of each could still be monitored by 1H
NMR spectroscopy. Thus, four cyclic bis-nucleophiles were available for testing in
the Pd-AA cascades.
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Scheme 2.17 Synthesis of methylcoumarins 138, 139, 141, and 140
54
2.4 Pd-AA Cascades with Prepared Substrates
2.4.1 Technical Challenges of Pd-AA Cascades and Initial
Exploration
Prior to testing the prepared substrates, it was necessary to gain competence in car-
rying out the experimentally challenging Pd-AA cascades by achieving consistency
in results of known reactions. Consistent experimental technique was essential in
order to maximise the validity of any results gained. This was achieved through
repeating Pd-AA cascades on substrates already tested by Bartlett and comparing
the results with those obtained previously.
Existing19 Pd-AA cascades were used as a platform to learn the Pd-AA cascade
techniques, namely coumarin 203 with pyran bis-electrophile cis-42, and pyrone 39
with acyclic bis-electrophile 40. This also opened up the possibility to test coumarin
203 as a substrate in the acyclic Pd-AA cascade (Scheme 2.18).
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Reagents and Conditions: i) 40, Pd2(dba)3, PPh3, NEt3, MeCN, rt,1h; ii) cis-42, Pd(PPh3)4,
toluene, rt, O/N.
Scheme 2.18 Bartlett’s Pd-AA results for synthesis of 45, 41 and 46 and planned
synthesis of 211
After a few attempts at the synthesis of 41, it became apparent just how sensitive
these cascades were to modifications in experimental technique and also to subtle
changes in the integrity of solvents or reagents. The initial runs of the Pd-AA
cascade were met with inconsistent results, from low conversion to no reaction at
all. In general, this was seen as a direct result of the sensitivity of the catalyst.
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With the exception of some novel air-stable palladium catalysts, organopalladium
chemistry typically requires rigorously inert conditions due to the tendency for pal-
ladium complexes to decompose upon reaction with oxygen or moisture.2 Pd2(dba)3
is a useful source of Pd(0) as, in contrast to Pd(PPh3)4, it is insensitive to oxygen
and so special care in handling and storage is unnecessary. When Pd2(dba)3 is in
solution in the presence of phosphine ligands, L, dba dissociates and allows the for-
mation of the active species, PdL2, in the reaction mixture.80 An attractive aspect
of these Pd-AA cascades is that they can be successfully performed without the use
of expensive equipment or special glassware.
In order to achieve consistent and reliable results, the following techniques were
deemed necessary. Firstly, all glassware used in the reactions, or in preparation of
the reactions, were thoroughly cleaned and heated to 600 ◦C with a heat gun under
high vacuum and then immediately placed under an inert atmosphere of either argon
or nitrogen. Secondly, all solvents and liquids were degassed by sparging with argon
or nitrogen for a minimum of 20 minutes, and then, when required, transferred
into the reaction flask via needles that had been dried in an oven overnight and
cooled in a dessicator prior to use. The quality of solvent was also found to be a
contributing player in the success of the reactions and freshly distilled solvents were
found to produce the best results, while solvents of poorer quality produced lower
yields or completely inhibited consumption of the bis-electrophiles. For overnight
reactions, rubber septa with minimal previous use were beneficial for eliminating
contamination by air and moisture. Furthermore, after all reagents were added,
all gas lines were removed and the septum was secured and doubly sealed with
insulation tape, forming, as much as possible, a closed system. This last technique
was deemed safe in this instance on small scale, due to the possibility of only a small
pressure build up, as only a stoichiometric amount of CO2 gas is produced from the
carbonate leaving groups.
Purging the reaction vessel was one of the more interesting technical challenges
faced upon performing the cascades. Prior to the addition of reagents, a Schlenk
line was used to purge the reaction vessel under oil-pump vacuum. However, upon
adding the catalyst and bis-nucleophile, the high pressure of the nitrogen line∗ in
conjunction with the light weight of the catalyst material made purging the vessel
with a Schlenk line detrimental to the success of the reaction. In most cases the
catalyst would get blown upwards into the septum, thereby making the true catalyst
loading in the reaction mixture unknown. Controlling the speed of introduction of
the gas in the purge was best done by the use of a nitrogen-balloon connected via a
glass tube and tap setup, a consequence of the lower pressure of the balloon.
∗The pressure of the reticulated gas in the building where labwork was conducted was abnor-
mally high.
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Employing the above techniques and Bartlett’s methods on the reported cascades
eventually led to consistent results; however, in both cases, the yields gained were
lower than those reported by Bartlett (Scheme 2.19). This result emphasises the de-
gree of sensitivity of these reactions where, despite considerable efforts, reproducibil-
ity of yields between researchers is limited. However, because the relative magnitude
of the yields matched the reactivity difference in substrates seen by Bartlett, and as
they were also high enough for synthetic purposes, it was possible to attempt ex-
tending the scope to include the reaction of hydroxycoumarin 203 with dicarbonate
40.
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O/N.
Scheme 2.19 Comparison of reported yields with yields obtained in this work for
selected Pd-AA cascades
Using Bartlett’s optimised conditions for Pd-AA cascades with acyclic bis-electrophile
40, the reaction of hydroxycoumarin 203 successfully produced the desired product
211 in a modest 52% yield, thereby adding to the scope of the reaction (Table 2.8).
This yield compared well with Bartlett’s results that showed the hydroxycoumarin
produced a lower yield than methylpyrone 39 when subjected to the same conditions
(viz. Scheme 2.18). To ensure that the conditions were optimal, a small study of
catalyst loadings and reaction concentration revealed that, indeed, decreasing cata-
lyst loading or increasing reaction concentration were detrimental to the success of
this reaction (Table 2.8).
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Table 2.8 Effect of changes to reaction variables on yield of Pd-AA cascade prod-
uct 211: catalyst loading and reaction concentration
O
O
OH
OCO2Me
OCO2Me
O
O
O
i
203 40 211
Reagents and Conditions: i) Pd2(dba)3, PPh3, NEt3, MeCN, rt, 1h.
Reaction Variables Conc. (40) (M)0.05 0.10 0.20
Mol % Pd
20 52% 41% -
10 47% 32% 26%
5 43% - -
2.4.2 Reactions of Methylcoumarins with Acyclic and Cyclic
Bis-Electrophiles
The synthesis of a variety of methylated 4-hydroxycoumarins (see Section 2.3.1,
page 51) allowed for exploration of their ability to act as bis-nucleophiles in the
Pd-AA cascades with both acyclic and cyclic bis-electrophiles, 40 and cis-42, re-
spectively. All four coumarins were found to successfully produce the corresponding
vinyl-substituted products when introduced to acyclic bis-electrophile 40 and the
optimised conditions associated with it. The yields summarised in Table 2.9 demon-
strate that the position of the aromatic methyl substituent provides little deviation
in the reactivity of the compounds towards the cascades. This is emphasised by the
consistency in the ratio of the starting material and product regioisomers during
the reaction of the m-cresol derived coumarins 139 and 141 (Table 2.9, Entry 2).
Despite achieving only modest yields for all three reactions, no further optimisation
studies were performed. It is highly likely, given the variance in yields between
previously reported work and this work as discussed in the previous section, that
higher yields can be achieved for these reactions.
When subjecting the methylated 4-hydroxycoumarins to Bartlett’s optimised con-
ditions for the reaction with cis-42, 1H NMR of the crude reaction mixtures showed
that no reaction occurred for any of the substrates. It was noticed that solubility
of the coumarins was limited in toluene and therefore a mixed solvent system of
3:1 toluene:DMF was tested. This modification was chosen as it was found to be
moderately successful with the 4-hydroxypyridinone substrate which was similarly
insoluble in earlier scope studies performed by Bartlett (Scheme 1.10). Indeed, in
the presence of DMF, the substrates were completely soluble and TLC analysis
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Table 2.9 Expansion of Pd-AA cascades with dicarbonate bis-electrophile 40 to
include methylcoumarins
O
O
OH
OCO2Me
OCO2Me
O
O
O
iR1
R2
R3
R4
R1
R2
R3
R4
212 40 213
Reagents and Conditions: i) Pd2(dba)3, PPh3, NEt3, MeCN, rt, 1h.
Entry Bis-Nucleophile Substituents YieldR1 R2 R3 R4
1 138 Me H H H 51%
2a 139+141 H Me/H H H/Me 46%b
3 140 H H Me H 46%
aReaction performed on a 1.3:1 mixture of 139:141
bComposed of a 1.3:1 mixture of 214:215
showed complete consumption of the bis-electrophile cis-42. However, after flash
column chromatography, the desired products were isolated in only low yields (Ta-
ble 2.10, Entries 4-6 ). The necessity of the methylated 4-hydroxycoumarins to have
a different solvent system than 4-hydroxycoumarin (203) was surprising due to the
minimal structural differences in the compounds. Furthermore, the mixed solvent
system induced a negative effect on the Pd-AA cascade of 4-hydroxycoumarin (203),
lowering the yield from 54% (see Scheme 2.19) to 22% (Table 2.10, Entry 7).
The low yields obtained upon modification of the solvent system was unexpected
and contradicted the exceptionally clean 1H NMR of the crude reaction mixtures
(e.g. Figure 2.11, blue spectrum), all of which showed no starting material remained,
instead revealing only peaks that correlated to the desired product, PPh3, and the
cleaved TBS group. It therefore seemed apparent that compounds remained on the
column after isolation of the desired product. The polar compounds that remained
on the column after purification of the reaction of 138 with cis-42 (Table 2.10,
Entry 4) were eluted with EtOAc and 1H NMR showed the presence of compounds
with shifts around 3.8-4.2 ppm and a multiplet at 2.0 ppm that were absent from the
1H NMR spectrum of the crude reaction mixture. Purification of the EtOAc-eluted
fractions by flash column chromatography afforded the main component, charac-
terised as a hemiacetal (219) (red spectrum Figure 2.11). This demonstrated that
the desired products were susceptible to hydrolysis on the column, potentially acid-
promoted hydrolysis due to the slightly acidic nature of silica gel.
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Table 2.10 Optimisation of expansion of Pd-AA cascades with dihydropyran bis-
electrophile cis-42 to include methylcoumarins
O
O
OH
OCO2Me
OTBS
O
O
O
iR1
R2
R3
R4
R1
R2
R3
R4
O
O
H
H
212 cis-42 216
Reagents and Conditions: i) Pd(PPh3)4, Solvent, rt, O/N.
Entry Solvent Bis-Nucleophile Substituents YieldR1 R2 R3 R4
1 Toluene 138 Me H H H 0%a
2b Toluene 139 + 141 H Me/H H H/Me 0%a
3 Toluene 140 H H Me H 0%a
4 Toluene:DMF 3:1 138 Me H H H 39%
5b Toluene:DMF 3:1 139 + 141 H Me/H H H/Me 30%c
6 Toluene:DMF 3:1 140 H H Me H 25%
7 Toluene:DMF 3:1 203 H H H H 22%
8d Toluene:DMF 3:1 140 H H Me H <10%
9e Toluene:DMF 3:1 138 Me H H H 49%
10e Toluene:DMF 3:1 140 H H Me H 47%
a1H NMR of the crude reaction mixture showed unreacted starting material and no desired
product
bReaction performed on a 1.3:1 mixture of 139:141
cComposed of a 1.3:1 mixture of 217:218
dPurified by alumina gel column chromatography
ePurified by column chromatography with solvent containing 1% NEt3
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Reagents and Conditions: i) Pd(PPh3)4, 3:1 toluene:DMF, rt, O/N; ii) silica column.
Key: Blue spectrum = crude reaction mixture of Pd-AA cascade of 138 and cis-42, Green
spectrum = purified desired product (220), Red spectrum = purified degradation product (219)
Figure 2.11 Comparison of 1H NMR spectra of Pd-AA cascade crude reaction
mixture (blue), desired product 220 (green), and by-product 219 (red)
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Two methods were tested to suppress this mode of degradation. The first replaced
silica with alumina as the stationary phase, tested with a crude mixture of the
reaction of p-cresol derived coumarin 140 and resulted in poor separation and low
isolated yields (<10%) of desired product. The second method was to treat the
silica gel with organic base prior to use in column chromatography and then to use
a solvent system containing a low percentage of base during elution. This method
was tested on a crude mixture of the reaction of 138. The column was packed
with a slurry of silica prepared from a solution of 1% NEt3 in petroleum ether, and
then eluted with 10-20% EtOAc in the NEt3-treated petroleum ether. This was a
more successful purification method, resulting in an increase in the isolated yield of
desired product 220 from 39% to 49%. An EtOAc elution, performed after isolation
of the desired product, demonstrated that this method did suppress the formation
of hemiacetal 219 through the absence of peaks that correspond to this degradation
product in the 1H NMR spectrum.
Overall, the yields of desired products obtained from the reactions of the methy-
lated 4-hydroxycoumarins with cis-42 reflected the observation, noted earlier with
the acyclic variant, that the placement of the aromatic methyl does not affect the
reactivity of the coumarins towards the Pd-AA cascade. The consistency of yields
of around 50% for the Pd-AA cascades with cis-42, at first glance might appear
significant, suggesting, perhaps, that these compounds may require two equivalents
of coumarin substrate as in the acyclic conditions. However, the simplicity of the
1H NMR spectrum of the crude reaction mixture would indicate that the modest
yields are not a result of suboptimal reaction conditions, but instead a problem with
purification technique, and further work is required in this area.
2.4.3 Reactions of Tri-Substituted Bis-Electrophiles
Finding a carbohydrate-derived bis-electrophile that was capable of undergoing a
Pd-AA cascade with Meldrum’s acid, in the same manner as does dihydropyran
cis-42 (Scheme 2.20), was crucial to the success of the thromboxane synthesis. In
this way, the bicyclic core of the thromboxane intermediate would be constructed in
a facile manner, providing a strong foundation for the proposed synthetic route to
the thromboxanes.
Of the four bis-electrophiles prepared in section 2.1 (viz. page 28), 154 was the
closest in functionality to cis-42 and, therefore, was tested first in a Pd-AA cascade
with Meldrum’s acid. Investigations began with conditions based on an unoptimised
version of Bartlett’s cascade, namely employing one equivalent of Meldrum’s acid
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Reagents and Conditions: i) 5 eq. of 52, Pd(PPh3)4 (10 mol%), THF:MeOH 10:1, rt, O/N.
Scheme 2.20 Bartlett’s synthesis of 53 from cis-42 with Meldrum’s acid (52)
and toluene as the solvent (Table 2.11, Entry 1). Analysis of the 1H NMR spectrum
of the crude reaction mixture showed the reaction had proceeded with good conver-
sion in that a distinctive doublet was observed at 6.64 ppm corresponding to the
enol ether proton at C-1 of the desired product (221). Isolation of the desired prod-
uct was unsuccessful, however, as it was co-eluted with unreacted Meldrum’s acid.
Therefore an isolated yield of 221 was unable to be quoted for these conditions. One
compound was isolated and was identified as bis-adduct 222 (Figure 2.12) formed
through double addition of the bis-electrophile to Meldrum’s acid. Due to the small
amount of material obtained, no stereochemical assignment was made. However, on
the basis that the Pd-AA mechanism was followed overall retention of configuration
at C-4 is assumed. Furthermore, a single relative stereochemical realationship at C-1
is proposed based on the identical NMR signals from both pyran rings. An excess (5
equiv.) of Meldrum’s acid was added to suppress the formation of bis-adduct 222
(Table 2.11, Entry 2). This reaction did not proceed at all, which is puzzling.
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Figure 2.12 Bis-adduct formed in Pd-AA cascade of 154 with Meldrum’s acid
Adoption of Bartlett’s conditions (Table 2.11, Entry 3) resulted in formation of the
desired product; however, isolation was again unsuccessful for the aforementioned
reason. It was also noticed that the reaction proceeded with limited conversion and
154 was able to be regenerated in 32% yield. Retaining the mixed solvent system
(THF/MeOH) and reverting back to addition of a single equivalent of Meldrum’s
acid (Table 2.11, Entry 4) decreased the conversion of the reaction, with 53% of start-
ing material 154 recovered from the reaction mixture; however, the reduction in the
amount of Meldrum’s acid in the crude reaction mixture allowed for the observation
of a small dark spot appearing just below the characterstic pink spot of Meldrum’s
acid on a TLC plate of the reaction mixture when stained with anisaldehyde dip.
With excess charring the dark spot was completely disguised by the Meldrum’s acid
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Table 2.11 Optimisation of Pd-AA cascade of bis-electrophile 154 with Mel-
drum’s acid (52)
O OTBS
MeO2CO
OCO2Me
O O
OO
2
1O
OCO2Me
i
O
O
H
H
MeO2C
154 52
221
Reagents and Conditions: i) catalyst, solvent, MeOH (5 eq.), rt, O/N
Entry Catalyst (Mol% Pd) Solvent Equiv. 52 Yield
1 Pd(PPh3)4 (5) Toluene 1 0%a,b
2 Pd(PPh3)4 (5) Toluene 5 0%c
3 Pd(PPh3)4 (5) THF:MeOH 10:1 5 0% a,d
4 Pd(PPh3)4 (5) THF:MeOH 10:1 1 18% e
5 Pd(PPh3)4 (15) Toluene 5 62%
6 Pd2(dba)3 / PPh3 (15) Toluene 5 13% f
7 Pd(PPh3)4 (20) Toluene 5 36%f
8g Pd(PPh3)4 (15) Toluene 5 17%f,g
aDesired product was observed in 1H NMR of crude reaction mixture, but was lost in isolation
bBis adduct 222 isolated in 7% yield (w.r.t. 154)
c 1H NMR of the crude reaction mixture showed unreacted starting materials and no desired
product
d154 recovered in 32% yield
e154 recovered in 53% yield
fPoor conversion
gReaction performed at 30-40 ◦C
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spot. Careful chromatography allowed the compound correlating to the dark spot
to be isolated separately from Meldrum’s acid and it was found to be the desired
product. The formation of 221 was evident from signals at δ 6.64 and δ 5.13 in the
1H NMR spectrum attributed to H-1 and H-2 respectively. The R-stereochemistry
at C-5 of 221 was assigned through a positive NOE correlation between H-5 (δ
3.57) and H-8 (δ 4.38). While this assignment appears surprising at first glance, a
3D model makes it evident that these protons can be in close proximity in only this
stereoisomer (Figure 2.13). Circumstantially, NOE correlations between H-1 and
H-5, and H-1 and H-7 were not observed.
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Figure 2.13 NOE correlation used to determine stereochemistry of Pd-AA cas-
cade product 221
Entries 1, 3 and 4 (Table 2.11) revealed that bis-addition can be suppressed by either
the use of excess Meldrum’s acid or by the use of THF:MeOH as a solvent, and using
excess equivalents of Meldrum’s acid or toluene as a solvent increases conversion of
the reaction. The conditions chosen for the next step of the optimisation, were based
of these observations in conjunction with an increased catalyst loading to combat
the decreased reactivity assumed to accompany the use of a mixture of 1,4-cis- and
trans-isomers of 154 (Table 2.11, Entry 5) (see also section 2.2 page 45). 1H NMR
spectroscopy of the crude reaction mixture showed complete consumption of starting
material 154 with very minimal evidence of undesired side products. The desired
product (221) was then isolated in a 62% yield, and these conditions were found
to give reproducible yields of 55-62% when repeated. Additional modifications of
the reaction conditions, namely the use of a different catalyst system (Entry 6), a
further increase in catalyst loading (Entry 7), or increasing reaction temperature
(Entry 8) were all found to have negative effects on the conversion and yield of the
reaction.
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Reagents and Conditions: i) Pd(PPh3)4 (15 mol%), MeOH (5 eq.) toluene, rt, O/N.
Scheme 2.21 Unsuccessful Pd-AA cascade of bis-electrophile 153 with Meldrum’s
acid (52)
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The acetate analogue of 154 (153), was found to be unreactive under the previ-
ously optimised Pd-AA conditions (Scheme 2.21). The 1H NMR spectrum of the
crude reaction mixture showed that the reaction did not proceed at all, displaying
only unreacted starting material. This result, although unsurprising given the poor
performance of acetates in Pd-AA cascades in Bartlett’s research, was incongruent
with previous results including those reported by Verdoorn et al.39 The variation in
C-1 leaving group of the substrate appears to be the only way in which Verdoorn’s
research deviates with respect to this reaction and so the complete lack of reac-
tivity was surprising. Exploration of reaction conditions in an attempt to provide
complimentary results to Verdoorn’s was not undertaken due to the success of the
carbonate variant (154) in this reaction and the time constraints of this project.
α, β-Unsaturated lactone bis-electrophile 172 was unreactive towards the Pd-AA
cascade with Meldrum’s acid (Scheme 2.22), despite the modification of reaction
conditions to better suit the nature of the substrate. These modifications included
lowering the catalyst loading as this was required to combat the anomeric mixtures
used previously, and also addition of NaH to generate an equivalent of methoxide
for the attack on the ketene at the end of the reaction. The modifications were
ineffective and the cascade failed to proceed, allowing all of starting material 172
to be recovered from the crude reaction mixture.
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Reagents and Conditions: i) Pd(PPh3)4 (5 mol%), NaH (1.1 eq.), MeOH (5 eq.) toluene, rt, O/N.
Scheme 2.22 Unsuccessful Pd-AA cascade of acetate bis-electrophile 172 with
Meldrum’s acid (52)
On the other hand, carbonate bis-electrophile 178, when subjected to the appropri-
ate Pd-AA cascade conditions (Scheme 2.23), was found to be extremely reactive,
with TLC analysis showing complete consumption of 178 after only 2.5 hours. 1H
NMR spectroscopy of the crude reaction mixture, however, showed clearly that
178 had not reacted with the Meldrum’s acid. Instead, it had undergone a trans-
formation in a high yield to one product that, upon purification, was found to
be 2H -pyran-2-one 225. An intense colour change from yellow to red-orange of
the reaction mixture was observed. This could indicate that the formation of this
compound is a palladium-assisted process. A plausible mechanism could involve
the initial pi-allyl Pd formation anticipated for the desired reaction. Then, instead
of C-4 alkylation by Meldrum’s acid, either β-hydride elimination or base induced
elimination of H-5 followed by dissociation of Pd, would form the observed pyranone
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(225) (Scheme 2.24). The observed colour change could be caused by complexation
of the diene to palladium. The lack of reactivity of the acetate analogue (172) is
consistent with either mechanism but could be a consequence of the less reactive C-4
acetate leaving group retarding the process, by inhibiting formation of the initial
pi-allyl Pd complex. The base involved in deprotonation of C-5 could be methoxide
or Meldrum’s acid. Performing this reaction without Meldrum’s acid would be re-
quired to test the proposed mechanisms.
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Reagents and Conditions: i) Pd(PPh3)4 (5 mol%), MeOH (5 eq.) toluene, rt, 2.5 h.
Scheme 2.23 Unexpected elimination reaction of lactone 178 under Pd-AA cas-
cade conditions
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Scheme 2.24 Possible mechanism for the formation of 2H -pyran-2-one 225
The facile and high yielding synthesis of pyranone 225 could be promoted by the
conjugation inherent to the 2H -pyran-2-one (a.k.a. α-pyrone) structure. Nature pro-
vides further evidence for the favoured formation of these compounds, as this type
of ring system has been found in a plethora of compounds isolated from plants, an-
imals, marine organisms, bacteria, insects and fungi. Some 2H -pyran-2-one deriva-
tives have been found to display a wide range of cytotoxic, neurotoxic and phytotoxic
properties whilst others have been used as synthetic precursors to pharmacologically
active compounds such as HIV protease inhibitors, antifungals, anticonvulsants, an-
timicrobials, pheromones, natural pigments, antitumour agents, and plant growth
regulators.81, 82 In particular, pyranone 225 provides access to 6-alkylpyran-2-ones,
examples of which include 6-pentylpyran-2-one (226) that exhibits tyrosinase in-
hibitory activity with an IC50 value of 0.8 µM and has been in the treatment of
hyperpigmentation diseases,83 6-(1-penten-1-yl)-pyran-2-one (227) which has been
67
identified as a queen pheromone of the red fire ant,84 and 6-propenylpyran-2-one
(228), known as sibirinone, which was isolated from a culture of Hypomyces semi-
translucens 85(Scheme 2.25). It should be noted that although this research does
provide a new synthetic route to this important class of compounds, the pathway
does not hold many advantages over the traditional strategies for the synthesis of
2H -pyran-2-ones, and will find limited use due to its atom and step inefficiency.
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Scheme 2.25 Examples of 6-alkylpyran-2-ones accessible from 2H -pyran-2-one
225
To conclude the scope studies of the tri-substituted bis-electrophiles, the most suc-
cessful bis-electrophile, carbonate 154, was reacted with the pyrone and coumarin
bis-nucleophiles, 39 and 203. These reactions, performed by Dr Mark Bartlett, pro-
vided the desired products in good and excellent yields, demonstrating that their
reactivity is comparable and sometimes, in the case of the cascade with hydroxy-
coumarin 203, greater than their C-5 unsubstituted analogue, cis-42 (2.4.3).
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Scheme 2.26 Pd-AA cascades of pyrone 39 and coumarin 203 with bis-
electrophile 154
2.5 Progress Towards the Synthesis of Thrombox-
anes A2 and B2
The final aim of this project was to employ a Pd-AA cascade with a tri-substituted
dihydropyran bis-electrophile to form the core of the thromboxane intermediates,
and in doing so, work towards improved total syntheses of the thromboxanes. A
retrosynthesis of the proposed synthetic plan in Section 1.5.2 shows that three com-
pounds were required in the early stages of the synthesis, namely Meldrum’s acid,
bis-electrophile 154 and HWE reagent 231 (Scheme 2.27).
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Scheme 2.27 Retrosynthesis of TXA2 (59) to starting materials: Meldrum’s acid
(52), 154 and 231
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Both Meldrum’s acid and bis-electrophile 154 were accessible and so the synthesis
of the HWE reagent, diethyl (hexanoylmethyl)phosphonate (231), to be used in the
attachment of the first thromboxane side-chain, was made a priority. A literature
method86 for the synthesis of 231 was successfully followed with only minor vari-
ations in the experimental procedure. The synthesis, developed by Kurangi et al.
involved acylation of triethyl phosphonoacetate (233) with hexanoyl chloride (234)
in the presence of MgCl2 and NEt3, followed by hydrolysis in water with p-TsOH
and decarboxylation (Scheme 2.28). In contrast to Kurangi’s procedure, where in-
termediate 235 was produced in a 96% yield and judged as pure by observation of
a single spot on TLC after aqueous workup, column chromatography was required
when the reaction was carried out in this work to remove by-products detected by
1H NMR of the crude reaction mixture. The intermediate (235) was able to be iso-
lated in an 89% yield; however, when subjected to the second step of the procedure
for the reported three hours, the desired product was isolated in a low 38% yield
after column chromatography, much less than Kurangi’s 75%. Reaction conversion
appeared to be the issue, and when the reaction was repeated and left to react
overnight, phosphonate 231 was able to be produced in an 81% yield after extrac-
tion with diethyl ether without the need for further purification. Coincidentally, the
modifications to Kurangi’s procedure implemented in this work did not change the
outcome of the synthesis of 231 as both procedures required the use of one column
and resulted in an overall yield of 72% over two steps.
O
(EtO)2P OEt
O
O
C5H11Cl
i
89%
(96%)
O
(EtO)2P C5H11
O
OEtO
ii
81%
(75%)
O
(EtO)2P C5H11
O
233
234
235
231
Reported yields86 shown in brackets
Reagents and Conditions: i) MgCl2, NEt3, toluene, 6 h, rt; ii) p-TsOH, H2O, ∆.
Scheme 2.28 Synthesis of HWE reagent 231 with comparative yields from the
reported procedure
The desired bicyclic thromboxane intermediate 232 deviates only slightly from
the bicyclic Pd-AA cascade product 221 generated from Meldrum’s acid and tri-
substituted bis-electrophile 154 (Figure 2.14). The formation of this compound was
therefore envisioned to be achievable through a one-pot synthesis involving a Pd-AA
cascade of 154 with Meldrum’s acid to produce the usual ketene intermediate. An
equivalent of water added to the reaction mixture could then quench the ketene to
form carboxylic acid 236 that, by warming up the reaction mixture, would undergo
thermal decarboxylation to provide 232 (see Scheme 1.24).
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Figure 2.14 Comparison in Pd-AA cascade product 221 and planned thrombox-
ane intermediate 232
Investigation of this process began with the reaction of Meldrum’s acid with 154
under the optimised conditions for the formation of 221 with the addition of five
equivalents of water (Table 2.12, Entry 1) to determine whether the presence of
water in the reaction hindered the activity of the catalyst. Gratifyingly, peaks
correlating to ester 221 were detected in the 1H NMR of the crude reaction mixture
with good conversion, but no other products were observed. Repeating the reaction
without methanol resulted in complete recovery of starting materials (Table 2.12,
Entry 2). It was postulated that the poor miscibility of water in toluene reduced its
availability for the use in the Pd-AA cascade, thereby hindering the process. When
acetonitrile was employed as a more water-miscible solvent (Table 2.12, Entry 3),
the reaction was found to proceed and give both 221 and 232, although the reaction
suffered from poor conversion of starting material 154. As the reaction mixture was
subjected to only mild heating during evaporation of the solvent in vacuo during
work up, it was a great surprise to discover that the product isolated from this
reaction was in fact the decarboxylated product 232. This is in contrast to the
procedure reported by Verdoorn,39 where a temperature of 170 ◦C was required for
decarboxylation of a similar substrate (107) to occur. The presence of 237 was
indicated through the similarity of signals compared to 221 together with the new
signals attributed to the H-5 ABX system at δ 2.87 (dd, J = 18.0, 8.5 Hz) and δ
2.48 (dd, J = 18.0, 2.0 Hz). Unfortunately, the decarboxylated compound 232 was
isolated as the major component of a mixture of unidentified compounds of similar
polarity and therefore only an estimated yield is able to be reported and is based
on integrations of the 1H NMR spectrum of the product mixture (Table 2.12, Entry
3).
A small increase in the equivalents of water (Table 2.12, Entry 4) resulted in a small
increase in yield of the desired product. Employing water as a co-solvent with THF
(Table 2.12, Entry 5) gave extremely promising results upon analysis of integrations
of the peaks in the 1H NMR of the crude reaction mixture, but a disappointingly
poor yield of 232 was isolated. This isolated yield is considered to not reflect
the true result for this set of reaction conditions and optimisation of this reaction
would benefit from its repetition. Finally, using water as the solvent, and employing
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Table 2.12 Exploration of Pd-AA cascade of 154 and Meldrum’s acid (52) in
presence of water
O OTBS
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OCO2Me
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i
O
O
H
H
154 52
232
Reagents and Conditions: i) catalyst (15 mol%), solvent, Meldrum’s acid (5 eq.), H2O, MeOH, rt,
O/N
Entry Catalyst Solvent Eq. Eq. Yield (232)H2O MeOH
1 Pd(PPh3)4 Toluene 5 5 0%a
2 Pd(PPh3)4 Toluene 5 0 0%b
3 Pd(PPh3)4 MeCN 5 0 <5%c
4 Pd(PPh3)4 MeCN 20 0 9%
5 Pd(PPh3)4 THF:H2O 9:1 - 0 7%d
6 PdCl2 H2O - 0 0%b
aSole product identified as 221 by analysis of 1H NMR of crude reaction mixture
b 1H NMR of the crude reaction mixture showed only unreacted starting materials
c232 isolated as the major component of a mixture of products
dIsolated yield of 232 inconsistent with integrations of 1H NMR of the crude reaction mixture
water-soluble PdCl2 as the catalyst, gave no desired product or consumption of
starting material, potentially as a result of the poor solubility of starting materials
(Table 2.12, Entry 6). Time constraints of this project have meant that this research
has been halted. However, future plans for the development of this reaction are
discussed in Section 3.4.
Further optimisation of this reaction is required and therefore work could not begin
on attachment of the first side-chain with HWE reagent 231. However, the current
results show promise for the extended Pd-AA cascade as an efficient transformation
en route to the synthesis of the Thromboxanes. The formation of product 232,
even in low yields, differentiates this research from Verdoorn’s, and establishes a
new extension to Bartlett’s Pd-AA cascade, carrying out a remarkable five-steps in
one-pot.
72
2.6 Bioactivity of Selected Pd-AA Cascade Prod-
ucts
4-Hydroxycoumarins are well established as a class of compounds that demonstrates
significant bioactivity.87 These structural motifs can be found in many well-known
bioactive compounds with examples including the anticogulant drug Warfarin88
(238) and the rodenticide Brodifacoum89 (239) (Figure 2.15). Bartlett noted the
potential for bioactivity in the compounds produced in the Pd-AA cascades and sub-
mitted several for testing of their cytotoxicity against HL-60, a human leukemia cell
line. The results of the studies showed a variety of cytotoxicities and an interesting
trend became apparent. Whilst the products of cascades formed with disubstituted
dihydropyran bis-electrophile cis-42 showed limited to no cytoxicity against HL-60,
the products of the cascades formed from the tri-substituted dihydropyran (154),
namely 229 and 230, were found to be active with IC50 values of 21 and 25 µM,
respectively.19
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O
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238 239
Figure 2.15 4-Hydroxycoumarin derived bioactive compounds: Warfarin (238)
and Brodifacoum (239)
A variety of Pd-AA cascade products synthesised in this work were therefore tested
against the human promyelocytic leukemia HL-60 cell line and the human ovarian
cancer 1A9 cell line. Their cytostatic activities were determined using MTT cell
proliferation assays (n = 1-3 experiments).90 The most active compounds prepared
by Bartlett (229 and 230) were also tested against the 1A9 cell line. Unsurprisingly,
229 and 230, were found to show cytotoxicity against 1A9. On the other hand,
the products of Pd-AA cascades; with acyclic precursor 40, viz. 211, 240, 214,
215 and 241, were all inactive against the cell lines at the concentrations tested.
Interestingly, the products formed from Meldrum’s acid, 221 and 232, were also
found to be inactive, demonstrating that the presence of a carbonate moiety on the
dihydropyran does not solely determine the cytotoxicity of a Pd-AA cascade product
(Table 2.13).
Bartlett also submitted several Pd-AA cascade products for testing of their antibac-
terial activity against E. coli, S. aureus and M. smegmatis.19 However only products
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formed from bis-electrophile cis-42 were tested. Of the compounds tested, one, 46,
was found to display antibacterial activity against S. aureus. With an IC90 value of
1.35 mM, the activity was not high, but based on the trend noted from the HL-60 cy-
totoxicity studies, analogues with carbonate substituents on the dihydropyran ring
showed promise for increasing antibacterial activity. Therefore, 230, 45 and 229
were submitted for assessment of their antibacterial activity to compare with that
displayed by 46. Bacterial growth was measured using optical density (OD) and re-
sazurin reduction for E. coli and S. aureus. Cell growth ofM. smegmatis, in addition
to resazurin and OD, was measured with green fluorescent protein (GFP) expression
to infer inhibitory activity of the selected compounds. Whilst methylpyrone-derived
45 was found to show no antibacterial activity at the concentrations tested, the
carbonate analogue, 229, showed activity against S. aureus, complying with the
observed trend. Unfortunately, 230 was found to be inactive at the highest concen-
tration able to be tested, 0.5 mM, due to the limited availability of the compound,
and so a comparison with 46 cannot be made.
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Table 2.13 Bioactivity of selected Pd-AA cascade products
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46 230 45 229
240 214 215 241
211 221 232
Compound Cytotoxicity
a (IC50) Antibacterialb (IC90)
HL-60 (µM) 1A9 (µM) E. coli S. aureus M. smegmatis
46c >100 - inactive 1.35 mM inactive
230c 25 30d inactive inactive inactive
45c >250 - inactive inactive inactive
229c 21 30e inactive 0.5 mM inactive
240 >250 - - - -
214, 215f >250 - - - -
241 >250 >250 - - -
211 >250 >100 - - -
221 - - - - -
232 - - - - -
aCytotoxicity testing was performed by Arun Kanakkanthara and Deepanjan Ghosh.
bAntibacterial screening was performed by Nathaniel Dasyam.
cCompound synthesised by Dr Mark Bartlett.
dAverage of 3 consistent values; standard deviation = 4.5 µM.
eAverage of 3 consistent values; standard deviation = 0.9 µM.
fCompounds tested as a 1.3:1 mixture of 214:215.
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Chapter 3
Future Work and Conclusion
Throughout this thesis, there have been indications of further work that could be
explored. These aspects are outlined below alongside research that was not able to
be carried out due to the time constraints of the project.
3.1 Future Work on Perlin Aldehydes and Syn-
thesis of Hemiacetals (Section 2.1)
The discovery of the incongruencies in the assignment of the struture of trans-
aldehyde 176 was an interesting exercise and demonstrated just how important
it is to fully characterise compounds even when they have been reported in the
literature. Although it is clear from the evidence discussed in Section 2.1.4 that
the NMR shifts corresponding to a trans-aldehyde reported by Fraser-Reid in 1975,
and again in this work, are correctly assigned to the structure of Perlin aldehyde
176, the structure of Perlin’s aldehyde (242) remains unclear. Therefore a small
project for future work could be the synthesis and characterisation of aldehyde 242.
This could be done through either the repetition of Perlin’s 1975 reaction involving
HgSO4 or, as demonstrated in this research, the less toxic heating of tri-O-acetyl-d-
glucal in boiling water in the presence of light to aid formation of aldehyde products
(Scheme 3.1).
Formation of the Perlin aldehydes was not a desired outcome in this research and yet,
when working towards the synthesis of diacetate bis-electrophiles (153 and 172),
they were repeatedly isolated as by-products. In particular, the synthesis of interme-
diate hemiacetal 165 suffered because of facile ring-opening to form these aldehydes
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Scheme 3.1 Synthesis of Perlin aldehydes for the isolation and characterisation
of Perlin’s misassigned aldehyde 242
and so only moderate yields of 165 were achieved. It was therefore surprising that
the hydrolysis of tri-O-(methoxycarbonyl)-d-glucal (198) was not similarly plagued
by the formation of aldehyde by-products. In contrast, the reaction afforded the
desired hemiacetal (199) in quantitative yields in only half an hour and required
no work up. A computational study on the differences between the acetate and
carbonate versions of this reaction could provide some insight as to why diacetate
hemiacetal 165 has a greater affinity to ring open and rearrange to aldehyde prod-
ucts than its carbonate analogue (199).
Secondly, the transformation of 3,4,6-tri-O-(methoxycarbonyl)-d-glucal (198) to
hemiacetal 199 could become a useful high-yielding synthetic transformation, how-
ever the low yielding synthesis of the starting material, 198, from d-glucal (158)
is currently a limiting factor. Therefore, further optimisation of the protection of
d-glucal with methyl chloroformate would need to be carried out in future research
(Scheme 3.2) to make this a more attractive pathway than its acetate analogue.
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Reagents and Conditions: i) ClCO2Me; ii) H2O, 80 ◦C, 30 mins.
Scheme 3.2 Synthesis of hemiacetal 199 from d-glucal (158)
3.2 Future Work on 13C NMR Shielding Profile
(Section 2.2)
The 13C NMR shielding profile developed in Section 2.2 was found to fit well for a
range of tri-substituted glucose-derived dihydropyrans. However, while diacetylated
dihydropyran 103 (Figure 3.1) was found to fit the silhouette of the profile, it devi-
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ated in the magnitude of the ∆δC values. Future work could involve the synthesis
of other dihydropyrans with C-1 isopropyl ether substituents to explore the scope of
this discrepancy and extend the analytical method to a broader range of compounds.
In addition to this, computational studies on the effects of C-1 isopropxy groups on
the overall conformation of the dihydropyrans, when compared to the silyl and other
C-1 substituted compounds used in this study, may provide useful information.
O
AcO
OAc
OiPr
103
Figure 3.1 Bartlett’s tri-substituted dihydropyran 103
Furthermore, an extension of this study that would enhance this method of analysis
would be exploring the shielding profile of galactose-derived dihydropyrans (243,
Figure 3.2). The configurational difference at C-4 would allow determination of
whether the profile is consistent for all compounds with a cis- vs trans-relationship
between C-1 and C-4, or whether a new profile needs to be developed to account for
the altered C-4 - C-5 stereochemical relationship.
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Figure 3.2 Galactose-derived tri-substituted dihydropyrans
3.3 FutureWork on Pd-AA Cascades (Section 2.4)
Isolation of the desired products from the Pd-AA cascades of the methylated 4-
hydroxy-coumarins with Bartlett’s disubstituted dihydropyran cis-42 (such as in
Scheme 3.3) were only achieved in modest yields in this project, despite the ob-
servation of extremely clean 1H NMR spectra of the crude reaction mixtures (see
Section 2.4.2). The identification and suppression of one of the undesired products
(219), which formed during purification, increased the isolated yields marginally.
However, the chromatographic procedure needs to be improved so that the isolated
yields better represent the apparently near-quantitative conversion observed. Future
work could involve the use of an alternative solid phase for chromatography of the
cascade products. This would require determination of the current reasons for the
poor mass balance from silica gel column chromatography.
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Scheme 3.3 Degradation of Pd-AA cascade product 220 to 219
Other avenues for future work inspired by the scope studies of the Pd-AA cascades
could be in developing conditions that allow for the C-4 acetate bis-electrophile
153 to successfully undergo a Pd-AA cascade with Meldrum’s acid (Scheme 3.4).
Verdoorn’s success with a similar diacetate substrate39 suggests that this trans-
formation should work and therefore investigating the reactivity of 153 under a
variety of Pd-AA cascade conditions might extend the scope of the Pd-AA cascade
with Meldrum’s acid (Scheme 3.4). If unsuccessful, it might be useful to repeat Ver-
doorn’s 1989 synthesis and probe whether the results of this Pd-catalysed reaction
are reproducible.
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Scheme 3.4 Proposed investigation of the Pd-AA cascade of diacetate hemiacetal
153 with Meldrum’s acid
On a different note, testing the bioactivity of pyranone 225 (Figure 3.3), formed by
the Pd-AA cascade of carbonate bis-electrophile 178 with Meldrum’s acid, could
be a sensible pursuit. Section 2.4.3 described a number of similar mono-substituted
pyranones, which have been found to show bioactivity in a variety of assays.81 In
addition to this, the presence of a carbonate substitutent was demonstrated to in-
crease the activity of compounds tested in Section 2.6. Therefore, pyranone 225 has
the potential to show good bioactivity.
O O
OCO2Me
225
Figure 3.3 2H -pyran-2-one 225
79
3.4 FutureWork on Thromboxane Synthesis (Sec-
tion 2.5)
The work carried out in this project towards the synthesis of the thromboxanes
showed promise for improving on the current synthetic routes. However, this re-
search was not able to be continued to fruition due to time constraints. There is
definitely potential for future work towards either formal or total syntheses of the
thromboxanes, through employment of the extended Pd-AA cascade of 154 with
Meldrum’s acid (52) and water (Scheme 3.5). Optimisation of this cascade would
be required and could be explored through the use of other Pd catalysts, especially
those known to perform catalysis in the presence of water, e.g. Pd(OAc)2 and PdCl2,
in conjunction with different organic-aqueous solvent mixtures e.g. MeCN:H2O or
DMF:H2O and phase-transfer catalysts. In addition, carrying out an NMR scale re-
action of the current optimised conditions would reveal if the decarboxylation step
occurs prior to heating or upon concentration in vacuo during workup. If it is found
to not undergo decarboxylation at room temperature then probing the effects of
temperature on the reaction would be beneficial to its optimisation.
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Reagents and Conditions: i) catalyst (15 mol%), solvent, Meldrum’s acid (5 eq.), H2O.
Scheme 3.5 Extended Pd-AA cascade of 154 with Meldrum’s acid and water.
If the extended Pd-AA cascade is developed into an efficient transformation, a for-
mal total synthesis of the thromboxane intermediate 70 could be achieved in only
a few steps from 232, and would clearly demonstrate the synthetic utility of this
reaction (Scheme 3.6). The proposed total synthesis of the thromboxanes should
also be approached as a goal for future research, as it would be interesting to deter-
mine whether the glycal moiety can be retained throughout the synthesis, thereby
providing the potential to synthesise TXA2 as the primary target en route to TXB2.
This would be the first instance of an approach to TXA2 from a precursor other
than TXB2.
80
O
OCO2Me
O
O
H
H
O
OCO2Me
O
O
H
H
OMe O
OH
O
O
H
H
OMe
i - ii iii
232 244 70
Reagents and Conditions: i) Br2, MeOH; ii) Bu3SnH, AIBN, toluene; iii) K2CO3, MeOH.
Scheme 3.6 Proposed formal total synthesis of thromboxane intermediate 70
3.5 Concluding Remarks
The objectives of this project, i.e. to explore both the scope and utility of the
recently discovered Pd-AA cascade, were successfully achieved. A series of regioiso-
meric methylated 4-hydroxycoumarins were tested and found to be equally effective
as substrates in the Pd-AA cascade with both acyclic and cyclic bis-electrophiles.
Furthermore, four differentially protected bis-electrophiles based on glucose were
synthesised and tested as Pd-AA cascade substrates. The carbonate bis-electrophile
154 was shown to be an excellent substrate for reaction with a number of cyclic bis-
nucleophiles which afforded products that were found to have antibacterial activity
and bioactivity against two human cancer cell lines. In addition, bis-electrophile
154 was used in an extension of the Pd-AA cascade with Meldrum’s acid in the
presence of water. The resulting reaction showed the capacity to perform five syn-
thetic transformations in one-pot. This extended cascade is currently in the early
stages of optimisation, and has the potential to improve on the current syntheses of
the thromboxanes.
During this project, a number of other interesting discoveries were made. The first
was the development of a novel Ferrier reaction with silanol nucleophiles that pro-
duced diacetate bis-electrophile 153 in one step. Secondly, incongruent NMR data of
Perlin’s aldehyde 242 was uncovered through close evaluation of spectroscopic data
reported in the literature, accompanied by the 1D and 2D NMR spectroscopic anal-
ysis of Perlin aldehydes synthesised in this work. Finally, Bartlett’s 13C NMR shield-
ing profile for the stereochemical assignments of dihydropyrans was expanded with
the development of an average shielding profile for glucose-derived tri-substituted
dihydropyrans.
This project has explored and extended a variety of avenues of organic synthesis, and
has set the platform for future research in a number of areas. Most importantly, this
project has demonstrated the exciting area of chemistry that has opened up upon the
development of the Pd-AA cascade. It remains to be seen whether this cascade will
improve on the synthesis of the thromboxanes, yet the groundwork has been laid.
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The Pd-AA cascade holds the potential for providing efficient and elegant syntheses
of numerous synthetic targets and will undoubtedly find many future applications.
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Chapter 4
Experimental
4.1 General Experimental
Unless otherwise stated, the following conditions apply. All reactions were performed
in oven-dried glassware with magnetic stirring under an atmosphere of argon or ni-
trogen. Moisture- and oxygen-sensitive liquids and solutions were transferred using a
stainless steel syringe. Before use, solvents were refluxed over the appropriate drying
agent and distilled under nitrogen: tetrahydrofuran (THF) from sodium benzophe-
none ketyl radical; dichloromethane (DCM), acetonitrile (MeCN) and triethylamine
(NEt3) from calcium hydride; methanol (MeOH) and toluene from sodium. Anhy-
drous N,N -dimethylformamide (DMF) and acetic anhydride were used as purchased,
without further purification. All other reagents were of commercial quality and used
as received, without further purification.
Analytical thin layer chromatography (TLC) was performed using plastic-backed
pre-coated silica TLC plates (Polygram SilG/UV254). Visualisation was achieved
by UV irradiation (254 nm) or by heating after treatment with a potassium per-
manganate dip (1.5 g KMnO4, 10 g K2CO3, 1.25 mL of 10% aqueous NaOH solution
and 200 mL of water) or p-anisaldehyde dip (0.7 mL p-anisaldehyde, 9.5 mL conc.
H2SO4, 2.7 mL acetic acid and 250 mL of EtOH). The purification of products by
flash column chromatography was conducted using silica gel 60 (220-240 mesh) with
the solvent systems indicated. 1H NMR spectra were recorded a Varian Unity Inova
500 spectrometer at 500 MHz, a Varian DirectDrive 600 spectrometer at 600 MHz
or a Varian Inova 300 at 300 MHz. Data are listed as follows: chemical shift in ppm
using, as internal standard, chloroform (7.26 ppm) or water (4.79 ppm) or dimethyl-
sulfoxide (DMSO) (2.50 ppm), multiplicity [s = singlet, d = doublet, t = triplet, q
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= quartet, quint = quintet, m = multiplet or overlap of non-equivalent resonances,
br = broad, apt. = apparent, obs. = (partially) obscured], integration, peak assign-
ment. 13C NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at
125 MHz or a Varian DirectDrive 600 spectrometer at 150 MHz and the data listed
as follows: chemical shift in ppm using chloroform as internal standard (77.0 ppm)
or DMSO (39.5 ppm), multiplicity, peak assignment. The assignments of signals
are exclusively based on atom connectivity and spatial relationships are derived
from 2D NMR correlations (NOESY, 1H/1H-COSY, 1H/13C-HMBC and 1H/13C-
HSQC). IR bands were measured as either a thin film on a Bruker FT-IR Tensor
27 spectrometer with ATR sampling accessory or a sold or thin film on a Bruker
ALPHA FT-IR spectrometer or as a KBr disc on a Perkin-Elmer Spectrum One FT-
IR spectrometer. High-resolution mass spectrometry (HRMS) was performed on an
Agilent 6530 Accurate-Mass Q-TOF LC/MS mass spectrometer with Agilent Jet
Stream ESI source. Melting points were measured on a Gallenkamp melting point
apparatus with samples in a melting tube and are uncorrected. Optical rotations
were measured on an Autopol II polarimeter from Rudolph Research Analytical.
The structure of each compound is presented with the corresponding method of
preparation and spectroscopic data.
4.2 Experimental Methods and Characterisation
4.2.1 Experimental Details for Section 2.1.1
Tetra-O-acetyl-α-d-glucopyranosyl bromide (245)
5
4 3 2
1
O
OAc
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Using a modification of Kozikowski’s procedure,91 a magnetically stirred solution
of d-glucose 246 (150 mg, 0.8 mmol) in acetic anhydride (76 mL, 804.0 mmol)
was treated dropwise with conc. perchloric acid (0.45 mL, 6.9 mmol). Additional
d-glucose 246 (19.50 g, 108.2 mmol) was added slowly over one hour, at a rate
that maintained a temperature of 40− 50 ◦C. Upon complete addition of d-glucose,
the solution was allowed to cool to room temperature, then treated with a 33%
(w/w) solution of hydrobromic acid in acetic acid (93 mL, 0.517 mmol). After 90
minutes, the solution was diluted with dichloromethane (180 mL) and washed with
84
ice-cold water (2 x 100 mL), then cold sat. sodium bicarbonate solution (6 x 80
mL). The organic phase was dried with anhydrous magnesium sulfate, filtered and
concentrated to afford crude tetra-O-acetyl-α-d-glucopyranosyl bromide 245 as a
white solid (43.68 g, 106.2 mmol, 96%) that was used without purification. Spectral
data matched those which have been previously reported.92
1H-NMR: (500 MHz; CDCl3) δH 6.61 (d, J = 4.0 Hz, 1H, H-1), 5.56 (t, J = 10.0
Hz, 1H, H-3), 5.16 (t, J = 10.0 Hz, 1H, H-4), 4.84 (dd, J = 10.0, 4.0 Hz, 1H, H-2),
4.33 (dd, J = 12.5, 4.0 Hz, 1H, H-6a), 4.30 (m, 1H, H-5), 4.13 (dd, J = 12.5, 2.0
Hz, 1H, H-6b), 2.100 (s, 3H, CH3CO), 2.096 (s, 3H, CH3CO), 2.05 (s, 3H, CH3CO),
2.03 (s, 3H, CH3CO); 13C-NMR: (125 MHz; CDCl3) δC 170.5 (C, CH3CO), 169.83
(C, CH3CO), 169.77 (C, CH3CO), 169.4 (C, CH3CO), 86.5 (CH, C-1), 72.1 (CH,
C-5), 70.6 (CH, C-2), 70.1 (CH, C-3), 67.1 (CH, C-4), 60.9 (CH2, C-6), 20.66 (CH3,
CH3CO), 20.64 (CH3, CH3CO), 20.61 (CH3, CH3CO), 20.54 (CH3, CH3CO).
Tri-O-acetyl-d-glucal (102)
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A mechanically stirred dispersion of zinc dust (47.92 g, 733.1 mmol) in water (150
mL) was cooled to 0 ◦C, diluted with acetic acid (150 mL), then treated dropwise
with a solution of glucosyl 245 in diethyl ether (150 mL) over one hour. The reaction
was allowed to warm to room temperature and left to proceed overnight. The
solution was filtered, then diluted with dichloromethane (200 mL). The solution was
washed successively with water (3 x 60 mL), sat. sodium bicarbonate solution (4 x 50
mL), then brine (60 mL). The organic phase was dried with anhydrous magnesium
sulfate, filtered and concentrated to provide 102 as a white solid (26.3 g, 96.6 mmol,
91%). Spectral data matched those which have been previously reported.93
Rf 0.3 (25% EtOAc / pet. ether); [α]23D -19.32 (c 0.98, CH2Cl2); m.p. 55.6 – 56.2 ◦C
(lit.94 m.p. 50 – 52 ◦C); 1H-NMR: (500 MHz; CDCl3) δH 6.47 (d, J = 6.0 Hz,
1H, H-1), 5.34 (m, 1H, H-3), 5.23 (dd, J = 7.5, 6.0 Hz, 1H, H-4), 4.85 (dd, J =
6.5, 3.5 Hz, 1H, H-2), 4.40 (dd, J = 12.0, 6.0 Hz, 1H, H-6a), 4.26 (m, 1H, H-5),
4.20 (dd, J = 12.0, 3.0 Hz, 1H, H-6b), 2.10 (s, 3H, CH3CO), 2.08 (s, 3H, CH3CO),
2.05 (s, 3H, CH3CO); 13C-NMR: (125 MHz; CDCl3) δC 170.6 (C, CH3CO), 170.4
(C, CH3CO), 169.6 (C, CH3CO), 145.6 (CH, C-1), 99.0 (CH, C-2), 73.9 (CH, C-5),
67.4 (CH, C-3), 67.2 (CH, C-4), 61.4 (CH, C-6), 21.0 (CH3, CH3CO), 20.8 (CH3,
CH3CO), 20.7 (CH3, CH3CO); IR: νmax 2959, 1731, 1647, 1370, 1208, 1024, 900
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cm-1.
d-Glucal (158)
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Sodium (77 mg, 0.033 mmol) was added to methanol (60 mL) and allowed to re-
act. This was followed by addition of protected glucal 102 (2.75 g, 0.01 mol).
The reaction was stirred at room temp for 10 minutes and then the solution was
concentrated to provide crude d-glucal 158. The crude product was treated with
methanol (2 mL), then successively diluted with acetone (10 mL) and diethyl ether
(20 mL), which led to the precipitation of impurities. The solution was filtered and
conentrated to afford 158 (1.33 g, 90%) as a very viscous orange oil. Spectral data
matched those which have been previously reported.91
1H-NMR: (500 MHz; D2O) δH 6.36 (dd, J = 6.0, 1.5 Hz, 1H, H-1), 4.74 (dd, J =
6.0, 2.0 Hz, 1H, H-2), 4.17 (dt, J = 7.0, 2.0 Hz, 1H, H-3), 3.82 (complex m, 3H,
H-5, 6-a, 6-b), 3.62 (dd, J = 9.0, 7.0 Hz, 1H, H-4); 13C-NMR: (125 MHz; D2O) δC
143.7 (CH, C-1), 102.8 (CH, C-2), 78.1 (CH, C-5), 68.7 (CH, C-4), 68.3 (CH, C-3),
60.0 (CH2, C-6).
(1R)-1-(2-Furanyl)-1,2-ethanediol (159)
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To a solution of d-glucal 158 (93 mg, 0.638 mmol) in 14:1 acetonitrile:water (2.8
mL:0.2 mL) was added FeCl3 · 6H2O (17 mg, 0.064 mmol). The reaction was heated
at reflux overnight then quenched with saturated aqueous NaHCO3 solution, ex-
tracted with DCM (3 x 20 mL), dried with anhydrous Na2SO4 and concentrated to
produce 159 (58 mg, 0.453 mmol, 71%) as a colourless oil. Spectral data matched
those which have been previously reported.47
1H-NMR: (500 MHz; CDCl3) δH 7.40 (s, 1H, H-1), 6.36 (dd, J = 3.0, 1.5 Hz, 1H,
H-2), 6.33 (apt. d, J = 3.5 Hz, 1H, H-3), 4.82 (t, J = 10.0 Hz, 1H, H-5), 3.89 (m,
2H, H-6a, 6b), 2.50 (br s, J = 5.0 Hz, 1H, OH), 2.04 (br s, J = 6.3 Hz, 1H, OH).
13C-NMR: (125 MHz; CDCl3) δC 153.5 (CH, C-4), 142.4 (CH, C-1), 110.3 (CH,
C-3), 107.1 (CH, C-2), 68.3 (CH, C-5), 65.1 (CH2, C-6).
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(1R)-1-(2-furanyl)-2-tert-butyldimethylsiloxyethan-ol (155) and (1R)- 1-
(2-furanyl)-1,2-di-tert-butyldimethylsiloxyethane (163)
A solution of diol 159 (100 mg, 0.781 mmol) in DCM (5 mL) and NEt3 (850 µL,
1.17 mmol) was cooled to -78 ◦C and TBSOTf (238 muL, 0.781 mmol) was added.
The reaction was left to warm to room temperature overnight. On return, the re-
action was diluted with DCM (10 mL), quenched with saturated aqueous NH4Cl
solution (10 mL), extracted with DCM (3 x 25 mL), dried with anhydrous Na2SO4
and concentrated to afford a mixture of products as a colourless oil (376 mg). Chro-
matography of the oil (5 - 15% EtOAc / pet. ether) afforded the desired product 155
(70 mg, 0.289 mmol, 37%) and di-protected furan 163 (68 mg, 0.191 mmol, 24%)
as colourless oils. Spectral data of 155 matched those which have been previously
reported.95
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Rf 0.3 (20% EtOAc / pet. ether); [α]26.4D +17.19 (c 1.015, CH2Cl2); (lit.96 [α]21.0D
+15.9 (c 1.37, CH2Cl2)); 1H-NMR: (500 MHz; CDCl3) δH 7.37 (s, 1H, H-1), 6.34-
6.30 (complex m, 2H, H-2,3), 4.76 (dd, J = 7.0, 4.0 Hz, 1H, H-5), 3.88-3.81 (complex
m, 2H, H-6a, 6b), 2.84 (d, J = 4.0 Hz, 1H, OH), 0.90 (s, 9H, OSiC(CH3)3), 0.07
(s, 3H, OSiCH3), 0.06 (s, 3H, OSiCH3), 13C-NMR: (125 MHz; CDCl3) δC 153.6
(C, C-4), 142.0 (CH, C-1), 110.2 (CH, C-3), 107.0 (CH, C-2), 68.3 (CH, C-5), 65.6
(CH2, C-6), 25.8 (CH3, OSiC(CH3)3), 18.3 (C, OSi(CH3)3), -5.4 (CH3, OSiCH3),
-5.5 (CH3, OSiCH3); IR: (Film from CDCl3) νmax 3437, 2954, 2930, 2885, 2858,
1472, 1464, 1255, 1148, 1117, 1006, 837, 778 cm-1.
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1H-NMR: (500 MHz; CDCl3) δH 7.34 (t, J = 1.0 Hz, 1H, H-1), 6.30 (dd, J = 3.0,
1.5 Hz, 1H, H-2), 6.22 (d, J = 3.0 Hz, 1H, H-3), 4.72 (t J = 6.5 Hz, 1H, H-5),
3.80 (dd J = 10.0, 6.0 Hz, 1H, H-6a), 3.75 (dd J = 10.0, 7.0 Hz, 1H, H-6b), 0.86
(s, 9H, OSiC(CH3)3), 0.85 (s, 9H, OSiC(CH3)3), 0.06 (s, 3H, OSiCH3), 0.01 (s, 3H,
OSiCH3), -0.01 (s, 3H, OSiCH3), -0.03 (s, 3H, OSiCH3).
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4.2.2 Experimental Details for Section 2.1.2
tert-Butyldimethylsilanol (164)
Si 2
1
1
1
3
HO
3
164
Following a literature method,54 a solution of TBSCl (402 mg, 2.66 mmol) in Et2O
(8 mL) was added dropwise to an ice-cold solution of KOH (146 mg, 2.60 mmol) in a
mixture of H2O (4 mL) and MeOH (1 mL). The acidic solution was then neutralised
by addition of aq. KOH solution. The reaction was stirred for 10 minutes and then
extracted with Et2O (3 x 20 mL). The combined organic extracts were dried over
MgSO4 and concentrated to afford the desired product 164 (291 mg, 2.20 mmol,
83%) as a colourless oil. Spectral data matched those which have been previously
reported.97
1H-NMR: (500 MHz; CDCl3) δH 1.45 (br s, OH), 0.91 (s, 9H, H-1), 0.10 (s, 6H,
H-3); 13C-NMR: (125 MHz; CDCl3) δC 25.6 (CH3, C-1), 18.0 (C, C-2), -3.6 (CH3,
C-3); IR: (Film from CDCl3) νmax 3299, 2955, 2929, 2857, 1471, 1464, 1254, 832,
770, 668 cm-1.
4,6-Di-O-acetyl-1-O-(tert-butyldimethylsilyl)-2,3-dideoxy-d-erythro-hex-2-
enopyranoside (153)
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Method AMolecular sieves were stirred in DCM (10 mL) for 5 minutes, whereupon
TBSOH (81 mg, 0.612 mmol) was added and the solution was stirred for a further
5 minutes. 3,4,6-Tri-O-acetyl-d-glucal (102) (166 mg, 0.610 mmol) and Montmo-
rillonite K10 (572 mg) were added and the reaction was heated at reflux overnight.
The reaction mixture was filtered through Celite™, washed with dichloromethane,
and concentrated to give the crude product as a yellow oil. Chromatography of the
oil (10% EtOAc / pet. ether) afforded a 1.7:1 α:β anomeric mixture of 153 (67 mg,
0.198 mmol, 32%) as a colourless oil.
Method B TBSCl (936 mg, 6.21 mmol) was added to a solution of hemiacetal 165
(1.3 g, 5.65 mmol), AgNO3 (1.05 g 6.21 mmol) and pyridine (502 µL, 6.21 mmol) in
DCM (50 mL) and left to react overnight. The solution was filtered through Celite™,
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washed with DCM (50 mL) and then the organic extract was extracted with aq.
sat. CuSO4 solution (2 x 50 mL) to afford the crude product as a colourless oil.
Chromatography of this oil (10% EtOAc / pet. ether) afforded a 2:1 α:β anomeric
mixture of 153 (1.43 g, 4.15 mmol, 73%) as a colourless oil.
Rf 0.6 (20% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH Major anomer
(α): 5.79 (complex m, 2H, H-2, 3), 5.36 (s, 1H, H-1), 5.27 (d, J = 9.5 Hz, 1H, H-4),
4.24-4.14 (obs. m, 3H, H-5, 6a, 6b), 2.09 (s, 6H, CH3CO), 0.91 (s, 9H, OSiC(CH3)3),
0.14 (s, 6H, OSiCH3); Minor Anomer (β): 5.87 (complex m, 2H, H-2, 3), 5.42
(s, 1H, H-1), 5.24 (dt, J = 6.0, 2.0 Hz, 1H, H-4), 4.24-4.14 (obs. m, 2H, H-6a,
6b), 3.96 (dd, J = 12.0, 5.5 Hz, 1H, H-5), 2.076 (s, 3H, CH3CO), 2.075 (s, 3H,
CH3CO), 0.90 (s, 9H, OSiC(CH3)3), 0.15 (s, 6H, OSiCH3); 13C-NMR: (125 MHz;
CDCl3) δC Major anomer (α): 170.9 (C, CH3CO), 170.34 (C, CH3CO), 130.3
(CH, C-2), 127.0 (CH, C-3), 89.1 (CH, C-1), 66.8 (CH, C-5), 65.4 (CH, C-4), 63.3
(CH2, C-6), 25.6 (CH3, OSiC(CH3)3), 21.0 (CH3, CH3CO), 20.8 (CH3, CH3CO),
18.0 (C, OSi(CH3)3), -4.4 (CH3, OSiCH3), -5.3 (CH3, OSiCH3); Minor Anomer
(β): 170.7 (C, CH3OCO), 170.30 (C, CH3OCO), 133.0 (CH, C-2), 125.3 (CH, C-
3), 91.0 (CH, C-1), 73.0 (CH, C-5), 64.8 (CH, C-4), 63.4 (CH2, C-6), 25.7 (CH3,
OSiC(CH3)3), 21.0 (CH3, CH3CO), 20.8 (CH3, CH3CO), 18.0 (C, OSi(CH3)3), -4.1
(CH3, OSiCH3), -5.0 (CH3, OSiCH3); IR: (Film from CDCl3) νmax 2955, 2930, 2897,
2858, 1743, 1370, 1225, 1033, 838, 781 cm-1; HRMS: m/z C16H28NaO6Si+ [M+Na]+
calcd 367.1547, found 367.1549.
tert-Butyldiphenylsilanol (247)
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A solution of TBDPSCl (100 mg, 0.364 mmol) in Et2O (8 mL) was added dropwise
to an ice-cold solution of KOH (20 mg, 0.364 mmol) in a mixture of H2O (4 mL) and
MeOH (1 mL). The acidic solution was then neutralised by addition of aq. KOH
solution. The reaction was stirred for 5 hours and then extracted with Et2O (3 x
20 mL). The combined organic extracts were dried over MgSO4 and concentrated to
afford the desired product 247 (47 mg, 2.20 mmol, 50%) as a white solid. Spectral
data matched those which have been previously reported.97
m.p. 63.8 – 65.2 ◦C; 1H-NMR: (500 MHz; CDCl3) δH 7.72 (d, J = 6.5 Hz, 4H,
H-4), 7.44-7.37 (complex m, 6H, H-5, 6), 2.15 (br s, 1H, OH), 1.08 (s, 9H, H-1);
13C-NMR: (125 MHz; CDCl3) δC 135.1 (C, C-3), 134.8 (CH, C-4), 129.6 (CH, C-
89
6), 127.7 (CH, C-5), 26.5 (CH3, C-1), 19.0 (C, C-2); IR: (Film from CDCl3) νmax
3619, 3417, 3071, 2957, 2930, 2890, 2857, 1471, 1428, 1113, 819, 699, 608 cm-1.
4.2.3 Experimental Details for Section 2.1.3
4,6-Di-O-acetyl-2,3-dideoxy-d-erythro-hex-2-enopyranose (165) and (2E,
4S,5R)-4,6-di-O-acetyl-5-hydroxy-hex-2-enal (166) and (2E,4S,5R)-5,6-
diacetate-4-hydroxy-hex-2-enal (176)
Under atmospheric conditions, in the dark, tri-O-acetyl-d-glucal (102) (1.99 mg,
7.30 mmol) was dissolved in 50 mL H2O and the mixture was heated to 80 ◦C
whereupon all solid dissolved. After 5 hours the reaction mixture was cooled to
room temperature, extracted with ethyl acetate (3 x 50 mL), dried with anhydrous
MgSO4, and concentrated to afford a crude 20:12:1 mixture of 165:166:176 . Chro-
matographic separation (25% - 50% EtOAc / pet. ether) afforded a 2:1 α:β anomeric
mixture of 165 (1.00 g, 4.34 mmol, 60%), 166 (504 mg, 2.19 mmol, 30%) and 176
(44 mg, 0.19 mmol, 3%) as colourless oils. Spectral data of all three matched those
reported previously.64, 45, 69
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Rf 0.5 (50% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH Major
Anomer (α): 5.89-5.84 (m, 2H, H-2,3), 5.43 (br s, 1H, H-1), 5.27 (d, J = 9.0
Hz, 1H, H-4), 4.25-4.15 (complex m, 3H, H-5, 6a, 6b), 3.67 (d, J = 5.0 Hz, 1H, OH),
2.08 (s, 3H, CH3CO), 2.07 (s, 3H, CH3CO); Minor Anomer (β): 5.94-5.89 (m,
2H, H-2,3), 5.42 (br s, 1H, H-1), 5.24 (d, J = 7.0 Hz, 1H, H-4), 4.25-4.17 (complex
m, 2H, H-6a, 6b), 3.94 (ddd, J = 7.0, 5.5, 4.5 Hz, 1H, H-5), 3.84 (d, J = 7.5 Hz, 1H,
OH), 2.07 (s, 3H, CH3CO), 2.06 (s, 3H, CH3CO); 13C-NMR: (125 MHz; CDCl3)
δC Major Anomer (α): 171.0 (C, CH3CO), 170.34 (C, CH3CO), 129.0 (CH, C-
3), 128.4 (CH, C-2), 88.7 (CH, C-1), 66.8 (CH, C-5), 65.1(CH, C-4), 63.0 (CH2,
C-6), 20.93 (CH3, CH3CO), 20.75 (CH3, CH3CO); Minor Anomer (β): 170.9 (C,
CH3CO), 170.30 (C, CH3CO), 131.2 (CH, C-3), 127.4 (CH, C-2), 90.9 (CH, C-1),
73.1 (CH, C-5), 64.5 (CH, C-4), 63.3 (CH2, C-6), 20.90 (CH3, CH3CO), 20.76 (CH3,
CH3CO); IR: (Film from CH2Cl2) νmax 3433, 2953, 1736, 1370, 1221, 1029, 1018
cm-1;
Rf 0.3 (60% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 9.59 (d, J = 7.5
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Hz, 1H, H-1), 6.88 (dd, J = 16.0, 5.0 Hz, 1H, H-3), 6.26 (dd, J = 16.0, 7.5 Hz, 1H,
H-2), 5.56 (apt. t, J = 5.0 Hz, 1H, H-4), 4.21 (d, J = 4.5 Hz, 2H, H-6a, 6b), 4.06
(dd, J = 11.0, 5.5 Hz, H-5), 2.67 (br s, 1H, OH), 2.16 (s, 3H, CH3CO), 2.11 (s, 3H,
CH3CO); 13C-NMR: (125 MHz; CDCl3) δC 192.6 (CH, C-1), 171.3 (C, CH3CO),
169.5 (C, CH3CO), 149.6 (CH, C-3), 133.2 (CH, C-2), 72.3 (CH, C-4), 71.1 (CH,
C-5), 64.7 (CH2, C-6), 20.76 (CH3, CH3CO), 20.75 (CH3, CH3CO); IR: (Film from
CDCl3) νmax 3470, 1740, 1690, 1373, 1225, 1042 cm-1.
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Rf 0.4 (60% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 9.60 (d, J =
7.5 Hz, 1H, H-1), 6.79 (dd, J = 16.0, 4.0 Hz, 1H, H-3), 6.41 (dd, J = 16.0, 8.0 Hz,
1H, H-2), 5.08 (obs. m, 1H, H-5), 4.58 (obs. m, 1H, H-4), 4.34 (obs.m, 2H, H-6a,
6b), 3.02 (br s, 1H, OH), 2.11 (s, 3H, CH3CO), 2.09 (s, 3H, CH3CO); 13C-NMR:
(125 MHz; CDCl3) δC 192.9 (CH, C-1), 171.1 (C, CH3CO), 170.3 (C, CH3CO),
152.4 (CH, C-3), 132.9 (CH, C-2), 73.4 (CH, C-5), 70.0 (CH, C-4), 61.8 (CH2, C-6),
20.9 (CH3, CH3CO), 20.7 (CH3, CH3CO); IR: (Film from CDCl3) νmax 3467, 2959,
1734, 1689, 1370, 1218, 1037 cm-1.
2-Iodoxybenzoic Acid (IBX) (248)
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Following a literature procedure,63 under atmospheric conditions, 2-iodobenzoic acid
(3.49 g, 0.014 mol) was added in one portion to a solution of Oxone (25.99 g, 0.042
mol) in deionized water (200 mL) The reaction mixture was warmed to 70 ◦C for
3 h. The suspension was then cooled to 0 ◦C and left at this temperature for 30
mins with slow stirring. The mixture was filtered through a sintered-glass funnel,
and the solid was washed with ice-cold water (50 mL) and acetone (50 mL). The
solid was left to dry in a dessicator for 5 days to give the desired product 248 (2.5
g, 8.93 mmol, 63%) as a white powder. CAUTION! IBX is explosive under impact
or sporadically upon heating to >200 ◦C.98
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m.p. 226.1 – 226.4 ◦C (lit.63 m.p. 232 – 233 ◦C).
Fétizon’s reagent
Following a literature procedure,99 Celite™ (2.00 g) was purified by washing succes-
sively with methanol containing 10% HCl solution (100 mL) and then with distilled
water until neutral and then oven-dried overnight. The purified Celite™ (1 g) was
added to a solution of silver nitrate (1.14 g, 6.71 mmol) in distilled water (6.7 mL).
A solution of Na2CO3.10H2O (1.02 g, 3.56 mmol) in distilled water (10 mL) was
then added slowly to the resulting homogeneous suspension and stirred vigorously
for 15 mins. The yellow-green precipitate formed was then filtered off and dried on
a rotary evaporator over six hours. The resulting grey solid, Fétizon’s reagent, was
stored in a dessicator under vacuum in the dark. According to the literature,99 the
reagent contains approx. 1 mmol of Ag2CO3 per 0.57 g.
4,6-Di-O-acetyl-2,3-dideoxy-d-erythro-hex-2-enono-1,5-lactone (172)
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To a solution of 165 (280 mg, 1.22 mmol) in benzene (13 mL) at 50 ◦C was added
Fétizon’s reagent 249 (0.72 g, 1.26 mmol). The solution was then heated at reflux
overnight. The resulting black suspension was cooled to room temperature, filtered
through Celite™, washed with ethyl acetate (50 mL) and concentrated to give 172
(240 mg, 1.05 mmol, 86%) as a colourless oil. Spectral data matched those which
have been previously reported.62
Rf 0.5 (50% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 6.79 (dd, J =
10.0, 3.0 Hz, 1H, H-3), 6.12 (dd, J = 10.0, 1.5 Hz, 1H, H-2), 5.54 (ddd, J = 8.0,
3.0, 2.0 Hz, 1H, H-4), 4.66 (ddd, J = 8.0, 4.5, 3.5 Hz, 1H, H-5), 4.35 (dd, J = 12.5,
4.5 Hz, 1H, H-6a), 4.27 (dd, J = 12.5, 4.0 Hz, 1H, H-6b), 2.15 (s, 3H, CH3CO), 2.10
(s, 3H, CH3CO); 13C-NMR: (125 MHz; CDCl3) δC 170.4 (C, CH3CO), 169.7 (C,
CH3CO), 161.1 (C, C-1), 143.2 (CH, C-3), 122.4 (CH, C-2), 77.3 (CH, C-5), 63.4
(CH, C-4), 62.0 (CH, C-6), 20.72 (CH3, CH3CO), 20.67 (CH3, CH3CO); IR: (Film
from CH2Cl2) νmax 2958, 1736, 1371, 1221, 1113, 1047, 818 cm-1.
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4.2.4 Experimental Details for Section 2.1.5
tert-Butyldimethylsilyl-2,3-dideoxy-d-erythro-hex-2-enopyranoside (179)
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Sodium (10 mg, 0.435 mmol) was added to methanol (2 mL) and allowed to re-
act. This was followed by addition of a solution of 165 (280 mg, 0.813 mmol) in
methanol (2 mL). The reaction was stirred at room temp for 15 minutes and then
the solution was concentrated to afford the crude product as a viscous yellow oil.
Chromatography of the oil (1:1 hexanes:ethyl acetate) afforded a 1.7:1 α:β anomeric
mixture of 179 (179 mg, 0.688 mmol, 85%) as a colourless oil.
Rf 0.3 (40% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH Major anomer
(α): 5.88 (d, J = 10.0 Hz, 1H, H-3), 5.72 (dt, J = 10.0, 2.5 Hz, 1H, H-2), 5.33
(s, 1H, H-1), 4.23 (m, 1H, H-4), 3.86-3.71 (obs. m, 3H, H-5, 6a, 6b), 1.89 (t, J =
6.0 Hz, 1H, OH), 1.84 (obs. m, 1H, OH), 0.90 (s, 9H, OSiC(CH3)3), 0.13 (s, 6H,
OSiCH3); Minor Anomer (β): 5.96 (ddd, J = 10.3, 3.5, 1.5 Hz, 1H, H-3), 5.77
(dt, J = 10.0, 1.5 Hz, 1H, H-2), 5.43 (s, 1H, H-1), 4.16 (m, 1H, H-4), 3.86-3.71 (obs.
m, 3H, H-5, 6a, 6b), 2.37 (t, J = 6.5 Hz, 1H, OH), 1.84 (obs. m, 1H, OH), 0.93 (s,
9H, OSiC(CH3)3), 0.16 (s, 6H, OSiCH3); 13C-NMR: (125 MHz; CDCl3) δC Major
anomer (α): 131.2 (CH, C-3), 129.0 (CH, C-2), 89.0 (CH, C-1), 71.1 (CH, C-5),
64.5 (CH, C-4), 63.0 (CH2, C-6), 25.68 (CH3, OSiC(CH3)3), 18.0 (C, OSi(CH3)3),
-4.3(CH3, OSiCH3), -5.3 (CH3, OSiCH3); Minor Anomer (β): 130.7 (CH, C-3),
130.1 (CH, C-2), 91.0 (CH, C-1), 78.4 (CH, C-5), 63.5 (CH, C-4), 63.4 (CH2, C-6),
25.69 (CH3, OSiC(CH3)3), 18.1 (C, OSi(CH3)3), -4.1 (CH3, OSiCH3), -4.9 (CH3,
OSiCH3); IR: (Film from CDCl3) νmax 3362, 2954, 2929, 2895, 2857, 1253, 1030,
999, 875, 837, 780 cm-1; HRMS: m/z C12H25O4Si+ [M+H]+ calcd 261.1517, found
261.1514.
(1R)-1-(2-furanyl)-2-(methoxycarbonyl)ethan-ol (182) and (4R)-4-(2-fura-
nyl)-1,3-dioxolan-2-one) (183) and (1R)-1-(2-furanyl)-1,2-di-(methoxycar-
bonyl)ethane (181)
A solution of diol 179 (67 mg, 0.258 mmol) in THF (5 mL) was cooled to 0 ◦C and
DMAP (79 mg, 0.647 mmol) and methyl chloroformate (50 µL, 0.652 mmol) was
added. The reaction was allowed to warm to room temperature overnight and then
the solution was concentrated to afford a yellow oil. Chromatography of the oil (20 -
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30% EtOAc / pet. ether) afforded three undesired furan products; diprotected furan
181 (17 mg, 0.071 mmol, 28%) as a colourless oil and a 1.4:1 mixture of 182 and
183 (11 mg, 0.062 mmol, 24%) as a colourless oil. Spectral data of 183 matched
those which have been previously reported.73
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Rf 0.6 (30% EtOAc / pet. ether); [α]23.0D +89.50 (c 0.9, CH2Cl2); 1H-NMR: (500
MHz; CDCl3) δH 7.42 (s, 1H, H-1), 6.48 (d, J = 3.0 Hz, 1H, H-3), 6.37 (dd, J = 3.0,
2.0 Hz, 1H, H-2), 5.95 (dd, J = 8.0, 4.0 Hz, 1H, H-5), 4.57 (dd, J = 12.0, 8.5 Hz,
1H, H-6a), 4.52 (dd, J = 12.0, 4.0 Hz, 1H, H-6b), 3.80 (s, 3H, CH3OCO), 3.79 (s,
3H, CH3OCO); 13C-NMR: (125 MHz; CDCl3) δC 155.3 (C, CH3OCO), 154.9 (C,
CH3OCO), 148.1 (CH, C-4), 143.4 (CH, C-1), 110.5 (CH, C-2), 110.4 (CH, C-3),
70.0 (CH, C-5), 66.4 (CH2, C-6), 55.12 (CH3, CH3OCO), 55.10 (CH3, CH3OCO);
IR: (Film from CH2Cl2) νmax 2960, 1745, 1441, 1279, 1239, 938, 787, 749 cm-1;
HRMS: m/z C10H16NO+7 [M+NH4]+ calcd 262.0921, found 262.0922.
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Rf 0.2 (40% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 182: 7.40 (s,
1H, H-1), 6.36 (m, 2H, H-2, 3), 5.00 (br s, 1H, H-5), 4.45-4.43 (obs. m, 2H, H-6a,
6b), 3.81 (s, 3H, CH3OCO), 2.49 (br s, 1H, OH); 183: 7.52 (s, 1H, H-1), 6.58 (d, J
= 2.5 Hz, 1H, H-2), 6.43 (dd, J = 3.0, 2.0 Hz, 1H, H-3), 5.69 (t, J = 8.0 Hz, 1H,
H-5), 4.69 (complex m, 2H, H-6a, 6b); IR: (Film from CH2Cl2) νmax 3469, 3127,
2961, 1796, 1747, 1444, 1269, 1168, 1151, 1067 cm-1.
3,4,6 Tri-O-methoxycarbonyl-d-glucal (198) and 3,6-di-O-methoxycarbonyl-
d-glucal (250) and 4,6-di-O-methoxycarbonyl-d-glucal (251)
To a solution of d-glucal 158 (1.87 g, 12.8 mmol) in THF (150 mL) at 0 ◦C was
added DMAP (5.01 g, 41.0 mmol), followed by methyl chloroformate (3.1 mL, 41.0
mmol). The reaction was allowed to warm to room temperature and left to proceed
overnight. The solution was filtered through Celite™, washed with dichloromethane
(50 mL), and concentrated to give the crude products 198:250:251 as an off-white
solid in 8:1:1 ratio. Chromatography of the solid (30% EtOAc / pet. ether) afforded
198 (2.15 g, 6.70 mmol, 52%) as a white solid, 250 (517 mg, 1.97 mmol, 15%) as
a colourless oil and 251 (300 mg, 1.14 mmol, 9%) as a colourless oil in a combined
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yield of 76%.
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Rf 0.45 (30% EtOAc / pet. ether); [α]21D -23.4 (c 1.085, CH2Cl2); m.p. 66.1 –
66.9 ◦C; 1H-NMR: (500 MHz; CDCl3) δH 6.48 (d, J = 6.0 Hz, 1H, H-1), 5.22 (t,
J = 4.0 Hz, 1H, H-3), 5.09 (t, J = 6.5 Hz, 1H, H-4), 4.94 (dd, J = 6.0, 3.5 Hz, 1H,
H-2), 4.47 (dd, J = 12.0, 6.0 Hz, 1H, H-6a), 4.36 (complex m, 1H, H-5), 4.32 (dd, J
= 12.0, 4.0 Hz, 1H, H-6b), 3.82 (s, 3H, CH3OCO), 3.80 (s, 3H, CH3OCO), 3.79 (s,
3H, CH3OCO); 13C-NMR: (125 MHz; CDCl3) δC 155.4 (C, CH3OCO), 154.9 (C,
CH3OCO), 154.5 (C, CH3OCO), 146.0 (CH, C-1), 97.9 (CH, C-2), 73.4 (CH, C-5),
70.7 (CH, C-4), 70.2 (CH, C-3), 64.7 (CH2, C-6), 55.4 (CH3, CH3OCO), 55.1 (CH3,
CH3OCO), 55.0 (CH3, CH3OCO); IR: (KBr) νmax 3012, 2962, 1758, 1736, 1654,
1447, 1318, 1267, 1244, 1097, 955, 937 cm-1; HRMS: m/z C12H16O10Na+ [M+Na]+
calcd 343.0636, found 343.0642.
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Rf 0.28 (30% EtOAc / pet. ether); [α]26.0D +38.42 (c 1.26, CH2Cl2); 1H-NMR: (500
MHz; CDCl3) δH 6.44 (d, J = 6.5 Hz, 1H, H-1), 5.20 (d, J = 6.5 Hz, 1H, H-3), 4.79
(dd, J = 6.0, 2.5 Hz, 1H, H-2), 4.56 (dd, J = 12.0, 4.0 Hz, 1H, H-6a), 4.48 (dd, J =
12.0, 2.0 Hz, 1H, H-6b), 4.02 (ddd, J = 10.0, 4.0, 2.0 Hz, 1H, H-5), 3.95 (ddd, J =
10.5, 6.5, 3.5 Hz, 1H, H-4), 3.82 (s, 6H, CH3OCO), 3.44 (d, J = 3.5 Hz, 1H, OH);
13C-NMR: (125 MHz; CDCl3) δC 156.4 (C, CH3OCO), 156.1 (C, CH3OCO), 146.3
(CH, C-1), 98.8 (CH, C-2), 76.2 (CH, C-5), 76.1 (CH, C-3), 66.9 (CH, C-4), 65.7
(CH2, C-6), 55.2 (CH3, CH3OCO), 55.2 (CH3, CH3OCO); IR: (Film from CH2Cl2)
νmax 3436, 2960, 1749, 1443, 1270, 1050, 790 cm-1; HRMS: m/z C10H14O8Na+
[M+Na]+ calcd 285.0581, found 285.0584.
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Rf 0.14 (30% EtOAc / pet. ether); [α]26D +43.45 (c 1.065, CH2Cl2); 1H-NMR:
(500 MHz; CDCl3) δH 6.40 (d, J = 5.5 Hz, 1H, H-1), 4.51 (obs. m, 2H, H-2,4),
4.44-4.39 (m, 3H, H-3,6a,6b), 4.19 (ddd, J = 8.5, 5.5, 3.0 Hz, 1H, H-5), 3.84 (s, 3H,
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CH3OCO), 3.80 (s, 3H, CH3OCO) 2.44 (d, J = 5.5 Hz, 1H, OH); 13C-NMR: (125
MHz; CDCl3) δC 155.6 (C, CH3OCO), 155.5 (C, CH3OCO), 144.1 (CH, C-1), 102.5
(CH, C-2), 74.9 (CH, C-4), 73.4 (CH, C-5), 66.8 (CH, C-3), 65.3 (CH2, C-6), 55.5
(CH3, CH3OCO), 55.1 (CH3, CH3OCO); IR: (Film from CH2Cl2) νmax 3497, 2961,
1749, 1650, 1443, 1259 cm-1; HRMS: m/z C10H14O8Na+ [M+Na]+ calcd 285.0581,
found 285.0583.
4,6-Di-O-(methoxycarbonyl)-2,3-dideoxy-d-erythro-hex-2-eno-pyranose (199)
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A solution of tricarbonate 198 (590 mg, 1.84 mmol) in H2O was stirred at 80 ◦C for
30 minutes. The solution was then cooled to room temperature and concentrated to
afford a 3:1 α:β anomeric mixture of 199 (470 mg, 1.79 mmol, 97%) as a colourless
oil.
Rf 0.43 (50% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH Major
Anomer (α): 6.02 - 5.89 (obs. m, 2H, H-2,3), 5.46 (br s, 1H, H-1), 5.17 (d, J =
10.0 Hz, 1H, H-4), 4.38 (dd, J = 12.0, 2.0 Hz, 1H, H-6a), 4.29 (dd, J = 12.0, 5.0
Hz, 1H, H-6b), 4.25-4.22 (obs. m, 1H, H-5), 3.82 (s, 3H, CH3OCO), 3.80 (s, 3H,
CH3OCO), 2.99 (d, J = 5.0 Hz, 1H, OH);Minor Anomer (β): 6.02 - 5.89 (obs. m,
2H, H-2,3), 5.46 (br s, 1H, H-1), 5.13 (d, J = 6.5 Hz, 1H, H-4), 4.35 (obs. m, 1H, H-
6a), 4.25-4.22 (obs. m, 1H, H-6b), 4.05 (dt, J = 10.0, 5.0 Hz, 1H, H-5), 3.81 (s, 3H,
CH3OCO), 3.80 (s, 3H, CH3OCO), 3.10 (d, J = 8.0 Hz, 1H, OH); 13C-NMR: (125
MHz; CDCl3) δC Major Anomer (α): 155.6 (C, CH3OCO), 155.03 (C, CH3OCO),
128.7 (CH, C-3), 128.6 (CH, C-2), 88.8 (CH, C-1), 68.6 (CH, C-4), 66.5 (CH, C-5),
66.3 (CH2, C-6), 55.21 (CH3, CH3OCO), 55.00 (CH3, CH3OCO); Minor Anomer
(β): 155.5 (C, CH3OCO), 154.99 (C, CH3OCO), 131.6 (CH, C-2), 126.9 (CH, C-
3), 90.9 (CH, C-1), 72.8 (CH, C-5), 67.9 (CH, C-4), 66.6 (CH2, C-6), 55.17 (CH3,
CH3OCO), 55.04 (CH3, CH3OCO); IR: (Film from CDCl3) νmax 3479, 3010, 2961,
1749, 1444, 1264, 1016 cm-1; HRMS: m/z C10H14O8Na+ [M+Na]+ calcd 285.0581,
found 285.0583.
4,6-Di-O-(methoxycarbonyl)-2,3-dideoxy-d-erythro-hex-2-enono-1,5-lactone
(178)
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A solution of 199 (240 mg, 0.916 mmol) in benzene (10 mL) was heated to 50 ◦C
at which point Fétizon’s reagent (1.04 g, 1.832 mmol) was added. The solution was
then heated to reflux overnight. The black solution was cooled to room temperature,
filtered through Celite™, washed with EtOAc (50 mL) and concentrated to give the
crude product as a yellow oil. Chromatography of the oil (30% EtOAc / pet. ether)
afforded 178 (232 mg, 0.89 mmol, 97%) as a white solid.
Rf 0.5 (40% EtOAc / pet. ether)m.p. 111 – 112.3 ◦C; [α]24D +92.09 (c 1.06, CH2Cl2);
1H-NMR: (500 MHz; CDCl3) δH 6.86 (dd, J = 10.0, 2.5 Hz, 1H, H-3), 6.13 (dd,
J = 10.0, 1.0 Hz, 1H, H-2), 5.47 (d, J = 8.0 Hz, 1H, H-4), 4.70 (dt, J = 8.0, 4.0
Hz, 1H, H-5), 4.42 (d, J = 3.5 Hz, 2H, H-6), 3.86 (s, 3H, CH3OCO), 3.81 (s, 3H,
CH3OCO); 13C-NMR: (125 MHz; CDCl3) δC 160.7 (C, C1), 155.2 (C, CH3OCO),
154.5 (C, CH3OCO), 142.7 (CH, C-3), 122.4 (CH, C-2), 76.7 (CH, C-5, (observed
by HSQC)), 66.8 (CH, C-4), 65.3 (CH, C-6), 55.7 (CH3, CH3OCO), 55.3 (CH3,
CH3OCO); IR: νmax 2962, 1746, 1443, 1261, 1231, 994, 788 cm-1; HRMS: m/z
C10H12O8Na+ [M+Na]+ calcd 283.0424, found 283.0427.
4,6-Di-O-(methoxycarbonyl)-1-O-(tert-butyldimethylsilyl)-2,3-dideoxy-d-
erythro-hex-2-enopyranoside (154)
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A solution of 199 (250 mg, 0.95 mmol) in DCM (10 mL) and pyridine (85 µL, 1.05
mmol) was cooled to 0 ◦C. Silver nitrate (178 mg, 1.05 mmol) was added and after
all solid was dissolved TBSCl (158 mg, 1.05 mmol) was added and the reaction was
allowed to warm to room temperature and left to proceed overnight. The solution
was filtered through Celite™, washed with DCM (50 mL) and concentrated to give
the crude product and pyridine as a white semi-crystalline solid. Chromatography
of the solid (10% EtOAc / pet. ether) afforded a 3:2 α:β anomeric mixture of 252
(287 mg, 0.76 mmol, 80%) as a colourless oil.
Rf 0.9 (30% EtOAc / pet. ether); 1H-NMR: (600 MHz; CDCl3) δH Major
Anomer (α): 5.86 (d, J = 10.8 Hz, 1H, H-3), 5.80 (dt, J = 10.8, 2.4 Hz, 1H,
H-2), 5.35 (d, J = 1.8 Hz, 1H, H-1), 5.16 (dd, J = 9.6, 0.6 Hz, 1H, H-4), 4.36 - 4.26
(obs. m, 2H, H-6), 4.19 (ddd, J = 9.6, 4.8, 3.0 Hz, 1H, H-5), 3.81 (s, 3H, CH3OCO),
3.78 (s, 3H, CH3OCO), 0.89 (s, 9H, OSiC(CH3)3), 0.12 (s, 3H, OSiCH3), 0.11 (s,
3H, OSiCH3); Minor Anomer (β): 5.93 (ddd, J = 10.2, 2.4, 1.0 Hz, 1H, H-3),
5.89 (d, J = 10.2 Hz, 1H, H-2), 5.40 (d, J = 1.2 Hz, 1H, H-1), 5.10 (dd, J = 6.6,
1.2 Hz, 1H, H-4), 4.36 - 4.26 (obs. m, 2H, H-6), 4.03 (apt. q, J = 5.7 Hz, 1H, H-
97
5), 3.80 (s, 3H, CH3OCO), 3.79 (s, 3H, CH3OCO), 0.89 (s, 9H, OSiC(CH3)3), 0.13
(s, 3H, OSiCH3), 0.12 (s, 3H, OSiCH3); 13C-NMR:(150 MHz; CDCl3) δC Major
Anomer (α): 155.7 (C, CH3OCO), 155.08 (C, CH3OCO), 130.7 (CH, C-2), 126.3
(CH, C-3), 89.0 (CH, C-1), 68.8 (CH, C-4), 66.41 (CH, C-5), 66.35 (CH2, C-6),
55.14 (CH3, CH3OCO), 54.89 (CH3, CH3OCO), 25.6 (CH3, OSiC(CH3)3), 17.95 (C,
OSi(CH3)3), -4.5 (CH3, OSiCH3), -5.4 (CH3, OSiCH3); Minor Anomer (β): 155.5
(C, CH3OCO), 155.06 (C, CH3OCO), 133.5 (CH, C-2), 124.7 (CH, C-3), 91.0 (CH,
C-1), 72.6 (CH, C-5), 68.2 (CH, C-4), 66.6 (CH2, C-6), 55.07 (CH3, CH3OCO),
54.94 (CH3, CH3OCO), 25.7 (CH3, OSiC(CH3)3), 17.98 (C, OSi(CH3)3), -4.1 (CH3,
OSiCH3), -5.1 (CH3, OSiCH3); IR: (Film from CDCl3) νmax 2957, 2931, 2858, 1749,
1442, 1248, 1020, 838, 704, 675 cm-1; HRMS: m/z C16H28O8SiNa+ [M+Na]+ calcd
399.1446, found 399.1452.
4.2.5 Experimental Details for Section 2.3.1
Synthesis of 3-oxo-3-phenoxypropanoic acids
Following a literature method,77 a mixture of cresol (6.94 mmol) and Meldrum’s
acid (6.94 mmol) was heated at 110 ◦C for 3 h. After cooling to room tempera-
ture overnight, the acetone formed was removed under vacuum to give the desired
phenoxypropanoic acid in a quantitative yield that was used without further purifi-
cation.
3-(2-Methylphenoxy)-3-oxo-propanoic acid (206)
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The reaction was performed with o-cresol (0.75 g, 6.94 mmol) according to the above
method to afford 206 as a brown solid. This is a known compound77 however no
spectral data was available for comparison in the literature.
1H-NMR: (500 MHz; CDCl3) δH 7.26-7.17 (obs. m, 3H, H-1,2,3), 7.05 (d, J =
8.5, 1H, H-4), 3.72 (s, 2H, H-8), 2.24 (s, 3H, H-10); 13C-NMR: (125 MHz; CDCl3)
δC 170.5 (C, C-9), 164.8 (C, C-7), 149.0 (C, C-6), 131.3 (CH, C-2), 130.0 (C, C-5),
127.0 (CH, C-3), 126.6 (CH, C-1), 121.6 (CH, C-4) 40.7 (CH2, C-8), 16.1 (CH3,
C-10).
98
3-(3-Methylphenoxy)-3-oxo-propanoic acid (209)
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The reaction was performed with m-cresol (0.73 mL, 6.94 mmol) according to the
above method to afford 209 as a pale-yellow oil. This is a known compound100
however no spectral data was available for comparison in the literature.
1H-NMR: (500 MHz; CDCl3) δH 7.29 (d, J = 8.0 Hz, 1H, H-2), 7.08 (d, J = 7.5
Hz, 1H, H-1), 6.95 (s, 1H, H-5), 6.94 (d, J = 12.0 Hz, 1H, H-3), 3.69 (s, 2H, H-8),
2.37 (s, 3H, H-10); 13C-NMR: (125 MHz; CDCl3) δC 165.5 (C, C-9), 155.4 (C,
C-7), 150.2 (C, C-6), 139.9 (C, C-4), 129.3 (CH, C-2), 127.2 (CH, C-1), 121.8 (CH,
C-5), 118.2 (CH, C-3), 40.7 (CH2, C-8), 21.3 (CH3, C-10).
3-(4-Methylphenoxy)-3-oxo-propanoic acid (210)
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The reaction was performed with p-cresol (0.75 g, 6.94 mmol) according to the above
method to afford 210 as an off-white solid. This is a known compound101 however
no spectral data was available for comparison in the literature.
1H-NMR: (500 MHz; CDCl3) δH 7.20 (d, J = 8.5 Hz, 2H, H-2), 7.02 (d, J = 8.5
Hz, 2H, H-3), 3.68 (s, 2H, H-5), 2.35 (s, 3H, H-7); 13C-NMR: (125 MHz; CDCl3)
δC 165.7 (C, C-7), 148.0 (C, C-5), 136.2 (C, C-4), 130.1 (CH, C-2), 120.9 (CH, C-3),
40.5 (CH2, C-6), 20.9 (CH3, C-8).
Synthesis of 4-Hydroxymethylcoumarins
Following a literature method,77 Eaton’s reagent (prepared from P2O5 (1.68 g) dis-
solved in methanesulfonic acid (10 mL))79 (7.6 mL) was added to the 3- oxo- 3-
phenoxypropanoic acid (6.94 mmol) and the reaction mixture was heated at 70 ◦C
with constant stirring for 5 h. After cooling to room temperature the reaction mix-
ture was poured into ice-cooled water (80 mL) with vigorous stirring. The aqueous
solution was stirred for 30 min at 0 ◦C and then filtered. The solid was washed with
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cold water, dried under high vacuum, and purified by recrystallisation from absolute
ethanol to afford the desired 4-hydroxymethyl-coumarin as a solid.
4-Hydroxy-8-methylcoumarin (138)
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The above reaction was performed with 206 (1.35 g, 6.94 mmol) to afford 138 as a
beige semi-crystalline solid (420 mg, 2.38 mmol, 34%). Spectral data matched those
which have been previously reported77
m.p. 241.4 – 243.6 ◦C (lit.77 m.p. 238 – 239 ◦C); 1H-NMR: (500 MHz; DMSO-d6)
δH 12.44 (s, 1H, OH), 7.65 (d, J = 7.5 Hz, 1H, H-4), 7.50 (d, J = 7.5 Hz, 1H, H-2),
7.23 (t, J = 7.5 Hz, 1H, H-3), 5.58 (s, 1H, H-8), 2.34 (s, 3H, H-10); 13C-NMR:
(125 MHz; DMSO-d6) δC 166.4 (C, C-9), 162.3 (C, C-7), 152.3 (C, C-6), 134.1 (CH,
C-2), 125.7 (C, C-1), 123.8 (CH, C-3), 121.3 (CH, C-4), 116.0 (C, C-5), 91.2 (CH,
C-8), 15.7 (CH3, C-10).
4-Hydroxy-7-methylcoumarin (139) and 4-hydroxy-5-methylcoumarin (141)
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The above reaction was performed with 209 (1.35 g, 6.94 mmol) to afford a 1.3:1
mixture of 139:141 as a beige solid (580 mg, 3.29 mmol, 47%). Spectral data of
141 matched those which have been previously reported.77
m.p. 193.9 – 198.9 ◦C; (139 lit.102 m.p. 222 – 223 ◦C); (141 lit.77 m.p. 238 –
239 ◦C); 1H-NMR: (500 MHz; DMSO-d6) δH 139: 12.41 (s, 1H, OH), 7.68 (d, J =
8.0 Hz, 1H, H-4), 7.19 - 7.15 (m, 2H, H-1,3), 5.52 (s, 1H, H-8), 2.49 (s, 3H, H-10);
141: 12.36 (s, 1H, OH’), 7.46 (t, J = 7.5 Hz, 1H, H-2’), 7.19 - 7.15 (m, 1H, H-1’),
7.10 (d, J = 6.5 Hz, 1H, H-3’), 5.54 (s, 1H, H-8’), 2.66 (s, 3H, H-10’); 13C-NMR:
(125 MHz; DMSO-d6) δC 139: 166.3 (C, C-9), 162.5 (C, C-7), 154.1 (C, C-6), 143.9
(C, C-2), 125.5 (CH, C-1), 123.4 (CH, C-4), 116.8 (CH, C-3), 113.7 (C, C-5), 90.6
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(CH, C-8), 21.6 (CH3, C-10). 141: 169.1 (C, C-9’), 161.9 (C, C-7’), 155.5 (C, C-6’),
137.6 (C, C-4’), 132.2 (CH, C-2’), 127.6 (CH, C-3’), 115.2 (CH, C-1’), 114.7 (C,
observed by HMBC, C-5’), 91.6 (CH, C-8’), 23.1 (CH3, C-10’).
4-Hydroxy-6-methylcoumarin (140)
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The above reaction was performed with 210 (1.35 g, 6.94 mmol) to afford 140 as
a brown semi-crystalline solid (410 mg, 2.33 mmol, 34%). Spectral data matched
those which have been previously reported.78
m.p. 270.7 – 272.0 ◦C (lit.103 m.p. 261 – 264 ◦C); 1H-NMR: (500 MHz; DMSO-d6)
δH 12.44 (s, 1H, OH), 7.60 (s, 1H, H-4), 7.45 (d, J = 8.5 Hz, 1H, H-1), 7.25 (d, J
= 8.5 Hz, 1H, H-2), 5.55 (s, 1H, H-8), 2.31 (s, 3H, H-10); 13C-NMR: (125 MHz;
DMSO-d6) δC 166.1 (C, C-9), 162.5 (C, C-7), 152.1 (C, C-6), 134.0 (CH, C-4), 133.6
(C, C-3), 123.2 (CH, C-1), 116.6 (CH, C-2), 115.9 (C, C-5), 91.4 (CH, C-8), 20.8
(CH3, C-10).
4.2.6 Experimental Details for Sections 2.4.1 and 2.4.2
Pd-AA cascade with Acyclic Substrate (Method A): β-Dicarbonyl bis-nucleophile
(2.3 eq.), PPh3 (0.4 eq.) and Pd2(dba)3 (0.1 eq.) were combined in a reaction vessel
which was then evacuated and back filled with nitrogen. Acetonitrile (ca. 0.05 M
w.r.t 40), degassed by sparging with nitrogen for approx. 20 minutes) was added,
followed by addition of both Z -but-2-ene-1,4-diyl dimethyl dicarbonate (40)∗ (1.0
eq.) and NEt3 (1.0 eq.) via syringe. After 1 hour the reaction mixture was concen-
trated and purified by flash column chromatography (10% then 25% EtOAc / pet.
ether).
Pd-AA cascade with Cyclic Substrate (Method B): β-Dicarbonyl bis-nucleophile
(1.0 eq.) and Pd(PPh3)4 (0.05 eq.) were combined in a reaction vessel which was
then evacuated and back filled with nitrogen. Toluene (ca. 0.05 M), degassed
by sparging with nitrogen for approx. 20 minutes) was added, followed by ad-
dition of cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl
∗Compound 40 was provided by Dr Mark Bartlett.
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carbonate (cis-42)† (1.0 eq.) via syringe. The reaction was stirred overnight at
room temperature before being concentrated and purified by flash column chro-
matography (10 - 20% EtOAc / pet. ether).
Pd-AA cascade with Cyclic Substrate (Method C): β-Dicarbonyl bis-nucleophile
(1.0 eq.) and Pd(PPh3)4 (0.05 eq.) were combined in a reaction vessel which was
then evacuated and back filled with nitrogen. Toluene/DMF (3:1, ca. 0.05 M), de-
gassed by sparging with nitrogen for approx. 20 minutes) was added, followed by ad-
dition of cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl
carbonate (cis-42)† (1.0 eq.) via syringe. The reaction was stirred overnight at
room temperature before being concentrated and purified by flash column chro-
matography (10 - 20% EtOAc / (1% NEt3 / pet. ether)).
6-Methyl-2-vinyl-2H -furo[3,2-c]pyran-4(3H )-one (41)
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The Pd-AA cascade reaction was performed with 4-hydroxy-6-methyl-2-pyrone (90
mg, 0.714 mmol) according Method A. The product (41) was purified as a colourless
oil (33 mg, 0.185 mmol, 59% yield). Spectral data matched those which have been
previously reported.19
Rf 0.25 (40% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 5.95 (obs.
m, 1H, H-5), 5.93 (br s, 1H, H-8), 5.38-5.32 (m, 2H, H-4, 6a), 5.28 (d, J = 10.5
Hz, 1H, H-6b) 3.21 (dd, J = 15.0, 10.0 Hz, 1H, H-3a), 2.80 (dd, J = 15.0, 7.5 Hz,
1H, H-3b), 2.25 (s, 3H, H-10); 13C-NMR: (125 MHz; CDCl3) δC 171.2 (C, C-7),
165.3 (C, C-1), 162.3 (C, C-9), 135.5 (CH, C-5), 118.1 (CH2, C-6), 99.0 (C, C-2),
95.7 (CH, C-8), 86.8 (CH, C-4), 31.6 (CH2, C-3), 20.3 (CH3, C-10); IR: (Film from
CDCl3) νmax 3088, 2927, 1718, 1637, 1581, 1452, 1418, 1256, 1166, 1109, 977, 924,
cm-1.
2-Vinyl-2H -furo[3,2-c]chromen-6(6bH)-one (211)
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†cis-42 was provided on separate occasions by Dr Mark Bartlett and Stephen Tat.
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The Pd-AA cascade reaction was performed with 4-hydroxycoumarin (116 mg, 0.715
mmol) according to Method A. The product (211) was purified as an off white solid
(35 mg, 0.164 mmol, 52%).
Rf 0.3 (25% EtOAc / pet. ether); m.p. 116.8 – 119.1 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.69 (d, J = 7.5 Hz, 1H, H-13), 7.57 (t, J = 8.0 Hz, 1H, H-12), 7.39 (d, J
= 8.0 Hz, 1H, H-10), 7.30 (td, J = 7.5, Hz, 1H, H-11), 6.06 (ddd, J = 17.0, 10.5, 6.5
Hz, 1H, H-5), 5.55 (dt, J = 10.0, 7.5 Hz, 1H, H-4), 5.47 (dt, J = 17.0, 1.5 Hz, 1H,
H-6a), 5.36 (dt, J = 10.5, 1.0 Hz, 1H, H-6b), 3.39 (dd, J = 15.0, 10.0 Hz, 1H, H-3a),
2.99 (dd, J = 15.0, 7.5 Hz, 1H, H-3b); 13C-NMR: (125 MHz; CDCl3) δC 166.4 (C,
C-7), 160.6 (C, C-1), 155.0 (C, C-9), 135.5 (CH, C-5), 132.4 (CH, C-12), 124.0 (CH,
C-11), 122.7 (CH, C-13), 118.4 (CH2, C-6), 117.0 (CH, C-10), 112.5 (C, C-8), 101.8
(C, C-2), 87.3 (CH, C-4), 32.7(CH2, C-3); IR: νmax 3050, 2990, 1710, 1638, 1497,
1409, 1247, 1018, 893, 749, 732 cm-1; HRMS: m/z C13H10NaO+3 [M+Na]+ calcd
237.0522, found 237.0526.
2,3-Dihydro-8-vinyl-4H -furo[3,2-c]chromen-6(6bH)-one (46)
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The Pd-AA cascade reaction was performed with 4-hydroxycoumarin (45 mg, 0.278
mmol) according to Method B. The product (46) was purified as a white solid (36
mg, 0.150 mmol, 54%). Spectral data matched those which have been previously
reported.19
Rf 0.5 (30% EtOAc / pet. ether) m.p. 159.6 – 162.0 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.67 (dd, J = 8.0, 1.5, 1H, H-4), 7.58 (td, J = 8.5, 1.5 Hz, 1H, H-3), 7.38
(d, J = 8.5 Hz, 1H, H-1), 7.28 (t, J = 7.5 Hz, 1H, H-2), 6.84 (d, J = 5.5 Hz, 1H,
H-13), 5.32-5.28 (m, 2H, H-12,11), 4.44 (dd, J = 9.5, 3.5 Hz, 1H, H-14a), 3.67-3.59
(m, 2H, H-14b, 10); 13C-NMR: (125 MHz; CDCl3) δC 167.7 (C, C-9), 160.4 (C,
C-7), 155.1 (C, C-6), 150.8 (CH, C-13), 132.9 (CH, C-3), 124.0 (CH, C-2), 123.0
(CH. C-4), 117.1 (CH, C-1), 112.6 (C, C-5), 102.6 (C, C-8), 98.4 (CH, C-12), 79.2
(CH, C-11), 64.7 (CH2, C-14), 37.7 (CH, C-10); IR: νmax 3070, 2951, 1706, 1636,
1413, 1234, 1158, 1064, 1031, 830, 753 cm-1; HRMS: m/z C14H11O+4 [M+H]+ calcd
243.0652, found 243.0659.
2,3-Dihydro-4-methyl-8-vinyl-4H -furo[3,2-c]chromen-6(6bH)-one (240)
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The Pd-AA cascade reaction was performed with 138 (126 mg, 0.176 mmol) ac-
cording to Method A. The product (240) was purified as a pale-yellow solid (37 mg,
0.162 mmol, 51%).
Rf 0.6 (30% EtOAc / pet. ether); m.p. 69.2 – 75.1 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.52 (d, J = 8.0 Hz, 1H, H-4), 7.41 (d, J = 7.0 Hz, 1H, H-2), 7.19 (t,
J = 7.5 Hz, 1H, H-3), 6.05 (ddd, J = 17.0, 10.5, 7.0 Hz, 1H, H-13), 5.53 (dt, J =
10.0, 7.5 Hz, 1H, H-12), 5.46 (d, J = 17.0 Hz, 1H, H-14a), 5.34 (d, J = 10.5 Hz,
1H, H-14b), 3.39 (dd, J = 15.0, 10.0 Hz, 1H, H-11a), 2.98 (dd, J = 15.0, 7.5 Hz,
1H, H-11b), 2.48 (s, 3H, H-10); 13C-NMR: (125 MHz; CDCl3) δC 166.8 (C, C-9),
160.8 (C, C-7), 153.4 (C, C-6), 135.6 (CH, C-13), 133.7 (CH, C-2), 126.5 (C, C-1),
123.5 (CH, C-3), 120.3 (CH, C-4), 118.2 (CH2, C-14), 112.2 (C, C-5), 101.5 (C, C-
8), 87.2 (CH, C-12), 32.7 (CH2, C-11), 16.0 (CH3, C-10); IR: (Film from CH2Cl2)
νmax 3061, 2987, 2925, 2865, 1713, 1640, 1606, 1581, 1489, 1395, 1184, 93, 746 cm-1;
HRMS: m/z C14H13O+3 [M+H]+ calcd 229.0860, found 229.0859.
2,3-Dihydro-3-methyl-8-vinyl-4H -furo[3,2-c]chromen-6(6bH)-one (214) and
2,3-dihydro-2-methyl-8-vinyl-4H -furo[3,2-c]chromen-6(6bH)-one (215)
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The Pd-AA cascade reaction was performed with a 1.3:1 mixture of 139 and 141
(126 mg, 0.176 mmol) according to Method A. The products (214 and 215) were
purified as a 1.3:1 mixture as a pale yellow solid (33 mg, 0.146 mmol, 46%).
Rf 0.6 (30% EtOAc / pet. ether); m.p. 76.2 – 79.4 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 253: 7.55 (d, J = 8.0 Hz, 1H, H-4), 7.19 (obs. m, 1H, H-3), 7.10 (d, J
= 7.5 Hz, 1H, H-1), 6.05 (obs. m, 1H, H-13), 5.52 (obs. m, 1H, H-12), 5.45 (d, J
= 17.0 Hz, 1H, H-14a), 5.34 (d, J = 8.5 Hz, 1H, H-14b), 3.37 (dd, J = 15.0, 10.5
Hz, 1H, H-11a), 2.96 (dd, J = 15.0, 7.5 Hz, 1H, H-11b), 2.46 (s, 3H, H-10); 254:
7.40 (t, J = 8.0 Hz, 1H, H-1), 7.22 (obs. m, 1H, H-4), 7.04 (d, J = 7.5 Hz, 1H,
H-3), 6.05 (obs. m, 1H, H-13), 5.52 (obs. m, 1H, H-12), 5.43 (d, J = 17.0 Hz, 1H,
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H-14a), 5.32 (d, J = 10.5 Hz, 1H, H-14b), 3.34 (dd, J = 15.0, 10.5 Hz, 1H, H-11a),
2.93 (dd, J = 15.0, 7.5 Hz, 1H, H-11b), 2.68 (s, 3H, H-10); 13C-NMR: (125 MHz;
CDCl3) δC 253: 166.6 (C, C-9), 160.9 (C, C-7), 155.2 (C, C-6), 143.7 (C, C-2),
135.6 (CH, C-13), 125.2 (CH, C-1), 122.3 (CH, C-4), 118.3 (CH2, C-14), 117.1 (C,
C-3), 110.0 (C, C-5) 101.0 (C, C-8), 87.2 (CH, C-12), 32.6 (CH2, C-11), 21.9 (CH3,
C-10); 254: 167.8 (C, C-9), 160.6 (C, C-7), 155.9 (C, C-6), 136.2 (C, C-4), 135.7
(CH, C-13), 131.6 (CH, C-2), 126.3 (CH, C-3), 117.6 (CH2, C-14), 114.9 (CH, C-1),
111.9 (C, C-5), 101.9 (C, C-8), 86.7 (CH, C-12), 32.1 (CH2, C-11), 21.3 (CH3, C-10);
IR: (Film from CH2Cl2) νmax 3060, 2929, 2864, 1713, 1628, 1603, 1386, 1205, 1044,
1022, 903 cm-1; HRMS: m/z C14H13O3 [M+H]+ calcd 229.0859, found 229.0864.
2,3-Dihydro-3-methyl-8-vinyl-4H -furo[3,2-c]chromen-6(6bH)-one (241)
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The Pd-AA cascade reaction was performed with 140 (126 mg, 0.176 mmol) ac-
cording to Method A. The product (241) was purified to give a beige solid (34 mg,
0.148 mmol, 46%).
Rf 0.6 (30% EtOAc / pet. ether); m.p. 95.9 – 98.2 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.47 (s, 1H, H-4), 7.37 (d, J = 8.5 Hz, 1H, H-1), 7.28 (d, J = 9.5 Hz,
1H, H-2), 6.05 (ddd, J = 17.0, 10.0, 7.0 Hz, 1H, H-13), 5.53 (dt, J = 10.0, 7.5 Hz,
1H, H-12), 5.46 (d, J = 17.0 Hz, 1H, H-14a), 5.35 (d, J = 10.5 Hz, 1H, H-14b), 3.38
(dd, J = 15.0, 10.0 Hz, 1H, H-11a), 2.97 (dd, J = 15.0, 7.5 Hz, 1H, H-11b), 2.42
(s, 3H, H-10); 13C-NMR: (125 MHz; CDCl3) δC 166.4 (C, C-9), 160.9 (C, C-7),
153.2 (C, C-6), 135.5 (CH, C-13), 133.7 (C, C-3), 133.5 (CH, C-4), 122.4 (CH, C-1),
118.3 (CH2, C-14), 116.7 (CH, C-2), 112.2 (C, C-5), 101.7 (C, C-8), 87.2 (CH, C-
12), 32.7 (CH2, C-11), 20.8 (CH3, C-10); IR: (Film from CH2Cl2) νmax 3059, 2989,
2926, 2866, 1712, 1643, 1610, 1576, 1499, 1438, 1427, 1397, 1205, 1100, 926 cm-1;
HRMS: m/z C14H13O3 [M+H]+ calcd 229.0859, found 229.0864.
cis-(±)-4-Methyl-7,10a-dihydropyrano[3’,4’:4,5]furo[3,2-c]chromen-6(6bH)-
one (220)
The Pd-AA cascade reaction was performed with 138 (31 mg, 0.176 mmol) according
to Method C. The product (220) was purified as a a cream coloured semi-crystalline
solid (22 mg, 0.086 mmol, 49%).
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Rf 0.5 (20% EtOAc / pet. ether); m.p. 152.1 – 153.5 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.52 (d, J = 7.5 Hz, 1H, H-4), 7.43 (d, J = 7.5 Hz, 1H, H-2), 7.19 (t,
J = 7.5 Hz, 1H, H-3), 6.84 (d, J = 6.0 Hz, 1H, H-14), 5.33-5.27 (complex m, 2H,
H-12, 13), 4.45 (d, J = 6.0 Hz, 1H, H-15a), 3.66-3.59 (m, 2H, H-11, 15b), 2.47 (s,
3H, H-10); 13C-NMR: (125 MHz; CDCl3) δC 168.1 (C, C-9), 160.5 (C, C-7), 153.5
(C, C-6), 150.8 (CH, C-14), 134.1 (CH, C-2), 126.6 (C, C-1), 123.6 (CH, C-3), 120.6
(CH, C-4), 112.3 (C, C-5), 102.4 (C, C-8), 98.5 (CH, C-13), 79.1(CH, C-12), 64.8
(CH2, C-15), 37.7 (CH, C-11), 16.0 (CH3, C-10); IR: (Film from CDCl3) νmax 3064,
2923, 1716, 1642, 1397, 1238, 831, 755 cm-1; HRMS: m/z C15H13O+4 [M+H]+ calcd
257.0808, found 257.0813.
cis-(±)-4-Methyl-7,10a-tetrahydro-2-hydroxy-2H -pyrano[4’,5’:4,5]furo[3,2-
c]chromen-6(6bH)-one (219)
The Pd-AA cascade reaction was performed with 138 (31 mg, 0.176 mmol) according
to Method B. Column chromatography (10 - 20% EtOAc / pet. ether) afforded the
product (220) as a a cream semi-crystalline solid (18 mg, 0.070 mmol, 39%). Elution
of the column with EtOAc afforded an orange oil (22 mg). Column chromatography
(50% EtOAc / pet. ether) afforded 219 as a red solid (9 mg, 0.033 mmol, 19%).
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Rf 0.26 (50% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 7.49 (d, J =
7.0 Hz, 1H, H-4), 7.42 (d, J = 7.5 Hz, 1H, H-2), 7.19 (t, J = 8.0 Hz, 1H, H-3), 5.39
(dt, J = 9.5, 3.5 Hz, 1H, H-12) 5.32 (m, 1H, H-14), 4.09 (m, 1H, H-15a), 3.92 (dd,
J = 12.5, 2.5 Hz, 1H, H-15b), 3.58 (ddd, J = 9.5, 3.5, 2.0 Hz, 1H, H-11), 2.86 (d,
J = 3.5 Hz, 1H, OH), 2.69 (ddd, J = 16.0, 5.5, 3.5 Hz, 1H, H-13a), 2.48 (s, 3H,
H-10), 2.05 (ddd, J = 16.0, 7.5, 3.5 Hz, 1H, H-13b); 13C-NMR: (125 MHz; CDCl3)
δC 167.9 (C, C-9), 160.6 (C, C-7), 153.6 (C, C-6), 133.8 (CH, C-2), 126.6 (C, C-1),
123.5 (CH, C-3), 120.4 (CH, C-4), 112.1 (C, C-5), 103.4 (C, C-8), 89.9 (CH, C-14),
82.9 (CH, C-12), 58.2 (CH2, C-15), 39.2 (CH, C-11), 31.0 (CH2, C-13), 16.0 (CH3,
C-10); IR: (Film from CDCl3) νmax 3400, 2958, 2926, 1713, 1643, 1399, 1203, 1036,
106
754 cm-1; HRMS: m/z C15H15O+5 [M+H]+ calcd 275.0914, found 275.0916.
cis-(±)-3-Methyl-7,10a-dihydropyrano[3’,4’:4,5]furo[3,2-c]chromen-6(6bH)-
one (217) and cis-(±)-1-methyl-7,10a-dihydropyrano[3’,4’:4,5]furo[3,2-c]
chromen-6(6bH)-one (218)
1
2
3
4
5
6
9
8
7O
O
10
1'
2'
3'
4'
5'
6'
9'
8'
7'O
O
10'
O 12
11
O 12'
11'
13
14
O
15
13'
14'
O15'
217 218
The Pd-AA cascade reaction was performed with a 1.3:1 mixture of 139 and 141
(49 mg, 0.278 mmol) according to Method C. Column chromatography (10 - 20%
EtOAc / pet. ether) afforded the products (217 and 218) in a 1.3:1 mixture as a
light-brown semi-crystalline solid (20 mg, 0.078 mmol, 30%).
Rf 0.4 (20% EtOAc / pet. ether); m.p. 158.2 – 169.5 ◦C; 1H-NMR: (300 MHz;
CDCl3) δH 217: 7.54 (d, J = 8.1 Hz, 1H, H-4), 7.18 (s, 1H, H-3), 7.11 (d, J = 8.1
Hz, 1H, H-1), 6.83 (d, J = 5.7 Hz, 1H, H-14), 5.29 (obs. m, 2H, H-12,13), 4.43 (obs.
m, 1H, H-15a), 3.59 (obs. m, 2H, H-11,15b), 2.46 (s, 3H, H-10); 218: 7.41 (t, J =
7.8 Hz, 1H, H-2), 7.21 (m, 1H, H-1), 7.05 (d, J = 7.5 Hz, 1H, H-3), 6.83 (d, J =
5.7 Hz, 1H, H-14), 5.29 (obs. m, 2H, H-12,13), 4.43 (obs. m, 1H, H-15a), 3.59 (obs.
m, 2H, H-11,15b), 2.67 (s, 3H, H-10); IR: (Film from CH2Cl2) νmax 3065, 2927,
1700, 1635, 1617, 1603, 1244, 1028, 841, 741 cm-1; HRMS: m/z C15H13O+4 [M+H]+
calcd 257.0808, found 257.0812. 13C NMR data was not obtained on this mixture
of compounds.
cis-(±)-2-Methyl-7,10a-dihydropyrano[3’,4’:4,5]furo[3,2-c]chromen-6(6bH)-
one (255)
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The Pd-AA cascade reaction was performed with 140 (31 mg, 0.176 mmol) according
to Method C. The product (255) was purified as a light brown semi-crystalline solid
(21 mg, 0.082 mmol, 47%)
Rf 0.4 (20% EtOAc / pet. ether); m.p. 158.0 – 161.6 ◦C; 1H-NMR: (500 MHz;
CDCl3) δH 7.46 (s, 1H, H-4), 7.38 (d, J = 8.5 Hz, 1H, H-2), 7.27 (obs. d, 1H,
H-1), 6.83 (d, J = 5.5 Hz, 1H, H-14), 5.31-5.27 (complex m, 2H, H-13,12), 4.44 (dd,
107
J = 10.0, 4.0 Hz, 1H, H-15a), 3.66-3.58 (complex m, 2H, H-15b, 11), 2.41 (s, 3H,
H-10); 13C-NMR: (125 MHz; CDCl3) δC 167.6 (C, C-9), 160.5 (C, C-7), 153.3 (C,
C-6), 150.8 (CH, C-14), 133.89 (CH, C-2), 133.87 (C, C-3), 122.6 (CH, C-4), 116.8
(CH, C-1), 112.3 (C, C-5), 102.5 (C, C-8), 98.5 (CH, C-13), 79.1 (CH, C-12), 64.8
(CH2, C-15), 37.8 (CH, C-11), 20.8 (CH3, C-10); IR: (Film from CDCl3) νmax 3069,
2926, 1717, 1644, 1238, 1069, 838, 766 cm-1; HRMS: m/z C15H13O+4 [M+H]+ calcd
257.0808, found 257.0813.
4.2.7 Experimental Details for Section 2.4.3
Methyl (methyl (3R, 3aS, 4R, 7aR)-2H -2-oxo-3,3a,4,7a-tetrahydrofuro[3,2-
c]pyran-3-carbox-4-yl)carbonate (221)
7
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O 221
Meldrum’s acid (96 mg, 0.664 mmol) and Pd(PPh3)4 (23 mg, 0.020 mmol) were
combined in a reaction vessel which was then evacuated and back-filled with nitro-
gen. Toluene (1.5 mL, degassed by sparging with nitrogen for approx. 20 minutes)
and MeOH (27 µL, degassed by sparging with nitrogen for approx. 20 minutes) were
added, followed by addition of a solution of 252 (50 mg, 0.133 mmol) in toluene
(0.5 mL). The reaction was left at room temperature overnight then concentrated.
Chromatography of the resulting brown oil (10% - 25% EtOAc / pet. ether) afforded
221 (23 mg, 0.080 mmol, 61%) as a colourless oil.
Rf 0.3 (30% EtOAc / pet. ether); [α]25.3D +71.41 (c 0.36, CH2Cl2); 1H-NMR: (500
MHz; CDCl3) δH 6.64 (dd, J = 6.3, 0.9 Hz, 1H, H-1), 5.13 (dd, J = 6.0, 3.9 Hz, 1H,
H-2), 5.05 (ddd, J = 6.3, 4.2, 0.9 Hz, 1H, H-3), 4.38 (d, J = 4.2 Hz, 2H, H-8), 3.92
(dt, J = 8.7, 4.2 Hz, 1H, H-7), 3.84 (s, 3H, CH3OCO), 3.81 (s, 3H, CH3OCO), 3.57
(d, J = 4.5 Hz, 1H, H-5), 3.08 (ddd, J = 9.0, 6.3, 4.5 Hz, 1H, H-6); 13C-NMR: (125
MHz; CDCl3) δC 169.7 (C, C-4), 166.7 (C, CH3OCO), 155.4 (C, CH3OCO), 147.7
(CH, C-1), 98.6 (CH, C-2), 71.2 (CH, C-7), 70.6 (CH, C-3), 66.2 (CH2, C-8), 55.3
(CH3, CH3OCO), 53.5 (CH3, CH3OCO), 49.4 (CH, C-5), 38.6 (CH, C-6); IR: (Film
from CH2Cl2) νmax 3007, 2959, 2925, 1776, 1736, 1649, 1441, 1266, 1242, 1166, 935
cm-1; HRMS: m/z C12H15O+8 [M+H]+ calcd 287.0761, found 287.0765.
Methyl-2-hydroxymethyl-2H -pyran-6-one carbonate (225)
108
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Meldrum’s acid (22 mg, 0.154 mmol) and Pd(PPh3)4 (9 mg, 0.001 mmol) were
combined in a reaction vessel which was then evacuated and back filled with nitrogen.
Toluene (2 mL, degassed by sparging with nitrogen for approx. 20 minutes) and
MeOH (31 µL, degassed by sparging with nitrogen for approx. 20 minutes) were
added, followed by addition of a solution of 178 (40 mg, 0.154 mmol). The reaction
was left at room temperature for 2.5 hours then concentrated. Chromatography of
the resulting orange oil (25 - 40% EtOAc / pet. ether) afforded 225 (27 mg, 0.148
mmol, 96%) as a white solid.
Rf 0.2 (40% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 7.31 (dd, J =
9.0, 7.0 Hz, 1H, H-2), 6.27 (complex m, 2H, H-3, 4), 4.90 (s, 1H, H-6), 3.84 (s, 3H,
CH3OCO); 13C-NMR: (125 MHz; CDCl3) δC 161.1 (C, C-1), 158.2 (C, C-5), 155.0
(C, CH3OCO), 142.8 (CH, C-2), 115.9 (CH, C-3) 104.0 (CH, C-4) 64.6 (CH2, C-6),
55.4 (CH3, CH3OCO); IR: (Film from CH2Cl2) νmax 3094, 3068, 2969, 1737, 1646,
1563, 1451, 1278 cm-1; HRMS: m/z C8H8NaO+5 [M+Na]+ calcd 207.0264, found
207.0264.
5,5-Bis-(6-O-(methoxycarbonyl)-1-O-(tert-butyldimethylsilyl)-2,3-dideoxy-
d-erythro-hex-2-enopyranos-4-yl)-2,2-dimethyl-1,3-dioxane-4,6-dione (222)
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222
Meldrum’s acid (23 mg, 0.159 mmol) and Pd(PPh3)4 (9 mg, 0.008 mmol) were
combined in a reaction vessel which was then evacuated and back filled with nitrogen.
Toluene (1.5 mL, degassed by sparging with nitrogen for approx. 20 minutes) and
MeOH (32 µL, degassed by sparging with nitrogen for approx. 20 minutes) were
added, followed by addition of a solution of 252 (60 mg, 0.159 mmol) in toluene
(1.5 mL). The reaction was left at room temperature for 2 hours then concentrated.
Chromatography of the resulting yellow oil (5% - 20% EtOAc / pet. ether) afforded
222 (4 mg, 0.005 mmol, 7%) as a colourless oil.
Rf 0.5 (20% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 5.99 (m, 4H,
109
H-2, 3), 5.13 (s, 2H, H-1), 4.39 (dd, J = 11.0, 5.5 Hz, 2H, H-6a), 4.16 (dd, J =
11.0, 8.0 Hz, 2H, H-6b), 4.05 (m, 2H, H-5), 3.77 (s, 6H, CH3OCO), 2.93 (d, J
= 4.5 Hz, 2H, H-4), 1.78 (s, 6H, H-10), 0.87 (s, 18H, OSiC(CH3)3), 0.10 (s, 6H,
OSiCH3), 0.09(s, 6H, OSiCH3); 13C-NMR: (125 MHz; CDCl3) δC 165.3 (C, C-7),
155.4 (C, CH3OCO), 132.9 (CH, C-2), 120.8 (CH, C-3), 106.3 (C, C-9), 87.8 (CH,
C-1) 69.1 (CH, C-5), 67.8 (CH2, C-6), 57.8 (CH3, CH3OCO), 54.9 (C, C-8), 39.9
(CH, C-4), 29.7 (CH3, C-10), 25.6 (CH3, OSiC(CH3)3), 17.9 (C, OSi(CH3)3), -4.3
(CH3, OSiCH3), -5.3 (CH3, OSiCH3); IR: (Film from CH2Cl2) νmax 2956, 2931,
2901, 2859, 1751, 1270, 1030 cm-1; HRMS: m/z C34H60NO14Si+2 [M+NH4]+ calcd
762.3547, found 762.3546.
4.2.8 Experimental Details for Section 2.5
Ethyl 2-Diethoxyphosphoryl-3-oxo-octanoate (235)
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Using a literature method,86 a solution of hexanoyl chloride (104 µL, 0.743 mmol) in
toluene (0.4 mL) was added dropwise to a cold solution (5 ◦C) of triethyl phospho-
noacetate (149 µL, 0.743 mmol), MgCl2 (71 mg, 0.743 mmol), and NEt3 (0.3 mL,
2.15 mmol) in toluene (2.2 mL). The reaction was stirred for 6 hours under nitrogen
at room temperature and then quenched by addition of an ice-cold solution of 10%
H2SO4 (2.2 mL) and stirred for 5 minutes. The two layers were separated and the
aqueous layer was extracted with EtOAc (4 x 25 mL). The combined organic ex-
tracts were dried with MgSO4 and concentrated. Chromatography of the resulting
yellow oil (20% - 40% EtOAc / pet. ether) afforded the desired product 235 (371
mg, 0.659 mmol, 89%) observed as a complex mixture of tautomers by 1H NMR,
which was used immediately.
Diethyl (hexanoylmethyl)phosphonate (231)
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Using a literature method,86 a solution of 235 (88 mg, 0.273 mmol) and p-toluenesulfonic
acid monohydrate (2.6 mg, 0.013 mmol) in H2O was heated under reflux overnight.
The reaction mixture was extracted with Et2O (3 x 25 mL). The combined organic
extracts were dried over MgSO4 and concentrated to afford the desired product 231
110
(55 mg, 0.220 mmol, 81%) as a colourless oil. Spectral data matched those which
have been previously reported.86
Rf 0.2 (40% EtOAc / pet. ether); 1H-NMR: (500 MHz; CDCl3) δH 4.15 (m, 4H,
H-2), 3.08 (d, J = 23.0 Hz, 2H, H-3), 2.62 (t, J = 7.5 Hz, 2H, H-5), 1.59 (q, J =
7.5 Hz, 2H, H-6), 1.34 (t, J = 7.0 Hz, 6H, H-1), 1.31-1.26 (m, 4H, H-7,8), 0.89 (t, J
= 7.0 Hz, 3H, H-9); 13C-NMR: (125 MHz; CDCl3) δC 202.3 (C, J = 6.3 Hz, C-4),
62.5 (CH2, J = 6.6 Hz, C-2), 44.1 (CH2, C-5), 42.4 (CH2, J = 126.5 Hz, C-3), 31.1
(CH2, C-7), 23.1 (CH2, C-6), 22.4 (CH2, C-8), 16.3 (CH3, J = 6.3 Hz, C-1), 13.9
(CH3, C-9); IR: (Film from CH2Cl2) νmax 2958, 2931, 2872, 1715, 1252, 1022, 965
cm-1.
Methyl (3R, 3aS, 4R, 7aR)-2H -2-oxo-3,3a,4,7a-tetrahydrofuro[3,2-c]pyran-
4-yl carbonate (232)
7
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Meldrum’s acid (96 mg, 0.664 mmol) and Pd(PPh3)4 (23 mg, 0.020 mmol) were
combined in a reaction vessel which was then evacuated and back filled with nitrogen.
MeCN (1.5 mL, degassed by sparging with nitrogen for approx. 20 minutes) was
added, followed by addition of a solution of 252 (50 mg, 0.133 mmoL) in MeCN
(0.5 mL). Distilled H2O (48 µL, degassed by sparging with nitrogen for approx. 20
minutes) was added vi syringe and then the reaction was left at room temperature
overnight then concentrated. Chromatography of the resulting brown oil (10% -
30% EtOAc / pet. ether) afforded 232 (3 mg, 0.013 mmol, 10%) as a colourless oil.
Rf 0.2 (30% EtOAc / pet. ether); [α]25.3D +8.40 (c 0.60, CH2Cl2); 1H-NMR: (500
MHz; CDCl3) δH 6.70 (d, J = 6.5 Hz, 1H, H-1), 5.18 (t, J = 4.5 Hz, 1H, H-2),
4.85 (t, J = 5.0 Hz, 1H, H-3), 4.34 (dd, J = 12.0, 2.5 Hz, 1H, H-8a), 4.32 (dd, J =
12.0, 5.0 Hz, 1H, H-8b), 3.82 (s, 3H, CH3OCO), 3.82-3.76 (m, 1H, H-7), 2.87 (dd,
J = 18.0, 8.5 Hz, 1H, H-5a), 2.74-2.70 (m, 1H, H-6), 2.48 (dd, J = 18.0, 2.0 Hz,
1H, H-5b); 13C-NMR: (125 MHz; CDCl3) δC 174.7 (C, C-4), 162.8 (C, CH3OCO),
148.5 (CH, C-1), 98.7 (CH, C-2), 72.1 (CH, C-7), 71.2 (CH, C-3), 66.4 (CH2, C-8),
55.2 (CH3, CH3OCO), 34.3 (CH, C-6), 31.8 (CH2, C-5); IR: (Film from CH2Cl2)
νmax 3006, 2960, 2928, 1746, 1647, 1443, 1272, 1241, 1168, 935 cm-1; HRMS: m/z
C10H13O+6 [M+H]+ calcd 229.0707, found 229.0710.
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Spectra of New and Selected
Compounds
112
O OTBS
AcO
OAc
153
		




	








	



	





































	










	

	




























	



	





















1H-NMR spectrum of 153 (500 MHz, CDCl3)
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13C-NMR spectrum of 153 (500 MHz, CDCl3)
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1H-NMR spectrum of 166 (500 MHz, CDCl3)
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13C-NMR spectrum of 166 (500 MHz, CDCl3)
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1H-NMR spectrum of 176 (500 MHz, CDCl3)
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13C-NMR spectrum of 176 (500 MHz, CDCl3)
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1H-NMR spectrum of 179 (500 MHz, CDCl3)
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13C-NMR spectrum of 179 (500 MHz, CDCl3)
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1H-NMR spectrum of 181 (500 MHz, CDCl3)
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13C-NMR spectrum of 256 (500 MHz, CDCl3)
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1H-NMR spectrum of 198 (500 MHz, CDCl3)
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13C-NMR spectrum of 198 (500 MHz, CDCl3)
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1H-NMR spectrum of 250 (500 MHz, CDCl3)
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13C-NMR spectrum of 250 (500 MHz, CDCl3)
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1H-NMR spectrum of 251 (500 MHz, CDCl3)
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13C-NMR spectrum of 251 (500 MHz, CDCl3)
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1H-NMR spectrum of 199 (500 MHz, CDCl3)
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13C-NMR spectrum of 199 (500 MHz, CDCl3)
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1H-NMR spectrum of 178 (500 MHz, CDCl3)
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13C-NMR spectrum of 178 (500 MHz, CDCl3)
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1H-NMR spectrum of 154 (600 MHz, CDCl3)
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13C-NMR spectrum of 154 (600 MHz, CDCl3)
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1H-NMR spectrum of 211 (500 MHz, CDCl3)
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13C-NMR spectrum of 211 (500 MHz, CDCl3)
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1H-NMR spectrum of 240 (500 MHz, CDCl3)
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13C-NMR spectrum of 240 (500 MHz, CDCl3)
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1H-NMR spectrum of 214 and 215 (500 MHz, CDCl3)
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13C-NMR spectrum of 214 and 215 (500 MHz, CDCl3)
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1H-NMR spectrum of 241 (500 MHz, CDCl3)
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13C-NMR spectrum of 241 (500 MHz, CDCl3)
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1H-NMR spectrum of 220 (500 MHz, CDCl3)
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13C-NMR spectrum of 220 (500 MHz, CDCl3)
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1H-NMR spectrum of 219 (500 MHz, CDCl3)
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13C-NMR spectrum of 219 (500 MHz, CDCl3)
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1H-NMR spectrum of 255 (500 MHz, CDCl3)
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13C-NMR spectrum of 255 (500 MHz, CDCl3)
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1H-NMR spectrum of 222 (500 MHz, CDCl3)
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1H-NMR spectrum of 232 (500 MHz, CDCl3)
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